UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~September~~June 30, ~~2022~~2023


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number: 000-50976

HURON CONSULTING GROUP INC.

(Exact name of registrant as specified in its charter)


Delaware						01-0666114
(State or other jurisdiction of incorporation or organization)						(IRS Employer Identification Number)

550 West Van Buren Street

Chicago, Illinois

60607

(Address of principal executive offices)

(Zip Code)

(312) 583-8700

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01 per share	HURN	NASDAQ Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer

☒

Accelerated Filer

☐

Non-accelerated Filer

☐

Smaller Reporting
Company

☐

Emerging Growth Company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

As of ~~October 25, 2022, 19,933,479~~July 20, 2023, 19,024,193 shares of the registrant’s common stock, par value $0.01 per share, were outstanding.

Table of Contents


Huron Consulting Group Inc.

HURON CONSULTING GROUP INC.

INDEX

Table of Contents

PART I - FINANCIAL INFORMATION

ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS

HURON CONSULTING GROUP INC.

CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share amounts)

(Unaudited)


		September 30, 2022		December 31, 2021			June 30, 2023		December 31, 2022
Assets	Assets					Assets
Current assets:	Current assets:					Current assets:
Cash and cash equivalents	Cash and cash equivalents	$	8,831	$	20,781	Cash and cash equivalents	$	16,583	$	11,834
Receivables from clients, net of allowances of $10,494 and $8,827, respectively		166,734		122,316
Unbilled services, net of allowances of $3,992 and $2,637, respectively		122,317		91,285
Receivables from clients, net of allowances of $16,808 and $10,600, respectively						Receivables from clients, net of allowances of $16,808 and $10,600, respectively	152,300		147,852
Unbilled services, net of allowances of $3,283 and $3,850, respectively						Unbilled services, net of allowances of $3,283 and $3,850, respectively	174,409		141,781
Income tax receivable	Income tax receivable	213		8,071		Income tax receivable	6,475		960
Prepaid expenses and other current assets	Prepaid expenses and other current assets	25,524		15,229		Prepaid expenses and other current assets	29,734		26,057
Total current assets	Total current assets	323,619		257,682		Total current assets	379,501		328,484
Property and equipment, net	Property and equipment, net	26,187		31,004		Property and equipment, net	23,440		26,107
Deferred income taxes, net	Deferred income taxes, net	1,625		1,804		Deferred income taxes, net	1,397		1,554
Long-term investments	Long-term investments	95,854		72,584		Long-term investments	97,227		91,194
Operating lease right-of-use assets	Operating lease right-of-use assets	32,112		35,311		Operating lease right-of-use assets	27,829		30,304
Other non-current assets	Other non-current assets	65,993		68,191		Other non-current assets	83,777		73,039
Intangible assets, net	Intangible assets, net	25,453		31,894		Intangible assets, net	19,188		23,392
Goodwill	Goodwill	623,841		620,879		Goodwill	624,966		624,966
Total assets	Total assets	$	1,194,684	$	1,119,349	Total assets	$	1,257,325	$	1,199,040
Liabilities and stockholders’ equity	Liabilities and stockholders’ equity					Liabilities and stockholders’ equity
Current liabilities:	Current liabilities:					Current liabilities:
Accounts payable	Accounts payable	$	15,115	$	13,621	Accounts payable	$	9,720	$	14,254
Accrued expenses and other current liabilities	Accrued expenses and other current liabilities	32,016		22,519		Accrued expenses and other current liabilities	27,472		27,268
Accrued payroll and related benefits	Accrued payroll and related benefits	118,195		139,131		Accrued payroll and related benefits	126,430		171,723

Current maturities of long-term debt		—		559

Current maturities of operating lease liabilities	Current maturities of operating lease liabilities	10,414		10,142		Current maturities of operating lease liabilities	11,208		10,530
Deferred revenues	Deferred revenues	20,378		19,212		Deferred revenues	24,703		21,909
Total current liabilities	Total current liabilities	196,118		205,184		Total current liabilities	199,533		245,684
Non-current liabilities:	Non-current liabilities:					Non-current liabilities:
Deferred compensation and other liabilities	Deferred compensation and other liabilities	31,487		43,458		Deferred compensation and other liabilities	34,363		33,614

Long-term debt, net of current portion		341,000		232,221
Long-term debt						Long-term debt	395,000		290,000
Operating lease liabilities, net of current portion	Operating lease liabilities, net of current portion	48,221		54,313		Operating lease liabilities, net of current portion	41,407		45,556
Deferred income taxes, net	Deferred income taxes, net	21,597		12,273		Deferred income taxes, net	35,404		32,146
Total non-current liabilities	Total non-current liabilities	442,305		342,265		Total non-current liabilities	506,174		401,316
Commitments and contingencies	Commitments and contingencies					Commitments and contingencies
Stockholders’ equity	Stockholders’ equity					Stockholders’ equity
Common stock; $0.01 par value; 500,000,000 shares authorized; 22,853,524 and 24,364,814 shares issued, respectively		225		239
Treasury stock, at cost, 2,696,264 and 2,495,172 shares, respectively		(137,000)		(135,969)
Common stock; $0.01 par value; 500,000,000 shares authorized; 21,863,932 and 22,507,159 shares issued, respectively						Common stock; $0.01 par value; 500,000,000 shares authorized; 21,863,932 and 22,507,159 shares issued, respectively	218		223
Treasury stock, at cost, 2,840,319 and 2,711,712 shares, respectively						Treasury stock, at cost, 2,840,319 and 2,711,712 shares, respectively	(141,407)		(137,556)
Additional paid-in capital	Additional paid-in capital	336,125		413,794		Additional paid-in capital	279,070		318,706
Retained earnings	Retained earnings	335,464		276,996		Retained earnings	390,679		352,548
Accumulated other comprehensive income	Accumulated other comprehensive income	21,447		16,840		Accumulated other comprehensive income	23,058		18,119
Total stockholders’ equity	Total stockholders’ equity	556,261		571,900		Total stockholders’ equity	551,618		552,040
Total liabilities and stockholders’ equity	Total liabilities and stockholders’ equity	$	1,194,684	$	1,119,349	Total liabilities and stockholders’ equity	$	1,257,325	$	1,199,040

The accompanying notes are an integral part of the consolidated financial statements.

Table of Contents

HURON CONSULTING GROUP INC.

CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME (LOSS)

(In thousands, except per share amounts)

(Unaudited)


		Three Months Ended September 30,				Nine Months Ended September 30,					Three Months Ended June 30,				Six Months Ended June 30,
		2022		2021		2022		2021			2023		2022		2023		2022
Revenues and reimbursable expenses:	Revenues and reimbursable expenses:									Revenues and reimbursable expenses:
Revenues	Revenues	$	285,370	$	224,007	$	818,744	$	657,346	Revenues	$	346,759	$	273,325	$	664,654	$	533,374
Reimbursable expenses	Reimbursable expenses	6,816		3,690		19,034		8,876		Reimbursable expenses	8,140		7,492		16,630		12,218
Total revenues and reimbursable expenses	Total revenues and reimbursable expenses	292,186		227,697		837,778		666,222		Total revenues and reimbursable expenses	354,899		280,817		681,284		545,592
Operating expenses:	Operating expenses:									Operating expenses:
Direct costs (exclusive of depreciation and amortization included below)	Direct costs (exclusive of depreciation and amortization included below)	193,368		153,902		569,848		463,543		Direct costs (exclusive of depreciation and amortization included below)	235,198		189,233		463,581		376,480
Reimbursable expenses	Reimbursable expenses	6,917		3,914		19,249		9,233		Reimbursable expenses	8,121		7,576		16,745		12,332
Selling, general and administrative expenses	Selling, general and administrative expenses	54,458		43,576		148,886		128,574		Selling, general and administrative expenses	64,019		46,033		126,308		94,428
Restructuring charges	Restructuring charges	1,332		1,677		4,956		3,166		Restructuring charges	1,699		2,069		3,983		3,624
Depreciation and amortization	Depreciation and amortization	6,812		6,322		20,578		19,031		Depreciation and amortization	6,143		6,902		12,517		13,766

Total operating expenses	Total operating expenses	262,887		209,391		763,517		623,547		Total operating expenses	315,180		251,813		623,134		500,630
Operating income	Operating income	29,299		18,306		74,261		42,675		Operating income	39,719		29,004		58,150		44,962
Other income (expense), net:	Other income (expense), net:									Other income (expense), net:
Interest expense, net of interest income	Interest expense, net of interest income	(3,111)		(2,217)		(7,753)		(5,965)		Interest expense, net of interest income	(5,796)		(2,446)		(10,099)		(4,642)
Other income (expense), net	Other income (expense), net	(785)		(394)		18,699		2,177		Other income (expense), net	1,062		(4,881)		2,781		19,484
Total other income (expense), net	Total other income (expense), net	(3,896)		(2,611)		10,946		(3,788)		Total other income (expense), net	(4,734)		(7,327)		(7,318)		14,842
Income before taxes	Income before taxes	25,403		15,695		85,207		38,887		Income before taxes	34,985		21,677		50,832		59,804
Income tax expense	Income tax expense	7,662		1,968		26,739		6,958		Income tax expense	10,273		7,802		12,701		19,077

Net income	Net income	$	17,741	$	13,727	$	58,468	$	31,929	Net income	$	24,712	$	13,875	$	38,131	$	40,727

Earnings per share:	Earnings per share:									Earnings per share:
Net income per basic share	Net income per basic share	$	0.88	$	0.65	$	2.85	$	1.48	Net income per basic share	$	1.30	$	0.67	$	2.00	$	1.97

Net income per diluted share	Net income per diluted share	$	0.86	$	0.64	$	2.80	$	1.46	Net income per diluted share	$	1.27	$	0.66	$	1.95	$	1.94
Weighted average shares used in calculating earnings per share:	Weighted average shares used in calculating earnings per share:									Weighted average shares used in calculating earnings per share:
Basic	Basic	20,109		21,242		20,511		21,574		Basic	18,939		20,582		19,029		20,715
Diluted	Diluted	20,615		21,531		20,899		21,904		Diluted	19,486		20,967		19,598		21,047
Comprehensive income (loss):	Comprehensive income (loss):									Comprehensive income (loss):
Net income	Net income	$	17,741	$	13,727	$	58,468	$	31,929	Net income	$	24,712	$	13,875	$	38,131	$	40,727
Foreign currency translation adjustments, net of tax	Foreign currency translation adjustments, net of tax	(1,034)		(246)		(1,733)		236		Foreign currency translation adjustments, net of tax	327		(656)		379		(699)
Unrealized gain (loss) on investment, net of tax	Unrealized gain (loss) on investment, net of tax	(830)		1,158		(2,718)		(2,068)		Unrealized gain (loss) on investment, net of tax	553		773		4,426		(1,888)
Unrealized gain on cash flow hedging instruments, net of tax	Unrealized gain on cash flow hedging instruments, net of tax	3,762		309		9,058		1,956		Unrealized gain on cash flow hedging instruments, net of tax	2,463		971		134		5,296
Other comprehensive income	Other comprehensive income	1,898		1,221		4,607		124		Other comprehensive income	3,343		1,088		4,939		2,709
Comprehensive income	Comprehensive income	$	19,639	$	14,948	$	63,075	$	32,053	Comprehensive income	$	28,055	$	14,963	$	43,070	$	43,436

The accompanying notes are an integral part of the consolidated financial statements.

Table of Contents

HURON CONSULTING GROUP INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(In thousands, except share amounts)

(Unaudited)


		Three Months Ended September 30,																					Three Months Ended June 30,
		Common Stock			Treasury Stock			Additional Paid-In Capital				Retained Earnings			Accumulated Other Comprehensive Income				Stockholders’ Equity				Common Stock						Treasury Stock			Additional Paid-In Capital			Retained Earnings			Accumulated Other Comprehensive Income			Stockholders’ Equity
		Shares	Amount		Shares	Amount								Shares								Amount			Shares			Amount
Balance at June 30, 2022		23,183,446	$	232	(2,935,799)	$	(136,425)			$	374,280						$	317,723			$	19,549		$	575,359
Balance at March 31, 2023																						Balance at March 31, 2023	21,910,425			$	220		(2,970,118)	$	(141,353)		$	284,420		$	365,967		$	19,715		$	528,969
Comprehensive income	Comprehensive income											17,741			1,898				19,639			Comprehensive income													24,712			3,343			28,055
Issuance of common stock in connection with:	Issuance of common stock in connection with:																					Issuance of common stock in connection with:
Restricted stock awards, net of cancellations	Restricted stock awards, net of cancellations	36,251	—		(835)	(46)		46											—			Restricted stock awards, net of cancellations	8,683			—			3,386	145		(145)									—
Exercise of stock options	Exercise of stock options	6,000	—					236											236			Exercise of stock options	7,464			—						360									360
Share-based compensation	Share-based compensation							7,160											7,160			Share-based compensation										9,806									9,806
Shares redeemed for employee tax withholdings	Shares redeemed for employee tax withholdings				(8,020)	(529)													(529)			Shares redeemed for employee tax withholdings							(2,464)	(199)											(199)

Share repurchases	Share repurchases	(685,641)	(7)					(45,597)											(45,604)			Share repurchases	(193,648)			(2)						(15,371)									(15,373)
Balance at September 30, 2022		22,540,056	$	225	(2,944,654)	$	(137,000)	$	336,125			$	335,464		$	21,447			$	556,261
Balance at June 30, 2023																						Balance at June 30, 2023	21,732,924			$	218		(2,969,196)	$	(141,407)	$	279,070		$	390,679		$	23,058		$	551,618

Balance at June 30, 2021		24,321,728	$	243	(2,899,933)	$	(135,364)	$	429,084			$	232,211		$	11,964			538,138
Balance at March 31, 2022																						Balance at March 31, 2022	23,639,953			$	237		(2,918,100)	$	(135,367)	$	395,103		$	303,848		$	18,461		$	582,282
Comprehensive income	Comprehensive income											13,727			1,221				14,948			Comprehensive income													13,875			1,088			14,963
Issuance of common stock in connection with:	Issuance of common stock in connection with:																					Issuance of common stock in connection with:
Restricted stock awards, net of cancellations	Restricted stock awards, net of cancellations	45,190	—		1,371	77		(77)											—			Restricted stock awards, net of cancellations	27,309			—			(15,115)	(931)		931									—
Exercise of stock options	Exercise of stock options	5,000	—					191											191			Exercise of stock options	13,731			—						538									538
Share-based compensation	Share-based compensation							5,693											5,693			Share-based compensation										6,049									6,049
Shares redeemed for employee tax withholdings	Shares redeemed for employee tax withholdings				(12,489)	(616)													(616)			Shares redeemed for employee tax withholdings							(2,584)	(127)											(127)
Share repurchases	Share repurchases	(518,045)	(5)					(24,981)											(24,986)			Share repurchases	(497,547)			(5)						(28,341)									(28,346)
Balance at September 30, 2021		23,853,873	$	238	(2,911,051)	$	(135,903)	$	409,910			$	245,938		$	13,185			$	533,368
Balance at June 30, 2022																						Balance at June 30, 2022	23,183,446			$	232		(2,935,799)	$	(136,425)	$	374,280		$	317,723		$	19,549		$	575,359


		Nine Months Ended September 30,
		Common Stock			Treasury Stock			Additional Paid-In Capital			Retained Earnings				Accumulated Other Comprehensive Income			Stockholders’ Equity				Six Months Ended June 30,
														Common Stock									Treasury Stock						Additional Paid-In Capital				Retained Earnings					Accumulated Other Comprehensive Income				Stockholders’ Equity
																						Shares			Amount			Shares								Amount
Balance at December 31, 2022																					Balance at December 31, 2022	22,231,593			$	223		(2,953,147)					$	(137,556)				$	318,706						$	352,548					$	18,119				$	552,040
Comprehensive income																					Comprehensive income																				38,131						4,939						43,070
Issuance of common stock in connection with:																					Issuance of common stock in connection with:
Restricted stock awards, net of cancellations																					Restricted stock awards, net of cancellations	306,264			3			121,835				5,877					(5,880)																—
Exercise of stock options																					Exercise of stock options	21,609			—												987																987
Share-based compensation																					Share-based compensation																24,895																24,895
Shares redeemed for employee tax withholdings																					Shares redeemed for employee tax withholdings							(137,884)				(9,728)																					(9,728)
Share repurchases																					Share repurchases	(826,542)			(8)												(59,638)																(59,646)
Balance at June 30, 2023																					Balance at June 30, 2023	21,732,924			$	218		(2,969,196)				$	(141,407)				$	279,070			$	390,679					$	23,058					$	551,618
		Shares	Amount		Shares	Amount				Additional Paid-In Capital							Retained Earnings					Accumulated Other Comprehensive Income			Stockholders’ Equity
Balance at December 31, 2021	Balance at December 31, 2021	23,868,918	$	239	(2,908,849)	$	(135,969)						Balance at December 31, 2021	23,868,918				$	239					(2,908,849)				$		(135,969)			$	413,794				$	276,996			$	16,840					$	571,900
Comprehensive income	Comprehensive income										58,468				4,607					63,075			Comprehensive income																					40,727						2,709					43,436
Issuance of common stock in connection with:	Issuance of common stock in connection with:																				Issuance of common stock in connection with:
Restricted stock awards, net of cancellations	Restricted stock awards, net of cancellations	341,189	3		114,290	6,509		(6,512)													—		Restricted stock awards, net of cancellations	304,938			3				115,125				6,555					(6,558)															—
Exercise of stock options	Exercise of stock options	36,536	—					1,421										1,421			Exercise of stock options	30,536			—												1,185																1,185
Share-based compensation	Share-based compensation							25,260										25,260			Share-based compensation																18,100																18,100
Shares redeemed for employee tax withholdings	Shares redeemed for employee tax withholdings				(150,095)	(7,540)												(7,540)			Shares redeemed for employee tax withholdings							(142,075)				(7,011)																					(7,011)
Share repurchases	Share repurchases	(1,706,587)	(17)					(97,838)										(97,855)			Share repurchases	(1,020,946)			(10)												(52,241)																(52,251)
Balance at September 30, 2022		22,540,056	$	225	(2,944,654)	$	(137,000)	$	336,125		$	335,464			$	21,447		$	556,261

Balance at December 31, 2020		24,560,855	$	246	(2,812,896)	$	(129,886)	$	454,512		$	214,009			$	13,061		$	551,942
Comprehensive income											31,929				124			32,053
Issuance of common stock in connection with:
Restricted stock awards, net of cancellations		443,741	4		82,380	3,250		(3,254)										—
Exercise of stock options		18,403	—					613										613
Share-based compensation								18,256										18,256
Shares redeemed for employee tax withholdings					(180,535)	(9,267)												(9,267)
Share repurchases		(1,169,126)	(12)					(60,217)										(60,229)
Balance at September 30, 2021		23,853,873	$	238	(2,911,051)	$	(135,903)	$	409,910		$	245,938			$	13,185		$	533,368
Balance at June 30, 2022																					Balance at June 30, 2022	23,183,446			$	232		(2,935,799)				$	(136,425)				$	374,280			$	317,723					$	19,549					$	575,359

The accompanying notes are an integral part of the consolidated financial statements.

Table of Contents

HURON CONSULTING GROUP INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)


		Nine Months Ended September 30,					Six Months Ended June 30,
		2022		2021			2023		2022
Cash flows from operating activities:	Cash flows from operating activities:					Cash flows from operating activities:
Net income	Net income	$	58,468	$	31,929	Net income	$	38,131	$	40,727
Adjustments to reconcile net income to cash flows from operating activities:	Adjustments to reconcile net income to cash flows from operating activities:					Adjustments to reconcile net income to cash flows from operating activities:
Depreciation and amortization	Depreciation and amortization	20,578		19,245		Depreciation and amortization	12,549		13,766
Non-cash lease expense	Non-cash lease expense	4,768		4,912		Non-cash lease expense	3,340		3,174

Lease-related impairment charge						Lease-related impairment charge	2,086		—

Share-based compensation	Share-based compensation	23,083		17,979		Share-based compensation	23,151		15,166
Amortization of debt discount and issuance costs	Amortization of debt discount and issuance costs	595		595		Amortization of debt discount and issuance costs	382		397

Allowances for doubtful accounts	Allowances for doubtful accounts	47		7		Allowances for doubtful accounts	53		47
Deferred income taxes	Deferred income taxes	7,133		2,434		Deferred income taxes	1,755		7,089
Gain on sale of property and equipment, excluding transaction costs		(1,117)		(254)
(Gain) loss on sale of property and equipment, excluding transaction costs						(Gain) loss on sale of property and equipment, excluding transaction costs	1		(1,117)

Change in fair value of contingent consideration liabilities	Change in fair value of contingent consideration liabilities	(34)		98		Change in fair value of contingent consideration liabilities	(233)		33
Change in fair value of preferred stock investment	Change in fair value of preferred stock investment	(26,964)		—		Change in fair value of preferred stock investment	—		(26,964)
Other, net		6		(78)

Changes in operating assets and liabilities, net of acquisitions and divestiture:	Changes in operating assets and liabilities, net of acquisitions and divestiture:					Changes in operating assets and liabilities, net of acquisitions and divestiture:
(Increase) decrease in receivables from clients, net	(Increase) decrease in receivables from clients, net	(44,759)		(23,294)		(Increase) decrease in receivables from clients, net	(4,440)		(28,825)
(Increase) decrease in unbilled services, net	(Increase) decrease in unbilled services, net	(31,937)		(40,883)		(Increase) decrease in unbilled services, net	(32,567)		(28,329)
(Increase) decrease in current income tax receivable / payable, net	(Increase) decrease in current income tax receivable / payable, net	14,704		3,159		(Increase) decrease in current income tax receivable / payable, net	(6,141)		9,394
(Increase) decrease in other assets	(Increase) decrease in other assets	3,468		98		(Increase) decrease in other assets	(4,880)		3,984
Increase (decrease) in accounts payable and other liabilities	Increase (decrease) in accounts payable and other liabilities	(14,538)		2,229		Increase (decrease) in accounts payable and other liabilities	(5,594)		(13,524)
Increase (decrease) in accrued payroll and related benefits	Increase (decrease) in accrued payroll and related benefits	(18,883)		(35,958)		Increase (decrease) in accrued payroll and related benefits	(44,277)		(43,420)
Increase (decrease) in deferred revenues	Increase (decrease) in deferred revenues	(397)		(10,424)		Increase (decrease) in deferred revenues	2,804		(1,834)
Net cash used in operating activities	Net cash used in operating activities	(5,779)		(28,206)		Net cash used in operating activities	(13,880)		(50,236)
Cash flows from investing activities:	Cash flows from investing activities:					Cash flows from investing activities:
Purchases of property and equipment	Purchases of property and equipment	(9,768)		(8,918)		Purchases of property and equipment	(3,725)		(6,800)

Investment in life insurance policies	Investment in life insurance policies	(283)		(574)		Investment in life insurance policies	(2,188)		—
Distributions from life insurance policies	Distributions from life insurance policies	2,958		—		Distributions from life insurance policies	2,956		—
Purchases of business, net of cash acquired		(1,948)		(5,886)
Purchases of businesses						Purchases of businesses	38		(1,948)
Capitalization of internally developed software costs	Capitalization of internally developed software costs	(6,855)		(3,603)		Capitalization of internally developed software costs	(12,998)		(3,974)
Proceeds from note receivable	Proceeds from note receivable	157		—		Proceeds from note receivable	154		157
Proceeds from sale of property and equipment	Proceeds from sale of property and equipment	4,753		255		Proceeds from sale of property and equipment	—		4,750
Divestiture of business	Divestiture of business	207		—		Divestiture of business	—		207
Net cash used in investing activities	Net cash used in investing activities	(10,779)		(18,726)		Net cash used in investing activities	(15,763)		(7,608)
Cash flows from financing activities:	Cash flows from financing activities:					Cash flows from financing activities:
Proceeds from exercises of stock options	Proceeds from exercises of stock options	1,421		613		Proceeds from exercises of stock options	987		1,185
Shares redeemed for employee tax withholdings	Shares redeemed for employee tax withholdings	(7,540)		(9,267)		Shares redeemed for employee tax withholdings	(9,728)		(7,011)
Share repurchases	Share repurchases	(95,474)		(60,229)		Share repurchases	(60,368)		(52,443)
Proceeds from bank borrowings	Proceeds from bank borrowings	287,000		189,000		Proceeds from bank borrowings	230,000		224,000
Repayments of bank borrowings	Repayments of bank borrowings	(178,780)		(129,362)		Repayments of bank borrowings	(125,000)		(114,780)

Deferred payments on business acquisitions		(1,875)		—
Net cash provided by (used in) financing activities		4,752		(9,245)
Payments for debt issuance costs						Payments for debt issuance costs	(58)		—
Deferred payments on business acquisition						Deferred payments on business acquisition	(1,500)		(1,875)
Net cash provided by financing activities						Net cash provided by financing activities	34,333		49,076
Effect of exchange rate changes on cash	Effect of exchange rate changes on cash	(144)		189		Effect of exchange rate changes on cash	59		(55)
Net decrease in cash and cash equivalents		(11,950)		(55,988)
Net increase (decrease) in cash and cash equivalents						Net increase (decrease) in cash and cash equivalents	4,749		(8,823)
Cash and cash equivalents at beginning of the period	Cash and cash equivalents at beginning of the period	20,781		67,177		Cash and cash equivalents at beginning of the period	11,834		20,781
Cash and cash equivalents at end of the period	Cash and cash equivalents at end of the period	$	8,831	$	11,189	Cash and cash equivalents at end of the period	$	16,583	$	11,958
Supplemental disclosure of cash flow information:	Supplemental disclosure of cash flow information:					Supplemental disclosure of cash flow information:
Non-cash investing and financing activities:	Non-cash investing and financing activities:					Non-cash investing and financing activities:
Property and equipment expenditures and capitalized software included in accounts payable, accrued expenses and accrued payroll and related benefits		$	3,474	$	2,140
Operating lease right-of-use asset obtained in exchange for operating lease liability		$	1,908	$	2,960
Property and equipment expenditures and capitalized software included in current liabilities						Property and equipment expenditures and capitalized software included in current liabilities	$	4,437	$	3,134
Operating lease right-of-use assets obtained in exchange for operating lease liabilities						Operating lease right-of-use assets obtained in exchange for operating lease liabilities	$	1,839	$	102
Contingent consideration related to purchase of business	Contingent consideration related to purchase of business	$	869	$	—	Contingent consideration related to purchase of business	$	—	$	869
Share repurchases included in accounts payable		$	2,572	$	—
Excise tax on net share repurchases included in current liabilities						Excise tax on net share repurchases included in current liabilities	$	385	$	—

The accompanying notes are an integral part of the consolidated financial statements.

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

1. Description of Business

Huron is a global professional services firm that ~~creates innovative~~partners with clients to develop growth strategies, ~~optimizes~~optimize operations and ~~accelerates~~accelerate digital transformation using an enterprise portfolio of technology, data and analytics solutions to empower clients to own their future. By collaborating with clients, embracing diverse perspectives, encouraging new ideas and challenging the status quo, we create sustainable results for the organizations we serve.

We provide our services and products and manage our business ~~under~~through three operating segments: Healthcare, Education and Commercial. See Note 1413 “Segment Information” for ~~a discussion of our three segments.~~

~~Effective January 1, 2022, we modified our operating model to expand and~~ more deeply integrate our industry expertise with our digital, strategic and financial advisory capabilities. The new operating model will strengthen Huron’s go-to-market strategy, drive efficiencies that support margin expansion, and position the company to accelerate growth.

To align with the new operating model, effective with reporting for periods beginning January 1, 2022, we began reporting under the following three industries, which are our reportable segments: Healthcare, Education and Commercial. The Commercial segment includes all industries outside of healthcare and education, including, but not limited to, financial services and energy and utilities. In the new reporting structure, each segment includes all revenue and costs associated with engagements delivered in the respective segments' industries. The new Healthcare and Education segments include some revenue and costs historically reported in the Business Advisory segment and the Healthcare segment includes some revenue and costs historically reported in the Education segment. We also provide revenue reporting across two principal capabilities: i) Consulting and Managed Services and ii) Digital. These changes create greater transparency for investors by improving visibility into the core drivers of our business.information.

2. Basis of Presentation and Significant Accounting Policies

The accompanying unaudited consolidated financial statements reflect the financial position, results of operations, and cash flows as of and for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021.~~2022. These financial statements have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission ("SEC") for Quarterly Reports on Form 10-Q. Accordingly, these financial statements do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America ("GAAP") for annual financial statements. In the opinion of management, these financial statements reflect all adjustments of a normal, recurring nature necessary for the fair statement of our financial position, results of operations, and cash flows for the interim periods presented in conformity with GAAP. These financial statements should be read in conjunction with our consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, ~~2021~~2022 and our Quarterly ~~Reports~~Report on Form 10-Q for the ~~periods~~period ended March 31, ~~2022 and June 30, 2022.~~2023. Our results for any interim period are not necessarily indicative of results for a full year or any other interim period.

In order to better align with industry standards, in the first quarter of 2022, we revised the presentation of our consolidated statement of operations and other comprehensive income (loss) to present depreciation and amortization expense inclusive of amortization of intangible assets and software development costs previously presented within total direct costs and reimbursable expenses. We also aggregated immaterial line items within selling, general and administrative expenses. The change in presentation has no effect on our consolidated results, and our historical consolidated statements of operations and other comprehensive income (loss) were revised for consistent presentation.

Preparation of our consolidated financial statements requires management to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and related disclosures. The business and economic uncertainty resulting from the coronavirus (COVID-19) pandemic has made such estimates and assumptions more difficult to predict. Accordingly, actual results and outcomes could differ from those estimates.

3. ~~New Accounting Pronouncements~~

~~Not Yet Adopted~~

~~In March 2020, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2020-04,~~ ~~Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. In January 2021, the FASB clarified the scope of that guidance with the issuance of ASU 2021-01,~~ ~~Reference Rate Reform (Topic 848): Scope. Together, these ASUs provide optional expedients and exceptions for a limited period of time to ease the potential burden in accounting for, or recognizing the effects of,~~

~~Table of Contents~~

~~HURON CONSULTING GROUP INC.~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Tabular amounts in thousands, except per share amounts)~~

~~(Unaudited)~~

reference rate reform on financial reporting under GAAP. These ASUs are optional and may be applied by entities after March 12, 2020, but no later than December 31, 2022. Our senior secured credit facility and related interest rate swaps are indexed to LIBOR, and we expect to adopt this standard when LIBOR is discontinued and a successor rate is established under these contracts. We do not expect the adoption of these ASUs to have a material impact on our consolidated financial statements.

4. Goodwill and Intangible Assets

The table below sets forth the changes in the carrying amount of goodwill by reportable segment for the ~~nine~~six months ended ~~September~~June 30, ~~2022.~~2023.

Healthcare Education
Commercial(1)
Total
Balance as of December 31, 2021:
Goodwill $ 642,951 $ 121,570 $ 312,250 $ 1,076,771
Accumulated impairment losses (208,081) — (247,811) (455,892)
Goodwill, net as of December 31, 2021 434,870 121,570 64,439 620,879
Goodwill reallocation(1)
18,057 (1,417) (16,640) —
Goodwill recorded in connection with business acquisitions(2)(3)
162 2,082 718 2,962
Goodwill, net as of September 30, 2022 $ 453,089 $ 122,235 $ 48,517 $ 623,841

~~(1)~~The goodwill balance as of December 31, 2021 shown within the Commercial segment related to our Business Advisory segment prior to the modification of our operating model. Effective January 1, 2022, we reallocated a portion of the goodwill within our Business Advisory segment to our Healthcare and Education segments. The remaining goodwill was allocated to our new Commercial segment.

~~(2)~~On January 18, 2022, we completed the acquisition of AIMDATA, LLC ("AIMDATA"), an advisory and implementation consulting services firm focused on strategy, technology and business transformation. The results of operations of AIMDATA are included within our consolidated financial statements as of the acquisition date and allocated among our three operating industries, which are our reportable segments, based on the engagements delivered by the business. The acquisition of AIMDATA is not significant to our consolidated financial statements.

~~(3)~~In the first quarter of 2022, we finalized the measurement of assets acquired, including goodwill, and liabilities assumed in the acquisition of Whiteboard Communications Ltd. ("Whiteboard"), a student enrollment advisory firm that helps colleges and universities with recruitment initiatives and financial aid strategies that we acquired in December 2021. The results of operations of Whiteboard are included in our consolidated financial statements and results of operations of our Education segment from the date of acquisition.

~~First Quarter 2022 Goodwill Reallocation~~

Effective January 1, 2022, we modified our operating model to expand and more deeply integrate our industry expertise with our digital, strategic and financial advisory capabilities. To align with the new operating model, effective with reporting for periods beginning January 1, 2022, we began reporting under the following three industries, which are our reportable segments: Healthcare, Education and Commercial. The Commercial segment includes all industries outside of healthcare and education, including, but not limited to, financial services and energy and utilities. In the new reporting structure, each segment includes all revenue and costs associated with engagements delivered in the respective segments' industries. The new Healthcare and Education segments include some revenue and costs historically reported in the Business Advisory segment and the Healthcare segment includes some revenue and costs historically reported in the Education segment.

~~Table of Contents~~

~~HURON CONSULTING GROUP INC.~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Tabular amounts in thousands, except per share amounts)~~

~~(Unaudited)~~

The three reportable segments of Healthcare, Education and Commercial are also our reporting units for goodwill impairment testing purposes. As a result of the reorganization, we reallocated the goodwill balances of our historical reporting units to our new reporting units based on the relative estimated fair values of each component of the historical reporting units to be allocated to the new reporting units. Additionally, we performed a goodwill impairment test on the goodwill balances of each of our reporting units as of January 1, 2022 by comparing the fair value of the reporting unit to its carrying value, including the reallocated goodwill. Based on the results of the goodwill impairment test, we determined the fair values of the Healthcare, Education, and Commercial reporting units exceeded their carrying values by 37%, 199%, and 105%, respectively. As such, we concluded that there was no indication of goodwill impairment for all three reporting units as of January 1, 2022.

We relied on the income approach to estimate the fair value of the reporting units for both the goodwill reallocation and the goodwill impairment test. The income approach utilized a discounted cash flow analysis, which involved estimating the expected after-tax cash flows that will be generated by each business and then discounting those cash flows to present value, reflecting the relevant risks associated with each reporting unit and the time value of money. This approach requires the use of significant estimates and assumptions, including forecasted revenue growth rates, forecasted EBITDA margins, and discount rates that reflect the risk inherent in the future cash flows. In estimating future cash flows, we relied on internally generated ten-year forecasts. Our forecasts are based on historical experience, current backlog, expected market demand, and other industry information.


	Healthcare		Education		Commercial		Total
Balance as of December 31, 2022:
Goodwill	$	644,238	$	123,652	$	312,968	$	1,080,858
Accumulated impairment losses	(190,024)		(1,417)		(264,451)		(455,892)
Goodwill, net as of December 31, 2022	$	454,214	$	122,235	$	48,517	$	624,966


Goodwill, net as of June 30, 2023	$	454,214	$	122,235	$	48,517	$	624,966

Intangible Assets

Intangible assets as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021~~2022 consisted of the following:


			As of September 30, 2022				As of December 31, 2021						As of June 30, 2023				As of December 31, 2022
		Useful Life (in years)	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization			Useful Life (in years)	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Customer relationships	Customer relationships	6 to 13	$	73,942	$	55,361	$	75,908	$	53,421	Customer relationships	5 to 13	$	65,083	$	50,630	$	74,583	$	57,219
Technology and software	Technology and software	2 to 5	13,330		7,383		13,330		5,607		Technology and software	2 to 5	13,330		9,051		13,330		7,975
Trade names	Trade names	6	6,000		5,717		6,000		5,148		Trade names	6	6,000		6,000		6,000		5,907
Non-competition agreements	Non-competition agreements	2 to 5	920		278		2,020		1,347		Non-competition agreements	2 to 5	920		464		920		340
Customer contracts		1	—		—		260		101

Total	Total		$	94,192	$	68,739	$	97,518	$	65,624	Total		$	85,333	$	66,145	$	94,833	$	71,441

Identifiable intangible assets with finite lives are amortized over their estimated useful lives. Customer relationships ~~and customer contracts,~~ as well as certain trade names and technology and software, are amortized on an accelerated basis to correspond to the cash flows expected to be derived from the assets. All other intangible assets with finite lives are amortized on a straight-line basis.

Intangible asset amortization expense was $2.8 million and $2.2 million for the three months ended September 30, 2022 and 2021, respectively; and $8.5 million and $6.9 million for the nine months ended September 30, 2022 and 2021. The table below sets forth the estimated annual amortization expense for the intangible assets recorded as of September 30, 2022.

Year Ending December 31, Estimated Amortization Expense
2022 $ 11,198
2023 $ 7,904
2024 $ 4,514
2025 $ 3,386
2026 $ 2,435

~~Actual future amortization expense could differ from these estimated amounts as a result of future acquisitions, dispositions, and other factors.~~

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

5.Intangible asset amortization expense was $2.0 million and $2.8 million for the three months ended June 30, 2023 and 2022, respectively; and $4.2 million and $5.7 million for the six months ended June 30, 2023 and 2022, respectively. The table below sets forth the estimated annual amortization expense for the intangible assets recorded as of June 30, 2023.


Year Ending December 31,	Estimated Amortization Expense
2023	$	8,122
2024	$	4,674
2025	$	3,503
2026	$	2,519
2027	$	1,773

Actual future amortization expense could differ from these estimated amounts as a result of future acquisitions, dispositions, and other factors.

4. Revenues

For the three months ended ~~September~~June 30, ~~2022~~2023 and ~~2021, we recognized revenues of $285.4 million and $224.0 million, respectively. Of the $285.4 million recognized in the third quarter of~~ 2022, we recognized revenues of ~~$3.5~~$346.8 million ~~from obligations satisfied, or partially satisfied, in prior periods, which was primarily due to the release of allowances on receivables from clients~~ and ~~unbilled services.~~$273.3 million, respectively. Of the ~~$224.0~~$346.8 million recognized in the ~~third~~second quarter of ~~2021,~~2023, we recognized revenues of ~~$4.3~~$14.8 million from obligations satisfied, or partially satisfied, in prior periods, of which $2.2 million was due to the release of allowances on receivables from clients and unbilled services and $2.1 million was primarily due to changes in the estimates of our variable consideration under performance-based billing arrangements.

For the nine months ended September 30, 2022 and 2021, we recognized revenues of $818.7 million and $657.3 million, respectively. Of the $818.7 million recognized in the first nine months of 2022, we recognized revenues of $4.7 million from obligations satisfied, or partially satisfied, in prior periods, of which $2.5$12.6 million was due to changes in the estimates of our variable consideration under performance-based billing arrangements and $2.2 million was ~~primarily~~ due to the release of allowances on receivables from clients and unbilled services. Of the ~~$657.3~~$273.3 million recognized in the ~~first nine months~~second quarter of ~~2021,~~2022, we recognized revenues of ~~$22.1~~$5.1 million from obligations satisfied, or partially satisfied, in prior periods, of which ~~$14.6~~$3.7 million was primarily due to changes in the estimates of our variable consideration under performance-based billing arrangements, and $1.4 million was primarily due to the release of allowances on receivables from clients and unbilled services.

For the six months ended June 30, 2023 and 2022, we recognized revenues of $664.7 million and $533.4 million, respectively. Of the $664.7 million recognized in the first six months of 2023, we recognized revenues of $6.3 million from obligations satisfied, or partially satisfied, in prior periods, of which $5.0 million was due to changes in the estimates of our variable consideration under performance-based billing arrangements, and ~~$7.5~~$1.3 million was primarily due to the release of allowances on receivables from clients and unbilled services. Of the $533.4 million recognized in the first six months of 2022, we recognized revenues of $3.4 million from obligations satisfied, or partially satisfied, in prior periods, of which $2.1 million was due to changes in the estimates of our variable consideration under performance-based billing arrangements, and $1.3 million was primarily due to the release of allowances on receivables from clients and unbilled services.

As of ~~September~~June 30, ~~2022,~~2023, we had ~~$156.3~~$240.0 million of remaining performance obligations under engagements with original expected durations greater than one year. These remaining performance obligations exclude variable consideration which has been excluded from the total transaction price due to the constraint and performance obligations under time-and-expense engagements which are recognized in the amount invoiced. Of the ~~$156.3~~$240.0 million of performance obligations, we expect to recognize ~~approximately $23.8~~$54.1 million as revenue in ~~2022, $63.8~~2023, $66.3 million in ~~2023,~~2024, and the remaining ~~$68.7~~$119.6 million thereafter. Actual revenue recognition could differ from these amounts as a result of changes in the estimated timing of work to be performed, adjustments to estimated variable consideration in performance-based arrangements, or other factors.

Contract Assets and Liabilities

The payment terms and conditions in our customer contracts vary. Differences between the timing of billings and the recognition of revenue are recognized as either unbilled services or deferred revenues in the consolidated balance sheets.

Unbilled services include revenues recognized for services performed but not yet billed to clients. Services performed that we are not yet entitled to bill because certain events, such as the completion of the measurement period or client approval in performance-based engagements, must occur are recorded as contract assets and included within unbilled services, net. The contract asset balance as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021~~2022 was ~~$28.2~~$43.7 million and ~~$23.7~~$50.2 million, respectively. The ~~$4.5~~$6.5 million ~~increase~~decrease primarily reflects timing differences between the completion of our performance obligations and the amounts billed or billable to clients in accordance with their contractual billing terms.

Client prepayments and retainers are classified as deferred revenues and recognized over future periods in accordance with the applicable engagement agreement and our revenue recognition accounting policy. Our deferred revenues balance as of ~~September~~June 30, ~~2022~~2023 and December 31, 2021, was $20.4 million and $19.2 million, respectively. The $1.2 million increase primarily reflects timing differences between client payments in accordance with their contract terms and the completion of our performance obligations. For the three and nine months ended September 30, 2022, $1.5 million and $18.0 million of revenues recognized were included in the deferred revenues balance as of December 31, 2021.

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

6.December 31, 2022, was $24.7 million and $21.9 million, respectively. The $2.8 million increase primarily reflects timing differences between client payments in accordance with their contract terms and the completion of our performance obligations. For the three and six months ended June 30, 2023, $3.9 million and $20.3 million of revenues recognized were included in the deferred revenue balance as of December 31, 2022, respectively.

5. Earnings Per Share

Basic earnings per share excludes dilution and is computed by dividing net income by the weighted average number of common shares outstanding for the period, excluding unvested restricted common stock. Diluted earnings per share reflects the potential reduction in earnings per share that could occur if securities or other contracts to issue common stock were exercised or converted into common stock under the treasury stock method. Such securities or other contracts include unvested restricted stock awards, unvested restricted stock units, and outstanding common stock options, to the extent dilutive. In periods for which we report a net loss, diluted weighted average common shares outstanding excludes all potential common stock equivalents as their impact on diluted net loss per share would be anti-dilutive.

Earnings per share under the basic and diluted computations are as follows:


		Three Months Ended September 30,				Nine Months Ended September 30,					Three Months Ended June 30,				Six Months Ended June 30,
		2022		2021		2022		2021			2023		2022		2023		2022
Net income	Net income	$	17,741	$	13,727	$	58,468	$	31,929	Net income	$	24,712	$	13,875	$	38,131	$	40,727

Weighted average common shares outstanding – basic	Weighted average common shares outstanding – basic	20,109		21,242		20,511		21,574		Weighted average common shares outstanding – basic	18,939		20,582		19,029		20,715
Weighted average common stock equivalents	Weighted average common stock equivalents	506		289		388		330		Weighted average common stock equivalents	547		385		569		332
Weighted average common shares outstanding – diluted	Weighted average common shares outstanding – diluted	20,615		21,531		20,899		21,904		Weighted average common shares outstanding – diluted	19,486		20,967		19,598		21,047

Net income per basic share	Net income per basic share	$	0.88	$	0.65	$	2.85	$	1.48	Net income per basic share	$	1.30	$	0.67	$	2.00	$	1.97
Net income per diluted share	Net income per diluted share	$	0.86	$	0.64	$	2.80	$	1.46	Net income per diluted share	$	1.27	$	0.66	$	1.95	$	1.94

The number of anti-dilutive securities excluded from the computation of the weighted average common stock equivalents presented above for the three and ~~nine~~six months ended ~~September~~June 30, 2023 and 2022 ~~and 2021~~ were both less than 0.1 million shares, and related to unvested restricted stock and outstanding common stock options.

In November 2020, our board of directors authorized a share repurchase program permitting us to repurchase up to $50 million of our common stock through December 31, 2021. ~~Through~~Subsequent to the ~~third quarter of 2022,~~initial authorization, our board of directors authorized extensions of the share repurchase program through December 31, 2023 and increased the authorized amount ~~to $200 million. In the fourth quarter of 2022, our board of directors increased the authorized amount under the share repurchase program from $200 million~~ to $300 million. The amount and timing of repurchases under the share repurchase program were and will continue to be determined by management and depend on a variety of factors, including the trading price of our common stock, capacity under our credit facility, general market and business conditions, and applicable legal requirements. All shares repurchased and retired are reflected as a reduction to our basic weighted average shares outstanding based on the trade date of the share repurchase.

In the three and ~~nine~~six months ended ~~September~~June 30, 2023, we repurchased and retired 193,648 and 826,542 shares for $15.4 million and $59.6 million, respectively. Additionally, in the first quarter of 2023, we settled the repurchase of 15,200 shares for $1.1 million which were accrued as of December 31, 2022. In the three and six months ended June 30, 2022, we repurchased and retired ~~685,641~~497,547 and ~~1,706,587~~1,020,946 shares for ~~$45.6~~$28.3 million and ~~$97.9~~$52.2 million, ~~respectively, including 38,568 shares for $2.6 million which were settled in the fourth quarter of 2022.~~respectively. Additionally in the first quarter of 2022, we settled the repurchase of 3,820 shares for $0.2 million that were accrued as of December 31, 2021. ~~In the three and nine months ended September 30, 2021, we repurchased and retired 518,045 and 1,169,126 shares for $25.0 million and $60.2 million, respectively.~~ As of ~~September~~June 30, ~~2022, $32.3~~2023, $49.6 million remained available for share repurchases under our share repurchase program.

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

7.6. Financing Arrangements

~~A summary of the carrying amounts of our debt follows:~~
September 30, 2022 December 31, 2021
Senior secured credit facility $ 341,000 $ 230,000
Promissory note due 2024 — 2,780
Total long-term debt 341,000 232,780
Current maturities of long-term debt — (559)
Long-term debt, net of current portion $ 341,000 $ 232,221

~~Senior Secured Credit Facility~~

The Company has a $600 million five-year senior secured revolving credit facility, subject to the terms of a ~~Second~~Third Amended and Restated Credit Agreement dated as of ~~March 31, 2015, as amended to date~~November 15, 2022 (as amended, ~~and modified~~ the "Amended Credit Agreement"), that becomes due and payable in full upon maturity on ~~September 27, 2024.~~November 15, 2027. The Amended Credit Agreement provides the option to increase the revolving credit facility or establish term loan facilities in an aggregate amount of up to ~~$150~~$250 million, subject to customary conditions and the approval of any lender whose commitment would be increased, resulting in a maximum available principal amount under the Amended Credit Agreement of ~~$750~~$850 million. The initial borrowings under the Amended Credit Agreement were used to refinance borrowings outstanding under a prior credit agreement, and future borrowings under the Amended Credit Agreement may be used for working capital, capital expenditures, ~~acquisitions of businesses,~~ share repurchases, permitted acquisitions, and other general corporate purposes.

Fees and interest on borrowings vary based on our Consolidated Leverage Ratio (as defined in the Amended Credit Agreement). At our option, borrowings under the Amended Credit Agreement will bear interest at one, ~~two,~~ three or ~~six-month LIBOR~~six month Term SOFR or an alternate base rate, in each case plus the applicable margin. The applicable margin will fluctuate between 1.125% per annum and 1.875% per annum, in the case of ~~LIBOR~~Term SOFR borrowings, or between 0.125% per annum and 0.875% per annum, in the case of base rate loans, based upon our Consolidated Leverage Ratio at such time.

In April 2023, the Company and PNC Capital Markets, LLC, as Sustainability Structuring Agent, with the consent of the Required Lenders (as defined in the Amended Credit Agreement), entered into the first amendment to the Amended Credit Agreement (the "First Amendment") to incorporate specified key performance indicators with respect to certain environmental, social and governance targets of the Company. Based upon the performance of the Company against those key performance indicators in each Reference Year (as defined in the First Amendment), certain adjustments to the otherwise applicable rates for interest, commitment fees and letter of credit fees will be made. These annual adjustments will not exceed an increase or decrease of 0.01% in the aggregate for all key performance indicators in the case of the commitment fee rate or an increase or decrease of 0.05% in the aggregate for all key performance indicators in the case of the Term SOFR borrowings, base rate borrowings or letter of credit fee rate.

Amounts borrowed under the Amended Credit Agreement may be prepaid at any time without premium or penalty. We are required to prepay the amounts outstanding under the Amended Credit Agreement in certain circumstances, including upon an Event of Default (as defined in the Amended Credit Agreement). In addition, we have the right to permanently reduce or terminate the unused portion of the commitments provided under the Amended Credit Agreement at any time.

The loans and obligations under the Amended Credit Agreement are secured pursuant to a ~~Second~~Third Amended and Restated Security Agreement and a ~~Second~~Third Amended and Restated Pledge Agreement (the “Pledge Agreement”) with Bank of America, N.A. as collateral agent, pursuant to which the Company and the subsidiary guarantors grant Bank of America, N.A., for the ratable benefit of the lenders under the Amended Credit Agreement, a first-priority lien, subject to permitted liens, on substantially all of the personal property assets of the Company and the subsidiary guarantors, and a pledge of 100% of the stock or other equity interests in all domestic subsidiaries and 65% of the stock or other equity interests in each “material first-tier foreign subsidiary” (as defined in the Pledge Agreement). entitled to vote and 100% of the stock or other equity interests in each material first-tier foreign subsidiary not entitled to vote.

The Amended Credit Agreement contains usual and customary representations and warranties; affirmative and negative covenants, which include limitations on liens, investments, additional indebtedness, and restricted payments; and two quarterly financial covenants as follows: (i) a maximum Consolidated Leverage Ratio (defined as the ratio of debt to consolidated EBITDA) of 3.75 to 1.00; however the maximum permitted Consolidated Leverage Ratio will increase to ~~4.00~~4.25 to 1.00 upon the occurrence of ~~certain transactions,~~a Qualified Acquisition (as defined in the Amended Credit Agreement), and (ii) a minimum Consolidated Interest Coverage Ratio (defined as the ratio of consolidated EBITDA to interest) of ~~3.50~~3.00 to 1.00. Consolidated EBITDA for purposes of the financial covenants is calculated on a continuing operations basis and includes adjustments to add back non-cash goodwill impairment charges, share-based compensation costs, certain non-cash restructuring charges, pro forma historical EBITDA for businesses acquired, and other specified items in accordance with the Amended Credit Agreement. For purposes of the Consolidated Leverage Ratio total debt is on a gross basis and is not netted against our cash balances. At ~~September~~June 30, ~~2022,~~2023, we were in compliance with these financial covenants with a Consolidated Leverage Ratio of ~~2.06~~2.17 to 1.00 and a Consolidated Interest Coverage Ratio of ~~18.36~~11.23 to 1.00.

Borrowings outstanding under the Amended Credit Agreement at ~~September~~June 30, ~~2022~~2023 totaled ~~$341.0 million.~~$395.0 million and are classified as long-term debt in our consolidated balance sheet. These borrowings carried a weighted average interest rate of ~~3.6%~~4.6%, including the effect of the interest rate swaps described in Note 98 “Derivative Instruments and Hedging Activity.” Borrowings outstanding under the Amended Credit Agreement at December 31, ~~2021~~2022 were ~~$230.0~~$290.0 million and carried a weighted average interest rate of ~~2.7%~~3.8%, including the effect of the interest rate ~~swaps.~~swaps in effect at that time. The borrowing capacity under the revolving credit facility is reduced by any outstanding borrowings under the revolving ~~credit facility and outstanding letters of credit. At September 30, 2022,~~

108

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

credit facility and outstanding letters of credit. At June 30, 2023, we had outstanding letters of credit totaling $0.7 million, which are used as security deposits for our office facilities. As of ~~September~~June 30, ~~2022,~~2023, the unused borrowing capacity under the revolving credit facility was ~~$258.3~~$204.3 million.

~~Promissory Note due 2024~~

On June 30, 2017, in conjunction with our purchase of an aircraft related to the acquisition of Innosight, we assumed from the sellers of the aircraft a promissory note with an outstanding principal balance of $5.1 million. In the first quarter of 2022, we completed the sale of the aircraft to a third-party and used a portion of the sale proceeds to pay the remaining principal and unpaid interest on the promissory note. Prior to the repayment of the promissory note, the principal balance of the promissory note was subject to scheduled monthly principal payments until the maturity date of March 1, 2024. Under the terms of the promissory note, we paid interest on the outstanding principal amount at a rate of one month LIBOR plus 1.97% per annum. At December 31, 2021, the outstanding principal amount of the promissory note was $2.8 million, and the aircraft had a carrying amount of $3.7 million. As a result of the sale, we recognized a gain of $1.0 million in the first quarter of 2022 and we no longer own any aircraft.

8.7. Restructuring Charges

Restructuring charges for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 were ~~$1.3~~$1.7 million and ~~$5.0 million.~~$4.0 million, respectively. The ~~$1.3~~$1.7 million of restructuring charges recognized in the ~~third~~second quarter of ~~2022~~2023 included ~~$0.7~~$0.9 million of employee-related expenses; $0.3 million related to the abandonment of a capitalized software development project; $0.2 million of rent and related expenses, net of sublease income, for previously vacated office ~~spaces, $0.5~~spaces; and $0.2 million related to non-cash lease impairment charges driven by updated sublease assumptions for ~~the early termination of a contract, and $0.1 million of employee-related expenses.~~previously vacated office spaces. The ~~$5.0~~$4.0 million of restructuring charges incurred in the first ~~nine~~six months of 2023 included a $1.9 million non-cash impairment charge on the fixed assets and right-of-use operating lease asset related to our office space in Hillsboro, Oregon, which we exited in the first quarter of 2023; $0.9 million of employee-related expenses; $0.6 million for rent and related expenses, net of sublease income, for previously vacated office spaces; $0.3 million related to the abandonment of a capitalized software development project; and $0.2 million related to non-cash lease impairment charges driven by updated sublease assumptions for previously vacated office spaces.

Restructuring charges for the three and six months ended June 30, 2022 were $2.1 million and $3.6 million. The $2.1 million of restructuring charges recognized in the second quarter of 2022 included ~~$1.7~~$1.1 million of employee-related ~~expenses, $1.7~~expenses; $0.4 million of rent and related expenses, net of sublease income, for previously vacated office ~~spaces,~~spaces; $0.5 million for third-party transaction expenses related to the modification of our operating model; and $0.1 million related to the divestiture of our Life Sciences business in the fourth quarter of 2021. The $3.6 million of restructuring charges incurred in the first six months of 2022 included $1.6 million of employee-related expenses; $1.0 million of rent and related expenses, net of sublease income, for previously vacated office spaces; $0.6 million for third-party transaction expenses related to the modification of our operating ~~model, $0.5 million for the early termination of a contract,~~model; $0.3 million of accelerated amortization of capitalized software implementation costs for a cloud-computing arrangement that is no longer in ~~use,~~use; and $0.1 million related to the divestiture of our Life Sciences business in the fourth quarter of 2021.

Restructuring charges for the three and nine months ended September 30, 2021 were $1.7 million and $3.2 million, respectively. The $1.7 million of restructuring charges recognized in the third quarter of 2021 consisted of $0.7 million of third-party transaction expenses related to the evaluation of the divestiture of our Life Sciences business, $0.5 million of rent and related expenses, net of sublease income, for previously vacated office spaces, and $0.5 million of employee-related expenses. Of the $3.2 million restructuring charge incurred in the first nine months of 2021, $1.8 million related to rent and related expenses, net of sublease income, and accelerated depreciation on furniture and fixtures for vacated office spaces; $0.9 million for third-party transaction expenses related to the evaluation of the divestiture of our Life Sciences business; and $0.5 million of employee-related expenses recognized in the third quarter of 2021.

The table below sets forth the changes in the carrying amount of our restructuring charge liability by restructuring type for the ~~nine~~six months ended ~~September~~June 30, ~~2022.~~
Employee Costs Office Space Reduction Other Total
Balance as of December 31, 2021 $ 573 $ — $ 567 $ 1,140
Additions 1,711 — 1,085 2,796
Payments (1,432) — (1,025) (2,457)
Adjustments
— 87 40 127
Balance as of September 30, 2022 $ 852 $ 87 $ 667 $ 1,606
2023.


	Employee Costs		Other		Total
Balance as of December 31, 2022	$	3,751	$	568	$	4,319
Additions	943		—		943
Payments	(3,489)		(74)		(3,563)
Adjustments	—		41		41
Balance as of June 30, 2023	$	1,205	$	535	$	1,740

All of the ~~$0.9~~$1.2 million restructuring charge liability related to employee costs at ~~September~~June 30, ~~2022~~2023 is expected to be paid in the next 12 months and is included as a component of accrued payroll and related benefits in our consolidated balance sheet. ~~The $0.1 million restructuring charge liability related to office space reductions at September 30, 2022 is included as a component of accrued expenses and other current liabilities.~~ All of the ~~$0.7~~$0.5 million other restructuring charge liability at ~~September~~June 30, 2023, which relates to the early termination of a contract in 2022, is expected to be paid ~~over~~in the next 12 months and is included as a component of accrued expenses and other current liabilities in our consolidated balance sheet.

9.8. Derivative Instruments and Hedging Activity

In the normal course of business, we use forward interest rate swaps to manage the interest rate risk associated with our variable-rate borrowings under our senior secured credit facility and we use non-deliverable foreign exchange forward contracts to manage the foreign currency exchange rate risk related to our Indian Rupee-denominated expenses of our operations in India. From time to time, we may enter into additional forward interest rate swaps or non-deliverable foreign exchange forward contracts to further hedge against our interest rate risk and foreign currency exchange rate risk. We do not use derivative instruments for trading or other speculative purposes.

~~Table of Contents~~

~~HURON CONSULTING GROUP INC.~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Tabular amounts in thousands, except per share amounts)~~

~~(Unaudited)~~

We have designated all of our derivative instruments as cash flow hedges. Therefore, changes in the fair value of the interest rate swaps and foreign exchange forward contracts are recorded to other comprehensive income (“OCI”) to the extent effective and reclassified to earnings upon settlement.

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

Interest Rate Swaps

We are party to forward interest rate swap agreements with an aggregate notional ~~amount~~amounts of $250.0 million and $200.0 million as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021.~~2022, respectively. Under the terms of the interest rate swap agreements, we receive from the counterparty interest on the notional amount based on one month ~~LIBOR~~Term SOFR and we pay to the counterparty a stated, fixed rate. The forward interest rate swap agreements have staggered maturities through ~~August 31, 2027.~~February 29, 2028.

As of ~~September~~June 30, ~~2022,~~2023, it was anticipated that ~~$4.1~~$6.2 million of the gains, net of tax, related to interest rate swaps ~~and~~ currently recorded in accumulated other comprehensive income will be reclassified into interest expense, net of interest income in our consolidated statement of operations within the next 12 months.

Foreign Exchange Forward Contracts

~~As of September 30, 2022, we~~We are party to non-deliverable foreign exchange forward contracts ~~with an~~that are scheduled to mature monthly through April 30, 2024. As of June 30, 2023 and December 31, 2022, the aggregate notional ~~amount~~amounts of these contracts were INR ~~405.1~~625.1 million, or ~~$5.0~~$7.6 million, and INR 657.9 million, or $8.0 million, respectively, based on the exchange ~~rate~~rates in effect as of September 30, 2022. These foreign exchange forward contracts will mature monthly through July 2023 to hedge a portion of our forecasted monthly Indian Rupee-denominated expenses against foreign currency fluctuation with the United States dollar.each period end.

As of ~~September~~June 30, ~~2022,~~2023, it was anticipated that all of the $0.1 million of ~~the losses,~~gains, net of tax, related to foreign exchange forward contracts ~~and~~ currently recorded in accumulated other comprehensive income will be reclassified into direct costs in our consolidated statement of operations within the next 12 months.

The table below sets forth additional information relating to our derivative instruments as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021.~~2022.


			Fair Value
Derivative Instrument	Derivative Instrument	Balance Sheet Location	September 30, 2022		December 31, 2021		Derivative Instrument	Balance Sheet Location	June 30, 2023		December 31, 2022
Interest rate swaps	Interest rate swaps	Prepaid expenses and other current assets	$	5,335	$	—	Interest rate swaps	Prepaid expenses and other current assets	$	8,293	$	7,108
Interest rate swaps	Interest rate swaps	Other non-current assets	6,536		1,210		Interest rate swaps	Other non-current assets	4,057		5,131

Foreign exchange forward contracts							Foreign exchange forward contracts	Prepaid expenses and other current assets	79		—
Total Assets	Total Assets		$	11,871	$	1,210	Total Assets		$	12,429	$	12,239

Interest rate swaps		Accrued expenses and other current liabilities	$	—	$	1,604

Interest rate swaps	Interest rate swaps	Deferred compensation and other liabilities	—		149		Interest rate swaps	Deferred compensation and other liabilities	$	126	$	—
Foreign exchange forward contracts	Foreign exchange forward contracts	Accrued expenses and other current liabilities	99		—		Foreign exchange forward contracts	Accrued expenses and other current liabilities	1		120
Total Liabilities	Total Liabilities		$	99	$	1,753	Total Liabilities		$	127	$	120

All of our derivative instruments are transacted under the International Swaps and Derivatives Association (ISDA) master agreements. These agreements permit the net settlement of amounts owed in the event of default and certain other termination events. Although netting is permitted, it is our policy to record all derivative assets and liabilities on a gross basis in our consolidated balance sheet. Refer to Note 1110 “Other Comprehensive Income (Loss)” for additional information on our derivative instruments.

~~Table of Contents~~

~~HURON CONSULTING GROUP INC.~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Tabular amounts in thousands, except per share amounts)~~

~~(Unaudited)~~

~~10.~~9. Fair Value of Financial Instruments

Certain of our assets and liabilities are measured at fair value. Fair value is defined as the price that would be received to sell an asset or the price that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a fair value hierarchy for inputs used in measuring fair value and requires companies to maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy consists of three levels based on the objectivity of the inputs as follows:


Level 1 Inputs						Quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.

Level 2 Inputs						Quoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.

Level 3 Inputs						Unobservable inputs for the asset or liability, and include situations in which there is little, if any, market activity for the asset or liability.

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

The table below sets forth our fair value hierarchy for our financial assets and liabilities measured at fair value on a recurring basis as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021.~~2022.


		Level 1		Level 2		Level 3		Total			Level 1		Level 2		Level 3		Total
September 30, 2022
June 30, 2023										June 30, 2023
Assets:	Assets:									Assets:
Interest rate swaps	Interest rate swaps	$	—	$	11,871	$	—	$	11,871	Interest rate swaps	$	—	$	12,224	$	—	$	12,224
Convertible debt investment	Convertible debt investment	—		—		62,224		62,224		Convertible debt investment	—		—		63,596		63,596
Foreign exchange forward contracts										Foreign exchange forward contracts	—		79		—		79
Deferred compensation assets	Deferred compensation assets	—		27,690		—		27,690		Deferred compensation assets	—		32,239		—		32,239
Total assets	Total assets	$	—	$	39,561	$	62,224	$	101,785	Total assets	$	—	$	44,542	$	63,596	$	108,138
Liabilities:	Liabilities:									Liabilities:

Foreign exchange forward contracts	Foreign exchange forward contracts	$	—	$	99	$	—	$	99	Foreign exchange forward contracts	$	—	$	1	$	—	$	1
Contingent consideration for business acquisitions	Contingent consideration for business acquisitions	—		—		3,199		3,199		Contingent consideration for business acquisitions	—		—		1,957		1,957
Total liabilities	Total liabilities	$	—	$	99	$	3,199	$	3,298	Total liabilities	$	—	$	1	$	1,957	$	1,958
December 31, 2021
December 31, 2022										December 31, 2022
Assets:	Assets:									Assets:
Interest rate swap		$	—	$	627	$	—	$	627
Interest rate swaps										Interest rate swaps	$	—	$	12,239	$	—	$	12,239
Convertible debt investment	Convertible debt investment	—		—		65,918		65,918		Convertible debt investment	—		—		57,563		57,563
Deferred compensation assets	Deferred compensation assets	—		39,430		—		39,430		Deferred compensation assets	—		29,875		—		29,875
Total assets	Total assets	$	—	$	40,057	$	65,918	$	105,975	Total assets	$	—	$	42,114	$	57,563	$	99,677
Liabilities:	Liabilities:									Liabilities:
Interest rate swaps		$	—	$	1,170	$	—	$	1,170
Foreign exchange forward contracts										Foreign exchange forward contracts	$	—	$	120	$	—	$	120
Contingent consideration for business acquisitions	Contingent consideration for business acquisitions	—		—		3,743		3,743		Contingent consideration for business acquisitions	—		—		3,190		3,190
Total liabilities	Total liabilities	$	—	$	1,170	$	3,743	$	4,913	Total liabilities	$	—	$	120	$	3,190	$	3,310

Interest rate swaps: The fair values of our interest rate swaps were derived using estimates to settle the interest rate swap agreements, which are based on the net present value of expected future cash flows on each leg of the swaps utilizing market-based inputs and a discount rate reflecting the risks involved. Refer to Note 98 “Derivative Instruments and Hedging Activity” for additional information on our interest rate swaps.

Foreign exchange forward contracts: The fair values of our foreign exchange forward contracts were derived using estimates to settle the foreign exchange forward contracts agreements, which are based on the net present value of expected future cash flows on each contract utilizing market-based inputs, including both forward and spot prices, and a discount rate reflecting the risks involved. Refer to Note 98 “Derivative Instruments and Hedging Activity” for additional information on our foreign exchange forward contracts.

~~Table of Contents~~

~~HURON CONSULTING GROUP INC.~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Tabular amounts in thousands, except per share amounts)~~

~~(Unaudited)~~

Deferred compensation assets: We have a non-qualified deferred compensation plan (the “Plan”) for the members of our board of directors and a select group of our employees. The deferred compensation liability is funded by the Plan assets, which consist of life insurance policies maintained within a trust. The cash surrender value of the life insurance policies approximates fair value and is based on third-party broker statements which provide the fair value of the life insurance policies' underlying investments, which are Level 2 inputs. The cash surrender value of the life insurance policies is invested primarily in mutual funds. The Plan assets are included in other non-current assets in our consolidated balance sheets. Realized and unrealized gains (losses) from the deferred compensation assets are recorded to other income (expense), net in our consolidated statements of operations.

Convertible debt investment: Since 2014, we have invested $40.9 million in the form of 1.69% convertible debt in Shorelight Holdings, LLC (“Shorelight”), the parent company of Shorelight, a U.S.-based company that partners with leading nonprofit universities to increase access to and retention of international students, boost institutional growth, and enhance an institution’s global footprint. The convertible notes will mature on January 17, ~~2024,~~2027, unless converted earlier.

To determine the appropriate accounting treatment for our investment, we performed a variable interest entity (“VIE”) analysis and concluded that Shorelight does not meet the definition of a VIE. We also reviewed the characteristics of our investment to confirm that the convertible notes are not in-substance common stock that would warrant equity method accounting. After we reviewed all of the terms of the investment,

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

we concluded the appropriate accounting treatment to be that of an available-for-sale debt security. We continue to monitor the key factors of our VIE analysis and the terms of the convertible notes to ensure our accounting treatment is appropriate. We have not identified any changes to Shorelight or our investment that would change our classification of the investment as an available-for-sale debt security.

The investment is carried at fair value with unrealized holding gains and losses excluded from earnings and reported in other comprehensive income. We estimate the fair value of our investment using a scenario-based approach in the form of a hybrid analysis that consists of a Monte Carlo simulation model and an expected return analysis. The conclusion of value for our investment is based on the probability-weighted assessment of both scenarios. The hybrid analysis utilizes certain assumptions including the assumed holding period through the maturity date of January 17, ~~2024;~~2027; the applicable waterfall distribution at the end of the expected holding period based on the rights and privileges of the various instruments; cash flow projections discounted at the risk-adjusted rate of 24.0% ~~and 22.5%~~ as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021, respectively;~~2022; and the concluded equity volatility of ~~35.0% and 45.0%~~40.0% as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021, respectively,~~2022, all of which are Level 3 inputs. The use of alternative estimates and assumptions could increase or decrease the estimated fair value of the investment, which would result in different impacts to our consolidated balance sheet and comprehensive income. Actual results may differ from our estimates. The fair value of the convertible debt investment is recorded in long-term investments in our consolidated balance sheets.

The table below sets forth the changes in the balance of the convertible debt investment for the ~~nine~~six months ended ~~September~~June 30, ~~2022.~~2023.


	Convertible Debt Investment
Balance as of December 31, ~~2021~~2022	$	~~65,918~~57,563

Change in fair value	~~(3,694)~~6,033
Balance as of ~~September~~June 30, ~~2022~~2023	$	~~62,224~~63,596

Contingent consideration for business acquisitions: We estimate the fair value of acquisition-related contingent consideration using either a probability-weighted assessment of the specific financial performance targets being measured or a Monte Carlo simulation model, as appropriate. These fair value measurements are based on significant inputs not observable in the market and thus represent Level 3 inputs. The significant unobservable inputs used in the fair value measurements of our contingent consideration are our measures of the estimated payouts based on internally generated financial projections on a probability-weighted basis and a discount rate which was ~~4.6%~~6.1% as of ~~September~~June 30, 2022. As of December 31, 2021, the discount rate used in the fair value measurements of our contingent consideration was in a range of 2.4% to 5.1% with a weighted average of 3.7%. The weighted average discount rate was calculated using the relative fair values of the contingent consideration liabilities2023 and 5.5% as of December 31, ~~2021.~~2022. The fair value of the contingent consideration is reassessed quarterly based on assumptions used in our latest projections and input provided by practice leaders and management. Any change in the fair value estimate is recorded in our consolidated statement of operations for that period. The use of alternative estimates and assumptions could increase or decrease the estimated fair value of our contingent consideration liability, which would result in different impacts to our consolidated balance sheets and consolidated statements of operations. Actual results may differ from our estimates.

~~Table of Contents~~

~~HURON CONSULTING GROUP INC.~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Tabular amounts in thousands, except per share amounts)~~

~~(Unaudited)~~

The table below sets forth the changes in the balance of the contingent consideration for business acquisitions for the ~~nine~~six months ended ~~September~~June 30, ~~2022.~~2023.


	Contingent Consideration for Business Acquisitions
Balance as of December 31, ~~2021~~2022	$	~~3,743~~3,190
~~Acquisition~~	~~869~~
Payment	~~(1,379)~~(1,000)
Change in fair value	~~(34)~~(233)
Balance as of ~~September~~June 30, ~~2022~~2023	$	~~3,199~~1,957

Financial assets and liabilities not recorded at fair value on a recurring basis are as follows:

Medically Home Preferred Stock Investment

In the fourth quarter of 2019, we invested $5.0 million in Medically Home Group, Inc. (“Medically Home”), a hospital-at-home company. The investment was made in the form of preferred stock. To determine the appropriate accounting treatment for our preferred stock investment, we performed a VIE analysis and concluded that Medically Home does not meet the definition of a VIE. We also reviewed the characteristics of our investment to confirm that the preferred stock is not in-substance common stock that would warrant equity method accounting. After we reviewed all of the terms of the investment, we concluded the appropriate accounting treatment for our investment in Medically Home to be that of an equity security with no readily determinable fair value. We elected to apply the measurement alternative at the time of the purchase and will continue to do so until the investment does not qualify to be so measured. Under the measurement alternative, the investment is carried at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

for ~~the~~an identical or similar investment in Medically Home. On a quarterly basis, we review the information available to determine whether an orderly and observable transaction for the same or similar equity instrument occurred, and remeasure to the fair value of the preferred stock using such identified transactions, with changes in the fair value recorded in our consolidated statement of operations.

~~As of December 31, 2021, the carrying amount of our preferred stock investment was $6.7 million.~~ During the first quarter of 2022, we recognized ana pre-tax unrealized gain of $27.0 ~~million to increase the carrying amount of our preferred stock investment to $33.6~~ million based on an observable price change of preferred stock issued by Medically Home with similar rights and preferences to our preferred stock ~~investment. This observable price change is~~investment, a Level 2 input. ~~The $27.0~~There were no observable price changes for the remainder of 2022 or in the first half of 2023. Since our initial investment, we have recognized cumulative pre-tax unrealized gains of $28.6 million, ~~unrealized gain was~~which were recorded to other income (expense), net in our consolidated statement of ~~operations. There were no observable price changes in the second or third quarters of 2022. Since our initial investment, we have recognized cumulative unrealized gains of $28.6 million,~~operations, and we have not identified any impairments of our investment. As of June 30, 2023 and December 31, 2022, the carrying amount of our preferred stock investment was $33.6 million.

Senior Secured Credit Facility

The carrying value of our borrowings outstanding under our senior secured credit facility is stated at cost. Our carrying value approximates fair value, using Level 2 inputs, as the senior secured credit facility bears interest at variable rates based on current market rates as set forth in the Amended Credit Agreement. Refer to Note 76 “Financing Arrangements” for additional information on our senior secured credit facility.

~~Promissory Note due 2024~~

In the first quarter of 2022, we completed the sale of our aircraft to a third-party and used a portion of the sale proceeds to pay the remaining principal and unpaid interest on our promissory note due 2024. The carrying value of our promissory note due 2024 was stated at cost. The carrying value approximated fair value, using Level 2 inputs, as the promissory note bore interest at rates based on then-current market rates as set forth in the terms of the promissory note. Refer to Note 7 “Financing Arrangements” for additional information on our promissory note due 2024.

Cash and Cash Equivalents and Other Financial Instruments

Cash and cash equivalents are stated at cost, which approximates fair market value. The carrying values of all other financial instruments not described above reasonably approximate fair market value due to the nature of the financial instruments and the short-term maturity of these items.

1513

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

~~11.~~10. Other Comprehensive Income (Loss)

The table below sets forth the components of other comprehensive income (loss), net of tax, for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021.~~2022.
Three Months Ended
September 30, 2022 Three Months Ended
September 30, 2021
Before
Taxes Tax
(Expense)
Benefit Net of
Taxes Before
Taxes Tax
(Expense)
Benefit Net of
Taxes
Foreign currency translation adjustments $ (1,034) $ — $ (1,034) $ (246) $ — $ (246)
Unrealized gain (loss) on investment $ (1,128) $ 298 $ (830) $ 1,577 $ (419) $ 1,158
Interest rate swaps:
Change in fair value $ 5,302 $ (1,402) $ 3,900 $ (192) $ 47 $ (145)
Reclassification adjustments into earnings (89) 24 (65) 613 (159) 454
Net unrealized gain (loss) on interest rate swaps $ 5,213 $ (1,378) $ 3,835 $ 421 $ (112) $ 309
Foreign exchange forward contracts:
Change in fair value $ (98) $ 26 $ (72) $ — $ — $ —
Reclassification adjustments into earnings (1) — (1) — — —
Net unrealized gain (loss) on foreign exchange forward contracts $ (99) $ 26 $ (73) $ — $ — $ —
Other comprehensive income (loss) $ 2,952 $ (1,054) $ 1,898 $ 1,752 $ (531) $ 1,221


	Three Months Ended June 30, 2023						Three Months Ended June 30, 2022
	Before Taxes		Tax (Expense) Benefit		Net of Taxes		Before Taxes		Tax (Expense) Benefit		Net of Taxes
Foreign currency translation adjustments	$	327	$	—	$	327	$	(656)	$	—	$	(656)
Unrealized gain (loss) on investment	$	754	$	(201)	$	553	$	1,051	$	(278)	$	773
Interest rate swaps:
Change in fair value	$	5,265	$	(1,400)	$	3,865	$	1,024	$	(271)	$	753
Reclassification adjustments into earnings	(1,941)		516		(1,425)		297		(79)		218
Net unrealized gain (loss) on interest rate swaps	$	3,324	$	(884)	$	2,440	$	1,321	$	(350)	$	971
Foreign exchange forward contracts:
Change in fair value	$	46	$	(12)	$	34	$	—	$	—	$	—
Reclassification adjustments into earnings	(14)		3		(11)		—		—		—
Net unrealized gain (loss) on foreign exchange forward contracts	$	32	$	(9)	$	23	$	—	$	—	$	—
Other comprehensive income (loss)	$	4,437	$	(1,094)	$	3,343	$	1,716	$	(628)	$	1,088



	Six Months Ended June 30, 2023						Six Months Ended June 30, 2022
	Before Taxes		Tax (Expense) Benefit		Net of Taxes		Before Taxes		Tax (Expense) Benefit		Net of Taxes
Foreign currency translation adjustments	$	379	$	—	$	379	$	(699)	$	—	$	(699)
Unrealized gain (loss) on investment	$	6,033	$	(1,607)	$	4,426	$	(2,566)	$	678	$	(1,888)
Interest rate swaps:
Change in fair value	$	3,458	$	(919)	$	2,539	$	6,692	$	(1,770)	$	4,922
Reclassification adjustments into earnings	(3,473)		923		(2,550)		509		(135)		374
Net unrealized gain (loss) on interest rate swaps	$	(15)	$	4	$	(11)	$	7,201	$	(1,905)	$	5,296
Foreign exchange forward contracts:
Change in fair value	$	200	$	(53)	$	147	$	—	$	—	$	—
Reclassification adjustments into earnings	(2)		—		(2)		—		—		—
Net unrealized gain (loss) on foreign exchange forward contracts	$	198	$	(53)	$	145	$	—	$	—	$	—
Other comprehensive income (loss)	$	6,595	$	(1,656)	$	4,939	$	3,936	$	(1,227)	$	2,709

Nine Months Ended
September 30, 2022 Nine Months Ended
September 30, 2021
Before
Taxes Tax
(Expense)
Benefit Net of
Taxes Before
Taxes Tax
(Expense)
Benefit Net of
Taxes
Foreign currency translation adjustments $ (1,733) $ — $ (1,733) $ 236 $ — $ 236
Unrealized gain (loss) on investment $ (3,694) $ 976 $ (2,718) $ (2,815) $ 747 $ (2,068)
Interest rate swaps:
Change in fair value $ 11,994 $ (3,172) $ 8,822 $ 692 $ (212) $ 480
Reclassification adjustments into earnings 420 (111) 309 1,994 (518) 1,476
Net unrealized gain (loss) on interest rate swaps $ 12,414 $ (3,283) $ 9,131 $ 2,686 $ (730) $ 1,956
Foreign exchange forward contracts:
Change in fair value $ (98) $ 26 $ (72) $ — $ — $ —
Reclassification adjustments into earnings (1) — (1) — — —
Net unrealized gain (loss) on foreign exchange forward contracts $ (99) $ 26 $ (73) $ — $ — $ —
Other comprehensive income (loss) $ 6,888 $ (2,281) $ 4,607 $ 107 $ 17 $ 124

The before tax amounts reclassified from accumulated other comprehensive income related to our interest rate swaps and foreign exchange forward contracts are recorded to interest expense, net of interest income, and direct costs, respectively. Refer to Note 98 “Derivative Instruments and Hedging Activity” for additional information on our derivative instruments.

1614

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

Accumulated other comprehensive income, net of tax, includes the following components:

Cash Flow Hedges
Foreign Currency Translation Available-for-Sale Investment Interest Rate Swaps Foreign Exchange Forward Contracts Total
Balance, December 31, 2021 $ (1,143) $ 18,374 $ (391) $ — $ 16,840
Current period change (1,733) (2,718) 9,131 (73) 4,607
Balance, September 30, 2022 $ (2,876) $ 15,656 $ 8,740 $ (73) $ 21,447


					Cash Flow Hedges
	Foreign Currency Translation		Available-for-Sale Investment		Interest Rate Swaps		Foreign Exchange Forward Contracts		Total
Balance as of December 31, 2022	$	(3,033)	$	12,228	$	9,012	$	(88)	$	18,119
Current period change	379		4,426		(11)		145		4,939
Balance as of June 30, 2023	$	(2,654)	$	16,654	$	9,001	$	57	$	23,058

~~12.~~11. Income Taxes

For the three months ended ~~September~~June 30, ~~2022,~~2023, our effective tax rate was ~~30.2%~~29.4% as we recognized income tax expense of ~~$7.7~~$10.3 million on income of ~~$25.4~~$35.0 million. The effective tax rate of ~~30.2%~~29.4% was less favorable than the statutory rate, inclusive of state income taxes, of 26.6% primarily due to certain nondeductible expense items. These unfavorable items were partially offset by a tax benefit related to non-taxable gains on our investments used to fund our deferred compensation liability.

For the three months ended June 30, 2022, our effective tax rate was 36.0% as we recognized income tax expense of $7.8 million on income of $21.7 million. The effective tax rate of 36.0% was less favorable than the statutory rate, inclusive of state income taxes, of 26.4%, primarily due to tax expense related to nondeductible losses on our investments used to fund our deferred compensation liability and certain nondeductible expense items.

For the ~~three~~six months ended ~~September~~June 30, ~~2021,~~2023, our effective tax rate was ~~12.5%~~25.0% as we recognized income tax expense of ~~$2.0~~$12.7 million on income of ~~$15.7~~$50.8 million. The effective tax rate of ~~12.5%~~25.0% was more favorable than the statutory rate, inclusive of state income taxes, of 26.6%, primarily due to a discrete tax benefit for ~~U.S. federal return to provision adjustments~~share-based compensation awards that vested during the first quarter of 2023 and a tax benefit related to ~~the 2020 corporate income tax return.~~non-taxable gains on our investments used to fund our deferred compensation liability. These favorable items were partially offset by certain nondeductible expense items.

For the ~~nine~~six months ended ~~September~~June 30, 2022, our effective tax rate was ~~31.4%~~31.9% as we recognized income tax expense of ~~$26.7~~$19.1 million on income of ~~$85.2~~$59.8 million. The effective tax rate of ~~31.4%~~31.9% was less favorable than the statutory rate, inclusive of state income taxes, of 26.4% primarily due to tax expense related to nondeductible losses on our investments used to fund our deferred compensation liability and certain nondeductible expense items.

For the nine months ended September 30, 2021, our effective tax rate was 17.9% as we recognized income tax expense of $7.0 million on income of $38.9 million. The effective tax rate of 17.9% was more favorable than the statutory rate, inclusive of state income taxes, of 26.6% primarily due to the ~~discrete tax benefit~~ recognized during the third quarter of 2021 for U.S. federal return to provision adjustments related to the 2020 corporate income tax return. The effective tax rate also reflected the positive impact of certain federal tax credits and a discrete tax benefit recognized during the second quarter of 2021 related to electing the Global Intangible Low-Taxed Income ("GILTI") high-tax exclusion retroactively for the 2018 tax year. On July 20, 2020, the U.S. Treasury issued and enacted final regulations related to GILTI that allow certain U.S. taxpayers to elect to exclude foreign income that is subject to a high effective tax rate from their GILTI inclusions. The GILTI high-tax exclusion is an annual election and is retroactively available. These favorable items were partially offset by certain nondeductible business expenses.

As of ~~September~~June 30, ~~2022,~~2023, we had ~~$0.7~~$0.6 million of unrecognized tax benefits which would affect the effective tax rate ~~of continuing operations~~ if recognized. It is reasonably possible that approximately ~~$0.1~~$0.6 million of the liability for unrecognized tax benefits could decrease in the next twelve months due to the expiration of statutes of limitations.

On August 16, 2022, the Inflation Reduction Act of 2022 (“IRA”) was signed into law. The IRA contains significant tax law changes, including a corporate alternative minimum tax of 15% on adjusted financial statement income for applicable corporations and a 1% excise tax on stock repurchases after December 31, 2022. We are currently evaluating the IRA and its requirements, as well as the effect of the new law on our future cash flows.

~~13.~~12. Commitments, Contingencies and Guarantees

Litigation

~~Oaktree~~

On November 9, 2018, Huron Consulting Services LLC, a wholly owned subsidiary of Huron, was engaged by Oaktree Medical Centre LLC, a management services organization (“Oaktree”), to perform interim management and financial advisory services. As part of the services, a Huron employee was appointed by Oaktree’s board of directors to serve as Chief Restructuring Officer of Oaktree (the “CRO”). The engagement letter through which Oaktree retained Huron’s services (the “Engagement Letter”) states that all disputes or claims arising thereunder are subject to binding arbitration, disclaims special, consequential, incidental and exemplary damages and losses and caps liability to the fees paid for the portion of the engagement giving rise to any liability. On September 19, 2019, Oaktree and certain of its affiliates filed for Chapter 7 liquidation in the U.S. Bankruptcy Court for the Western District of North Carolina, with the cases subsequently

~~Table of Contents~~

~~HURON CONSULTING GROUP INC.~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Tabular amounts in thousands, except per share amounts)~~

~~(Unaudited)~~

transferred to the District of South Carolina. As a result of the bankruptcy filing, a Chapter 7 trustee was appointed to oversee the bankruptcy estates, at which time Huron’s services for Oaktree concluded.

In April 2021, Trustee’s counsel communicated in writing to Huron its intent to pursue various claims against Huron and the CRO, among others, on behalf of the bankruptcy estates related to the services carried out by Huron and the CRO during the engagement.

On September 17, 2021, the Trustee filed a complaint in the Bankruptcy Court for the District of South Carolina against Huron and the CRO, among others (the “Complaint”), alleging breach of fiduciary duty, aiding and abetting a breach of fiduciary duty, negligence, violations of the South Carolina Unfair Trade Practices Act, fraud, civil conspiracy, unjust enrichment, and recovery of avoided transfers under sections 547, 548 and 550 of the Bankruptcy Code. On December 7, 2021, the Trustee filed an amended version of the Complaint (the “Amended Complaint”), generally alleging the same claims asserted in the initial Complaint but (i) removing the claim for a violation of the South Carolina Unfair Trade Practices Act and (ii) adding a claim for breach of contract.

In the Amended Complaint, the Trustee asserted that Huron and the CRO, among others, did not develop and implement a Chapter 11 restructuring plan on a timely basis and that their failure to do so led to significant damages. The Trustee sought an unspecified amount of monetary damages in the Amended Complaint. We believe the Trustee’s allegations with respect to Huron and the CRO are without merit. On December 21, 2021, we filed a motion to dismiss all of the claims in the Amended Complaint. On April 19, 2022, the bankruptcy court entered an order staying all of the Trustee’s claims against Huron and the CRO after (i) finding that the state law claims were subject to arbitration and (ii) exercising its discretion to stay the non-state-law claims pending the arbitration proceeding. The Trustee did not appeal the court’s order prior to the deadline of May 3, 2022. In October 2022, Huron, the CRO and the Trustee reached agreement on a settlement which provides for the Trustee’s dismissal of the Amended Complaint with prejudice as it relates to Huron and the CRO and a mutual release of claims in exchange for a settlement payment to the Trustee of $1.5 million. As a result, we increased our accrued liability and insurance receivable to $1.5 million as of September 30, 2022, which had a net zero impact in our consolidated statement of operations. The final settlement agreement, which is subject to bankruptcy court approval, was filed with the court on October 24, 2022.

From time to time, we are involved in legal proceedings and litigation arising in the ordinary course of business. As of the date of this Quarterly Report on Form 10-Q, we are not a party to any litigation or legal proceeding or subject to any claim that, in the current opinion of management, could reasonably be expected to have a material adverse effect on our financial position or results of ~~operations, including the matter discussed above.~~operations. However, due to the risks and uncertainties inherent in legal proceedings, actual results could differ from current expected results.

Guarantees

Guarantees in the form of letters of credit totaling $0.7 million were outstanding at both ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021~~2022, to support certain office lease obligations.

In connection with certain business acquisitions, we may be required to pay post-closing consideration to the sellers if specific financial performance targets are met over a number of years as specified in the related purchase agreements. As of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, the total estimated fair value of our outstanding contingent consideration liability was $2.0 million and $3.2 million, ~~and $3.7 million,~~ respectively.

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

To the extent permitted by law, our bylaws and articles of incorporation require that we indemnify our officers and directors against judgments, fines and amounts paid in settlement, including attorneys’ fees, incurred in connection with civil or criminal action or proceedings, as it relates to their services to us if such person acted in good faith. Although there is no limit on the amount of indemnification, we may have recourse against our insurance carrier for certain payments made.

~~14.~~13. Segment Information

Segments are defined as components of a company that engage in business activities from which they may earn revenues and incur expenses, and for which separate financial information is available and is evaluated regularly by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. Our chief operating decision maker, who is our chief executive officer, manages the business under three operating segments, which are our reportable segments: Healthcare, Education and Commercial.

Effective January 1, 2022, we modified our operating model to expand and more deeply integrate our industry expertise with our digital, strategic and financial advisory capabilities. The new operating model will strengthen Huron’s go-to-market strategy, drive efficiencies that support margin expansion, and position the company to accelerate growth.

~~Table of Contents~~

~~HURON CONSULTING GROUP INC.~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Tabular amounts in thousands, except per share amounts)~~

~~(Unaudited)~~

•Healthcare

Our Healthcare segment serves acute care providers, including national and regional health ~~systems,~~systems; academic health ~~systems,~~systems; community health ~~systems,~~systems; and public, children’s and critical access hospitals, and non-acute care providers, including physician practices and medical ~~groups, payors,~~groups; payors; and long-term care or post-acute providers. Our Healthcare professionals have a depth of expertise in business operations, including financial and operational improvement, care transformation, and revenue cycle managed services; digital solutions, spanning technology and analytic-related services and a portfolio of software products; organizational transformation; financial advisory and strategy and innovation. ~~Most healthcare~~Healthcare organizations are focused on establishing a sustainable long-term strategy and business model centered around growth, optimal cost structures, reimbursement models, financial strategies, and consumer-focused digital transformation; changing the way care is delivered, particularly in light of personnel shortages, and improving access to care; and evolving their digital capabilities to more effectively manage their business. Our solutions help clients adapt to this rapidly changing healthcare environment to become a more agile, efficient and consumer-centric organization. We use our deep industry, functional and technical expertise to help clients solve a diverse set of business issues, including, but not limited to, identifying new opportunities for growth, optimizing financial and operational performance, improving care delivery and clinical outcomes, increasing physician, patient and employee satisfaction, and maximizing return on technology investments.

•Education

Our Education segment serves public and private colleges and universities, research institutes and other education-related organizations. Our Education professionals have a depth of expertise in strategy and innovation; business operations, including the research enterprise and student and alumni lifecycle; digital solutions, spanning technology and analytic-related services and ~~a portfolio of~~Huron Research Suite, the leading software ~~products;~~suite designed to facilitate and improve research administration service delivery and compliance; and organizational transformation. Our Education segment clients are increasingly faced with strategic, financial and/or enrollment challenges, increased competition, and a need to modernize their businesses using technology to advance their missions. We combine our deep industry, functional and technical expertise to help clients solve their most pressing challenges, including, but not limited to, transforming business operations with technology and analytics; strengthening research strategies and support services; evolving their organizational strategy; optimizing financial and operational performance; applying innovative enrollment strategies; and enhancing the student lifecycle.

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

•Commercial

Our Commercial segment is focused on serving industries and organizations facing significant disruption and regulatory change by helping them adapt to rapidly changing environments and accelerate business transformation. Our Commercial professionals work primarily with six primary buyers: the chief executive officer, the chief financial officer, the chief strategy officer, the chief human resources officer, the chief operating officer, and organizational advisors, including lenders and law firms. We have a deep focus on serving organizations in the financial services, energy and utilities, industrials and manufacturing industries and the public sector while opportunistically serving ~~the~~ commercial industries more broadly, including professional and business services, life sciences, consumer products, and nonprofit. Our Commercial professionals ~~have~~use their deep industry, functional and technical expertise ~~that they put forward when delivering~~to deliver our digital services and software products, ~~and~~ strategy and innovation, and financial advisory (special situation advisory and corporate finance advisory) services. In today’s disruptive environment, organizations must reimagine their historical strategies and financial and operating models to sustain and advance their competitive advantage. Our experts help organizations across industries with a variety of business challenges, including, but not limited to, embedding technology and analytics throughout their internal and customer-facing ~~operations,~~operations; developing analytics and insights ~~into~~to identify the needs of tomorrow’s customers, ~~in order to evolve~~evolving their ~~enterprise~~strategies, and ~~business unit strategies,~~ bringing new products to ~~market,~~market; managing through stressed and distressed situations to create a viable path forward for ~~stakeholders~~stakeholders; and ~~executing mergers~~providing financial, risk and ~~acquisitions, finance offerings and risk mitigation strategies.~~

~~Table of Contents~~

~~HURON CONSULTING GROUP INC.~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Tabular amounts in thousands, except per share amounts)~~

~~(Unaudited)~~

regulatory advisory offerings.

Segment operating income consists of the revenues generated by a segment, less operating expenses that are incurred directly by the segment. Unallocated costs include corporate costs related to administrative functions that are performed in a centralized manner that are not attributable to a particular segment. These administrative function costs include corporate office support costs, office facility costs, costs related to accounting and finance, human resources, legal, marketing, information technology, and company-wide business development functions, as well as costs related to overall corporate management. Our chief operating decision maker does not evaluate segments using asset information.

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

The table below sets forth information about our operating segments for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021,~~2022, along with the items necessary to reconcile the segment information to the totals reported in the accompanying consolidated financial statements.


		Three Months Ended September 30,						Nine Months Ended September 30,							Three Months Ended June 30,						Six Months Ended June 30,
		2022			2021			2022			2021				2023			2022			2023			2022
Healthcare:	Healthcare:													Healthcare:
Revenues	Revenues	$	131,319		$	104,620		$	381,669		$	315,345		Revenues	$	173,768		$	128,474		$	322,817		$	250,350
Operating income	Operating income	$	33,045		$	32,157		$	91,441		$	86,511		Operating income	$	49,151		$	30,364		$	81,406		$	58,396
Segment operating income as a percentage of segment revenues	Segment operating income as a percentage of segment revenues	25.2		%	30.7		%	24.0		%	27.4		%	Segment operating income as a percentage of segment revenues	28.3		%	23.6		%	25.2		%	23.3		%
Education:	Education:													Education:
Revenues	Revenues	$	94,347		$	63,244		$	263,234		$	175,061		Revenues	$	110,694		$	88,225		$	214,841		$	168,887
Operating income	Operating income	$	22,851		$	14,516		$	58,848		$	37,195		Operating income	$	27,397		$	21,691		$	50,562		$	35,997
Segment operating income as a percentage of segment revenues	Segment operating income as a percentage of segment revenues	24.2		%	23.0		%	22.4		%	21.2		%	Segment operating income as a percentage of segment revenues	24.8		%	24.6		%	23.5		%	21.3		%
Commercial:	Commercial:													Commercial:
Revenues	Revenues	$	59,704		$	56,143		$	173,841		$	166,940		Revenues	$	62,297		$	56,626		$	126,996		$	114,137
Operating income	Operating income	$	14,153		$	8,262		$	38,282		$	29,152		Operating income	$	10,472		$	11,915		$	24,539		$	24,129
Segment operating income as a percentage of segment revenues	Segment operating income as a percentage of segment revenues	23.7		%	14.7		%	22.0		%	17.5		%	Segment operating income as a percentage of segment revenues	16.8		%	21.0		%	19.3		%	21.1		%
Total Huron:	Total Huron:													Total Huron:
Revenues	Revenues	$	285,370		$	224,007		$	818,744		$	657,346		Revenues	$	346,759		$	273,325		$	664,654		$	533,374
Reimbursable expenses	Reimbursable expenses	6,816			3,690			19,034			8,876			Reimbursable expenses	8,140			7,492			16,630			12,218
Total revenues and reimbursable expenses	Total revenues and reimbursable expenses	$	292,186		$	227,697		$	837,778		$	666,222		Total revenues and reimbursable expenses	$	354,899		$	280,817		$	681,284		$	545,592

Segment operating income	Segment operating income	$	70,049		$	54,935		$	188,571		$	152,858		Segment operating income	$	87,020		$	63,970		$	156,507		$	118,522
Items not allocated at the segment level:	Items not allocated at the segment level:													Items not allocated at the segment level:
Other operating expenses	Other operating expenses	35,679			31,430			99,139			94,634			Other operating expenses	42,923			29,912			89,263			63,460
Depreciation and amortization	Depreciation and amortization	5,071			5,199			15,171			15,549			Depreciation and amortization	4,378			5,054			9,094			10,100

Operating income	Operating income	29,299			18,306			74,261			42,675			Operating income	39,719			29,004			58,150			44,962
Other income (expense), net		(3,896)			(2,611)			10,946			(3,788)
Total other income (expense), net														Total other income (expense), net	(4,734)			(7,327)			(7,318)			14,842
Income before taxes	Income before taxes	$	25,403		$	15,695		$	85,207		$	38,887		Income before taxes	$	34,985		$	21,677		$	50,832		$	59,804

2018

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

The following table illustrates the disaggregation of revenues by ~~capability, including~~our two principal capabilities: i) Consulting and Managed Services and ii) Digital, and includes a reconciliation of the disaggregated revenues to revenues from our three operating segments for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021.~~2022.


		Three Months Ended September 30,				Nine Months Ended September 30,					Three Months Ended June 30,				Six Months Ended June 30,
Revenues by Capability	Revenues by Capability	2022		2021		2022		2021		Revenues by Capability	2023		2022		2023		2022
Healthcare:	Healthcare:									Healthcare:
Consulting and Managed Services	Consulting and Managed Services	$	88,626	$	75,992	$	256,340	$	228,576	Consulting and Managed Services	$	124,944	$	83,955	$	226,680	$	167,714
Digital	Digital	42,693		28,628		125,329		86,769		Digital	48,824		44,519		96,137		82,636
Total revenues	Total revenues	$	131,319	$	104,620	$	381,669	$	315,345	Total revenues	$	173,768	$	128,474	$	322,817	$	250,350
Education:	Education:									Education:
Consulting and Managed Services	Consulting and Managed Services	$	49,363	$	33,822	$	142,823	$	95,331	Consulting and Managed Services	$	53,426	$	49,279	$	106,653	$	93,460
Digital	Digital	44,984		29,422		120,411		79,730		Digital	57,268		38,946		108,188		75,427
Total revenues	Total revenues	$	94,347	$	63,244	$	263,234	$	175,061	Total revenues	$	110,694	$	88,225	$	214,841	$	168,887
Commercial:	Commercial:									Commercial:
Consulting and Managed Services	Consulting and Managed Services	$	17,912	$	25,207	$	55,193	$	78,669	Consulting and Managed Services	$	18,885	$	14,637	$	41,116	$	37,281
Digital	Digital	41,792		30,936		118,648		88,271		Digital	43,412		41,989		85,880		76,856
Total revenues	Total revenues	$	59,704	$	56,143	$	173,841	$	166,940	Total revenues	$	62,297	$	56,626	$	126,996	$	114,137
Total Huron:	Total Huron:									Total Huron:
Consulting and Managed Services	Consulting and Managed Services	$	155,901	$	135,021	$	454,356	$	402,576	Consulting and Managed Services	$	197,255	$	147,871	$	374,449	$	298,455
Digital	Digital	129,469		88,986		364,388		254,770		Digital	149,504		125,454		290,205		234,919
Total revenues	Total revenues	$	285,370	$	224,007	$	818,744	$	657,346	Total revenues	$	346,759	$	273,325	$	664,654	$	533,374

For the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021,~~2022, substantially all of our revenues were recognized over time. At ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, no single client accounted for greater than 10% of our combined balance of receivables from clients, net and unbilled services, net. During the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021,~~2022, no single client generated greater than 10% of our consolidated revenues.

2119

Table of Contents


ITEM 2.			MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

In this Quarterly Report on Form 10-Q, unless the context otherwise requires, the terms “Huron,” “Company,” “we,” “us” and “our” refer to Huron Consulting Group Inc. and its subsidiaries.

Statements in this Quarterly Report on Form 10-Q that are not historical in nature, including those concerning the Company’s current expectations about its future results, are “forward-looking” statements as defined in Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the Private Securities Litigation Reform Act of 1995. Forward-looking statements are identified by words such as “may,” “should,” “expects,” “provides,” “anticipates,” “assumes,” “can,” “will,” “meets,” “could,” “likely,” “intends,” “might,” “predicts,” “seeks,” “would,” “believes,” “estimates,” “plans,” “continues,” “goals,” “guidance,” or “outlook,” or similar expressions. These forward-looking statements reflect our current expectations about our future requirements and needs, results, levels of activity, performance, or achievements. Some of the factors that could cause actual results to differ materially from the forward-looking statements contained herein include, without limitation: the impact of the COVID-19 pandemic on the economy; our clients and client demand for our services, and our ability to sell and provide services, including the measures taken by governmental authorities and businesses in response to the pandemic, which may cause or contribute to other risks and uncertainties that we face; failure to achieve expected utilization rates, billing rates, and the necessary number of revenue-generating professionals; inability to expand or adjust our service offerings in response to market demands; our dependence on renewal of client-based services; dependence on new business and retention of current clients and qualified personnel; failure to maintain third-party provider relationships and strategic alliances; inability to license technology to and from third parties; the impairment of goodwill; various factors related to income and other taxes; difficulties in successfully integrating the businesses we acquire and achieving expected benefits from such acquisitions; risks relating to privacy, information security, and related laws and standards; and a general downturn in market conditions. These forward-looking statements involve known and unknown risks, uncertainties, and other factors, including, among others, those described under Item 1A. “Risk Factors,” in our Annual Report on Form 10-K for the year ended December 31, ~~2021~~2022 that may cause actual results, levels of activity, performance or achievements to be materially different from any anticipated results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements. We disclaim any obligation to update or revise any forward-looking statements as a result of new information or future events, or for any other reason.

OVERVIEW

Our Business

~~Effective January 1, 2022, we modified~~We provide our ~~operating model to expand~~services and ~~more deeply integrate~~products and manage our ~~industry expertise with our digital, strategic and financial advisory capabilities. The new~~business under three operating ~~model will strengthen Huron’s go-to-market strategy, drive efficiencies that support margin expansion, and position the company to accelerate growth.~~

~~To align with the new operating model, effective with reporting for periods beginning January 1, 2022, we began reporting under the following three industries, which are our reportable~~ segments: Healthcare, Education and Commercial. The Commercial segment includes all industries outside of healthcare and education, including, but not limited to, financial services and energy and utilities. In the new reporting structure, each segment includes all revenue and costs associated with engagements delivered in the respective segments' industries. The new Healthcare and Education segments include some revenue and costs historically reported in the Business Advisory segment and the Healthcare segment includes some revenue and costs historically reported in the Education segment. We also provide revenue reporting across two principal capabilities: i) Consulting and Managed Services and ii) Digital. These changes create greater transparency for investors by improving visibility into the core drivers of our business. While our consolidated results have not been impacted, our historical segment information has been recast for consistent presentation. See below for additional information on our principal capabilities and operating industries.

Capabilities

Within each of our reportable segments, we provide services under two principal capabilities: i) Consulting and Managed Services and ii) Digital.

•Consulting and Managed Services

Our Consulting and Managed Services capabilities represent ~~all of~~ our management consulting services, managed services (excluding technology-related managed services) and outsourcing services delivered across industries. Our Consulting and Managed Services experts help our clients address a variety of strategic, operational, financial, people and organizational-related challenges. These services are often combined with technology, analytic and data-driven solutions powered by our Digital capability to support long-term relationships with our clients and drive lasting impact. Examples include the areas of revenue cycle management and research administration at our healthcare and education clients, where our consulting and managed services projects are often coupled with our digital services and ~~products~~product offerings.

~~Table of Contents~~

•Digital

Our Digital capabilities represent ~~all of~~ our technology and analytics services, including technology-related managed services, and software products delivered across industries. Our Digital experts help clients address a variety of business challenges, including, but not limited to, designing and implementing technologies to accelerate transformation, facilitate data-driven decision making and improve customer and employee experiences.

We have expanded our ecosystem to work with more than 25 technology partners. We are ana Leading Modern Oracle ~~partner,~~Network Partner; a ~~Gold-level~~Summit-level consulting partner with Salesforce.com and a Premium Partner with ~~Salesforce.org,~~Salesforce.org; a Workday Services, Preferred Channel, Extend, and ~~Software Partner,~~Application Management Services Partner; an Amazon Web Services consulting ~~partner, a Silver-level system integrator with~~partner; an Informatica ~~and~~Platinum Partner; an SAP Concur implementation ~~partner.~~ partner; and a Boomi Elite Partner.

Table of Contents

We have also grown our proprietary software product portfolio to address our clients' challenges with solutions that expand our base of recurring revenue and further differentiate our consulting, digital and managed services offerings. Our product portfolio bundles our deep industry expertise and unique intellectual property together to serve our clients outside of our traditional consulting offerings. Our product portfolio includes, among others: Huron Research Suite, the leading software suite designed to facilitate and improve research administration service delivery and compliance; Huron Intelligence™ Rounding, the #1 ranked Digital Rounding solution in the 2023 Best in KLAS® report; and Huron Intelligence™ Analytic Suite in Healthcare, a predictive analytics suite to improve care delivery while lowering costs.

Operating Industries

We provide our services and products and manage our business under three operating industries, which are ~~also~~ our operating segments: Healthcare, Education and Commercial.

•Healthcare

To best serve our clients, we continue to diversify our portfolio of offerings. For example, we have broadened our capabilities beyond our leading profit and loss-focused offerings (e.g., revenue cycle, cost transformation) into offerings dedicated to optimizing our clients' financial positions through financial advisory and transaction-related services; transforming care delivery models through virtual health, health equity and social determinants of health models; and evolving organizations by supporting change management and developing the next generation of leaders by applying our best practices (e.g., revenue cycle leadership).

•Education

•Commercial

Our Commercial segment is focused on serving industries and organizations facing significant disruption and regulatory change by helping them adapt to rapidly changing environments and accelerate business transformation. Our Commercial professionals work primarily with six primary buyers: the chief executive officer, the chief financial officer, the chief strategy officer, the chief human resources officer, the chief operating officer, and organizational advisors, including lenders and law firms. We have a deep focus on serving organizations in the financial services, energy and utilities, industrials and manufacturing industries and the public sector while opportunistically serving ~~the~~ commercial industries more broadly, including professional and business services, life sciences, consumer products, and nonprofit. Our Commercial professionals ~~have~~use their deep industry, functional and technical expertise ~~that they put forward when delivering~~to deliver our digital services and software products, ~~and~~ strategy and innovation, and financial advisory (special situation advisory and corporate finance advisory) services. In today’s disruptive environment, organizations must reimagine their historical strategies and financial and operating models to sustain and advance their competitive advantage. Our experts help organizations across industries with a variety of business challenges, including, but not limited to, embedding technology and analytics throughout their internal and customer-facing operations, developing analytics and insights into the needs of tomorrow’s customers in order to evolve their enterprise and business unit strategies, bringing new

2321

Table of Contents

embedding technology and analytics throughout their internal and customer-facing operations; developing analytics and insights to identify the needs of tomorrow’s customers, evolving their strategies, and bringing new products to ~~market,~~market; managing through stressed and distressed situations to create a viable path forward for ~~stakeholders~~stakeholders; and ~~executing mergers~~providing financial, risk and ~~acquisitions, finance offerings and risk mitigation strategies.~~regulatory advisory offerings.

Business Strategy, Opportunities and Challenges

Our ~~primary~~ strategy is to be the premier transformation partner to our clients ~~meeting~~by helping them address a variety of strategic, operational, financial, people, and organizational challenges through an array of industry-differentiated consulting, digital and managed services offerings that meet their ~~needs by providing a balanced portfolio of services and digital product offerings so that we can adapt quickly and effectively to emerging opportunities in the marketplace.~~unique needs. To achieve our strategic and financial objectives that will drive increased shareholder value, we remain focused onon:

•Extending our leading market positions and accelerating growth in healthcare and education, ~~growing~~

•Growing our presence in ~~the~~ commercial industries, ~~advancing~~

•Advancing our integrated, global digital platform, ~~building~~

•Building a more sustainable base of revenue and executing on our margin levers to drive more consistent growth ~~strategically~~and improved profitability,

•Strategically deploying capital to accelerate our strategy and return capital to shareholders, and ~~investing~~

•Investing in and growing our talented team, including attracting and retaining our managing directors ~~our~~- the senior most practitioners that lead our revenue generation efforts.

We regularly evaluate the performance of our businesses to ensure our investments meet these objectives.

COMPONENTS OF OPERATING RESULTS

Revenues

Our revenues are primarily generated by our employees who provide consulting and other professional services to our clients and are billable to our clients based on the number of hours worked, services provided, or achieved outcomes. We refer to these employees as our revenue-generating professionals. Revenues are primarily driven by the number of revenue-generating professionals we employ as well as the total value, scope, and terms of the consulting contracts under which they provide services. We also engage independent contractors to supplement our revenue-generating professionals on client engagements as needed.

We generate our revenues from providing professional services and software products under the following four types of billing arrangements: fixed-fee (including software license revenue); time-and-expense; performance-based; and software support, maintenance and subscriptions.

•Fixed-fee (including software license revenue): In fixed-fee billing arrangements, we agree to a pre-established fee in exchange for a predetermined set of professional services. We set the fees based on our estimates of the costs and timing for completing the engagements. Fixed-fee arrangements also include software licenses for ~~our revenue cycle management software and research administration and compliance software.~~certain digital products.

•Time-and-expense: Under time-and-expense billing arrangements, we require the client to pay based on the number of hours worked by our revenue-generating professionals at agreed upon rates. Time-and-expense arrangements also include speaking engagements, conferences and publications purchased by our clients.

•Performance-based: In performance-based fee billing arrangements, fees are tied to the attainment of contractually defined objectives. We enter into performance-based engagements in essentially two forms. First, we generally earn fees that are directly related to the savings formally acknowledged by the client as a result of adopting our recommendations for improving operational and cost effectiveness in the areas we review. Second, we earn a success fee when and if certain predefined outcomes occur. Often, performance-based fees supplement our time-and-expense or fixed-fee engagements. The level of performance-based fees earned may vary based on our clients’ risk sharing preferences and the mix of services we provide.

•Software support, maintenance and subscriptions: Clients that have purchased one of our software licenses can pay an annual fee for software support and maintenance. We also generate subscription revenue from ~~our~~certain cloud-based ~~analytic tools and solutions.~~digital products. Software support, maintenance and subscription revenues are recognized ratably over the support or subscription period. These fees are generally billed in advance and included in deferred revenues until recognized.

Time-and-expense engagements do not provide us with a high degree of predictability as to performance in future periods. Unexpected changes in the demand for our services can result in significant variations in utilization and revenues and present a challenge to optimal hiring and staffing. Moreover, our clients typically retain us on an engagement-by-engagement basis, rather than under long-term recurring contracts. The volume of work performed for any particular client can vary widely from period to period.

Table of Contents

Our quarterly results are impacted principally by the total value, scope, and terms of our client contracts, the number of our revenue-generating professionals who are available to work, our revenue-generating professionals' utilization rate, and the bill rates we charge our clients. Our utilization rate can be negatively affected by increased hiring because there is generally a transition period for new professionals that results in a temporary drop in our utilization rate. Our utilization rate can also be affected by seasonal variations in the demand for our services from our clients. For example, during the third and fourth quarters of the year, vacations taken by our clients can result in the deferral of activity on existing and new engagements, which would negatively affect our utilization rate. The number of business work days is also affected by the number of vacation days taken by our consultants and holidays in each quarter. We typically have fewer business work days available in the fourth quarter of the year, which can impact revenues during that period.

~~Table of Contents~~

Reimbursable Expenses

Reimbursable expenses that are billed to clients, primarily relating to travel and out-of-pocket expenses incurred in connection with client engagements, are included in total revenues and reimbursable expenses. Reimbursable expenses are recognized as expenses in the period in which the expense is incurred. Subcontractors that are billed to clients at cost are also included in reimbursable expenses. When billings do not specifically identify reimbursable expenses, we allocate the portion of the billings equivalent to these expenses to reimbursable expenses.

We manage our business on the basis of revenues before reimbursable expenses, which we believe is the most accurate reflection of our services because it eliminates the effect of reimbursable expenses that we bill to our clients at cost.

Operating Expenses

Our most significant expenses are costs classified as direct costs. Direct costs primarily consist of compensation costs for our revenue-generating professionals, which includes salaries, performance bonuses, share-based compensation, signing and retention bonuses, payroll taxes and ~~benefits for our revenue-generating professionals.~~benefits. Direct costs also include fees paid to independent contractors that we retain to supplement our revenue-generating professionals, typically on an as-needed basis for specific client engagements, and technology costs, product and event costs, and commissions. Direct costs exclude amortization of intangible assets and software development costs and reimbursable expenses, both of which are separately presented in our consolidated statements of operations.

Selling, general and administrative expenses consist primarily of ~~salaries, performance bonuses, share-based~~ compensation ~~payroll taxes, and benefits~~costs for our support personnel. ~~Selling,~~Also included in selling, general and administrative expenses ~~also include~~is third-party professional fees, software licenses and data hosting expenses, rent and other office related expenses, sales and marketing related expenses, recruiting and training expenses, and practice administration and meetings expenses.

Other operating expenses include restructuring charges, depreciation expense, ~~and~~ amortization expense related to internally developed software costs and amortization of intangible assets acquired in business combinations. In the first quarter of 2022, we began presenting depreciation and amortization expense inclusive of amortization of intangible assets and software development costs previously presented within total direct costs and reimbursable expenses. We have recast our historical presentation of our consolidated statement of operations for consistent presentation.

~~Segment Results~~

Segment operating income consists of the revenues generated by a segment, less operating expenses that are incurred directly by the segment. ~~Unallocated costs~~Other operating expenses not allocated at the segment level include corporate costs related to administrative functions that are performed in a centralized manner that are not attributable to a particular segment. These administrative function costs include corporate office support costs, office facility costs, costs related to accounting and finance, human resources, legal, marketing, information technology, and company-wide business development functions, ~~as well as~~and costs related to overall corporate management.

Non-GAAP Measures

We also assess our results of operations using the following non-GAAP financial measures: earnings before interest, taxes, depreciation and amortization (“EBITDA”), adjusted EBITDA, adjusted EBITDA as a percentage of revenues, adjusted net income, and adjusted diluted earnings per share (“EPS”). These non-GAAP financial measures differ from GAAP because they exclude a number of items required by GAAP, each discussed below. These non-GAAP financial measures should be considered in addition to, and not as a substitute for or superior to, any measure of performance, cash flows, or liquidity prepared in accordance with GAAP. Our non-GAAP financial measures may be defined differently from time to time and may be defined differently than similar terms used by other companies, and accordingly, care should be exercised in understanding how we define our non-GAAP financial measures.

Our management uses the non-GAAP financial measures to gain an understanding of our comparative operating performance, for example when comparing such results with previous periods or forecasts. These non-GAAP financial measures are used by management in their financial and operating decision making because management believes they reflect our ongoing business in a manner that allows for meaningful period-to-period comparisons. Management also uses these non-GAAP financial measures when publicly providing our business outlook, for internal management purposes, and as a basis for evaluating potential acquisitions and dispositions. We believe that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating Huron’s current operating performance and future prospects in the same manner as management does and in comparing in a consistent manner Huron’s current financial results with Huron’s past financial results.

These non-GAAP financial measures include adjustments for the following items:

Amortization of intangible assets: We exclude the effect of amortization of intangible assets from the calculation of adjusted net income, as it is inconsistent in its amount and frequency and is significantly affected by the timing and size of our acquisitions.

2523

Table of Contents

Restructuring charges: We have incurred charges due to restructuring various parts of our business. These restructuring charges have primarily consisted of costs associated with office space consolidations, including lease impairment charges and accelerated depreciation on lease-related property and equipment, and employee severance charges. We exclude the effect of the restructuring charges from our non-GAAP measures to permit comparability with periods that are not impacted by these items. We do not include normal, recurring, cash operating expenses in our restructuring charges.

Other losses (gains): We exclude the ~~effect~~effects of other losses (gains), which primarily relate to changes in the estimated fair value of our liabilities for contingent consideration related to business acquisitions and litigation settlement losses and gains, to permit comparability with periods that are not impacted by these items.

Transaction-related expenses: To permit comparability with prior periods, we exclude the impact of third-party legal and accounting fees incurred related to business acquisitions.

Unrealized gain on preferred stock investment: We exclude the effect of unrealized gains related to changes in the fair value of our preferred stock investment in Medically Home Group, Inc. (“Medically Home”), which are recognized when an observable price change occurs. These unrealized gains are included as a component of other income (expense), net. We believe that these unrealized gains are not indicative of the ongoing performance of our business and their exclusion permits comparability with prior periods.

Foreign currency transaction losses (gains), net: We exclude the effect of foreign currency transaction losses and gains from the calculation of adjusted EBITDA because the amount of each loss or gain is significantly affected by changes in foreign exchange rates.

Tax effect of adjustments: The non-GAAP income tax adjustment reflects the incremental tax impact applicable to the non-GAAP adjustments.

Income tax expense, Interest expense, net of interest income, ~~and~~ Depreciation and amortization: We exclude the effects of income tax expense, interest expense, net of interest income, and depreciation and amortization in the calculation of EBITDA, as these are customary exclusions as defined by the calculation of EBITDA to arrive at meaningful earnings from core operations excluding the effect of such items. ~~Within~~We include, within the depreciation and amortization adjustment, ~~we include~~ the amortization of capitalized implementation costs of our ~~ERP~~enterprise resource planning ("ERP") and other related software, which is included within selling, general and administrative expenses onin our consolidated ~~statement~~statements of operations.

Revenue-Generating Professionals

Our revenue-generating professionals consist of our full-time consultants who generate revenues based on the number of hours worked; full-time equivalents, which consists of coaches and their support staff within the Culture and Organizational excellence solution, consultants who work variable schedules as needed by clients, and full-time employees who provide software support and maintenance services to clients; and our Healthcare Managed Services employees who provide revenue cycle billing, collections insurance verification and change integrity services to clients.

Utilization Rate

The utilization rate of our revenue-generating professionals is calculated by dividing the number of hours our billable consultants worked on client assignments during a period by the total available working hours for these billable consultants during the same period. Available hours are determined by the standard hours worked by each billable consultant, adjusted for part-time hours, and U.S. standard work weeks. Available working hours exclude local country holidays and vacation days. Utilization rates are presented for our revenue-generating professionals who primarily bill on an hourly basis. We do not present utilization rates for our Managed Services professionals as most of the revenues generated by these employees are not billed on an hourly basis.

RESULTS OF OPERATIONS

Executive Highlights

Highlights from the second quarter of 2023 include:

•Total revenues increased 26.9% to $346.8 million for the second quarter of 2023 from $273.3 million for the second quarter of 2022.

•Diluted EPS increased 92.4% to $1.27 for the second quarter of 2023, compared to $0.66 for the second quarter of 2022.

•Adjusted diluted EPS increased 66.3% to $1.38 for the second quarter of 2023, compared to $0.83 for the second quarter of 2022.

•Net cash provided by operating activities was $78.2 million in the second quarter of 2023, compared to $28.9 million for the second quarter of 2022.

•Returned $59.6 million to shareholders in the first six months of 2023 by repurchasing 826,542 shares of our common stock.

Table of Contents

~~RESULTS OF OPERATIONS~~

~~Executive Highlights~~

~~Highlights from the third quarter of 2022 include:~~

•~~Revenues~~Total revenues increased ~~27.4%~~$73.4 million, or 26.9%, to ~~$285.4~~$346.8 million for the ~~third~~second quarter of ~~2022~~2023 from ~~$224.0~~$273.3 million for the ~~third~~second quarter of ~~2021~~

•~~Revenues within our Digital capability increased 45.5% in the third quarter of 2022, compared to the third quarter of 2021~~

•~~Operating margin increased to 10.3% for the third quarter of 2022, compared to 8.2% for the third quarter of 2021~~

•~~Diluted EPS increased 34.4% to $0.86 for the third quarter of 2022, compared to $0.64 for the third quarter of 2021~~

•~~Adjusted diluted EPS increased 29.5% to $1.01 for the third quarter of 2022, compared to $0.78 for the third quarter of 2021~~

•Returned $45.6 million to shareholders by repurchasing 685,641 shares of our common stock in the third quarter of 2022; for a total of $97.9 million, or 1,706,587 shares, repurchased in the first nine months of 2022

~~Revenues increased $61.4 million, or 27.4%, to $285.4 million for the third quarter of 2022 from $224.0 million for the third quarter of 2021.~~2022. The increase in revenues reflects continued strength in demand for ~~our Digital capability services across all industries as companies continue to invest in cloud-based technology and analytic solutions, as well as strengthened demand for~~both our Consulting and Managed Services ~~offerings within~~capability and Digital capability across all segments, which reflects our ~~Education~~focus on accelerating growth in our healthcare and ~~Healthcare segments. Revenues for the third quarter of 2022 increased 4.4% compared to the second quarter of 2022.~~education industries and growing our presence in commercial industries.

In our Consulting and Managed Services capability, revenues for the ~~third~~second quarter of ~~2022~~2023 increased ~~15.5%~~33.4%, compared to the ~~third~~second quarter of ~~2021, and reflected strengthened demand in our Education and Healthcare segments. The utilization rate within our Consulting capability increased to 72.5% in the third quarter of~~ 2022, ~~compared to 71.5% in the third quarter of 2021.~~

~~Revenues within our Digital capability increased 45.5% in the third quarter of 2022 compared to the third quarter of 2021,~~ and reflected strengthened demand in all of our segments. The utilization rate within our Consulting capability increased to 76.0% in the second quarter of 2023, compared to 73.2% in the second quarter of 2022.

Revenues within our Digital capability ~~decreased to 70.1%~~increased 19.2% in the ~~third~~second quarter of 2023, compared to the second quarter of 2022, and reflected strength in demand in all of our segments. The utilization rate within our Digital capability increased to 74.7% in the second quarter of 2023, compared to ~~74.2%~~74.3% in the ~~third~~second quarter of ~~2021.~~2022.

The total number of revenue-generating professionals increased to ~~4,571~~5,174 as of ~~September~~June 30, ~~2022,~~2023, compared to ~~3,724~~4,243 as of ~~September~~June 30, ~~2021,~~2022, as a result of hiring to support the overall increase in demand for our services within all of our ~~segments, as well as headcount increases in connection with business acquisitions.~~segments. We proactively plan and manage the size and composition of our workforce and take actions as needed to address changes in the anticipated demand for our services as employee compensation costs are the most significant portion of our operating expenses.

Operating margin, which is defined as operating income expressed as a percentage of revenues, increased to 10.3% for the three months ended September 30, 2022 compared to 8.2% for the three months ended September 30, 2021, driven by strong revenue growth that outpaced increases in operating expenses.

Net income increased ~~$4.0~~$10.8 million to ~~$17.7~~$24.7 million for the three months ended ~~September~~June 30, ~~2022~~2023 from ~~$13.7~~$13.9 million for the same period last year. As a result of the increase in net income, diluted earnings per share for the ~~third~~second quarter of ~~2022~~2023 was ~~$0.86~~$1.27, compared to ~~$0.64~~$0.66 for the ~~third~~second quarter of ~~2021.~~2022. Adjusted diluted earnings per share ~~was $1.01~~increased 66.3% to $1.38 for the ~~third~~second quarter of ~~2022,~~2023, compared to ~~$0.78~~$0.83 for the ~~third~~second quarter of ~~2021.~~2022.

~~During~~Net cash provided by operating activities was $78.2 million in the ~~third~~second quarter of ~~2022,~~2023, compared to $28.9 million for the second quarter of 2022. The increase in net cash provided by operating activities was primarily related to an increase in cash collections in the second quarter of 2023, compared to the second quarter of 2022; partially offset by increases in salaries and related expenses for our revenue-generating professionals and payments for selling, general and administrative expenses in the second quarter of 2023, compared to the second quarter of 2022.

In the first six months of 2023, we ~~repurchased 685,641~~deployed $59.6 million of capital to repurchase 826,542 shares of our common stock, ~~for $45.6 million. In the first nine months of 2022, we repurchased 1,706,587 shares of our common stock for $97.9 million,~~ representing ~~7.8%~~4.2% of our common stock outstanding as of December 31, ~~2021.~~2022.

~~Table of Contents~~

Summary of Results

Effective January 1, 2022, we modified our operating model to expand and more deeply integrate our industry expertise with our digital, strategic and financial advisory capabilities. The new operating model will strengthen Huron’s go-to-market strategy, drive efficiencies that support margin expansion, and position the company to accelerate growth.

The following table sets forth, for the periods indicated, selected segment and consolidated operating results and other operating data, including non-GAAP measures.


Segment and Consolidated Operating Results (in thousands, except per share amounts):	Segment and Consolidated Operating Results (in thousands, except per share amounts):	Three Months Ended September 30,						Nine Months Ended September 30,						Segment and Consolidated Operating Results (in thousands, except per share amounts):	Three Months Ended June 30,						Six Months Ended June 30,
		2022			2021			2022			2021				2023			2022			2023			2022
Healthcare:	Healthcare:													Healthcare:
Revenues	Revenues	$	131,319		$	104,620		$	381,669		$	315,345		Revenues	$	173,768		$	128,474		$	322,817		$	250,350
Operating income	Operating income	$	33,045		$	32,157		$	91,441		$	86,511		Operating income	$	49,151		$	30,364		$	81,406		$	58,396
Segment operating income as a percentage of segment revenues	Segment operating income as a percentage of segment revenues	25.2		%	30.7		%	24.0		%	27.4		%	Segment operating income as a percentage of segment revenues	28.3		%	23.6		%	25.2		%	23.3		%
Education:	Education:													Education:
Revenues	Revenues	$	94,347		$	63,244		$	263,234		$	175,061		Revenues	$	110,694		$	88,225		$	214,841		$	168,887
Operating income	Operating income	$	22,851		$	14,516		$	58,848		$	37,195		Operating income	$	27,397		$	21,691		$	50,562		$	35,997
Segment operating income as a percentage of segment revenues	Segment operating income as a percentage of segment revenues	24.2		%	23.0		%	22.4		%	21.2		%	Segment operating income as a percentage of segment revenues	24.8		%	24.6		%	23.5		%	21.3		%
Commercial:	Commercial:													Commercial:
Revenues	Revenues	$	59,704		$	56,143		$	173,841		$	166,940		Revenues	$	62,297		$	56,626		$	126,996		$	114,137
Operating income	Operating income	$	14,153		$	8,262		$	38,282		$	29,152		Operating income	$	10,472		$	11,915		$	24,539		$	24,129
Segment operating income as a percentage of segment revenues	Segment operating income as a percentage of segment revenues	23.7		%	14.7		%	22.0		%	17.5		%	Segment operating income as a percentage of segment revenues	16.8		%	21.0		%	19.3		%	21.1		%
Total Huron:	Total Huron:													Total Huron:
Revenues	Revenues	$	285,370		$	224,007		$	818,744		$	657,346		Revenues	$	346,759		$	273,325		$	664,654		$	533,374
Reimbursable expenses	Reimbursable expenses	6,816			3,690			19,034			8,876			Reimbursable expenses	8,140			7,492			16,630			12,218
Total revenues and reimbursable expenses	Total revenues and reimbursable expenses	$	292,186		$	227,697		$	837,778		$	666,222		Total revenues and reimbursable expenses	$	354,899		$	280,817		$	681,284		$	545,592

Segment operating income	Segment operating income	$	70,049		$	54,935		$	188,571		$	152,858		Segment operating income	$	87,020		$	63,970		$	156,507		$	118,522
Items not allocated at the segment level:	Items not allocated at the segment level:													Items not allocated at the segment level:
Other operating expenses	Other operating expenses	35,679			31,430			99,139			94,634			Other operating expenses	42,923			29,912			89,263			63,460
Depreciation and amortization	Depreciation and amortization	5,071			5,199			15,171			15,549			Depreciation and amortization	4,378			5,054			9,094			10,100
Operating income		29,299			18,306			74,261			42,675
Other income (expense), net		(3,896)			(2,611)			10,946			(3,788)
Income before taxes		25,403			15,695			85,207			38,887
Income tax expense		7,662			1,968			26,739			6,958
Net income		$	17,741		$	13,727		$	58,468		$	31,929
Earnings per share:
Basic		$	0.88		$	0.65		$	2.85		$	1.48
Diluted		$	0.86		$	0.64		$	2.80		$	1.46

Other Operating Data:
Number of revenue-generating professionals by segment (at period end) (5):
Healthcare		1,686			1,575			1,686			1,575
Education		1,543			958			1,543			958
Commercial (1)		1,342			1,191			1,342			1,191
Total		4,571			3,724			4,571			3,724

2825

Table of Contents


Segment and Consolidated Operating Results (in thousands, except per share amounts):	Segment and Consolidated Operating Results (in thousands, except per share amounts):	Three Months Ended September 30,						Nine Months Ended September 30,						Segment and Consolidated Operating Results (in thousands, except per share amounts):	Three Months Ended June 30,						Six Months Ended June 30,
		2022			2021			2022			2021				2023			2022			2023			2022
Operating income														Operating income	39,719			29,004			58,150			44,962
Total other income (expense), net														Total other income (expense), net	(4,734)			(7,327)			(7,318)			14,842
Income before taxes														Income before taxes	34,985			21,677			50,832			59,804
Income tax expense														Income tax expense	10,273			7,802			12,701			19,077
Net income														Net income	$	24,712		$	13,875		$	38,131		$	40,727
Earnings per share:														Earnings per share:
Basic														Basic	$	1.30		$	0.67		$	2.00		$	1.97
Diluted														Diluted	$	1.27		$	0.66		$	1.95		$	1.94

Other Operating Data:														Other Operating Data:
Number of revenue-generating professionals by segment (at period end):														Number of revenue-generating professionals by segment (at period end):
Healthcare														Healthcare	2,059			1,619			2,059			1,619
Education														Education	1,701			1,407			1,701			1,407
Commercial (1)														Commercial (1)	1,414			1,217			1,414			1,217
Total														Total	5,174			4,243			5,174			4,243

Revenue by capability:	Revenue by capability:													Revenue by capability:
Consulting and Managed Services (2)	Consulting and Managed Services (2)	$	155,901		$	135,021		$	454,356		$	402,576		Consulting and Managed Services (2)	$	197,255		$	147,871		$	374,449		$	298,455
Digital	Digital	129,469			88,986			364,388			254,770			Digital	149,504			125,454			290,205			234,919
Total	Total	$	285,370		$	224,007		$	818,744		$	657,346		Total	$	346,759		$	273,325		$	664,654		$	533,374

Number of revenue-generating professionals by capability (at period end):	Number of revenue-generating professionals by capability (at period end):													Number of revenue-generating professionals by capability (at period end):
Consulting and Managed Services (3)	Consulting and Managed Services (3)	2,098			1,871			2,098			1,871			Consulting and Managed Services (3)	2,473			2,018			2,473			2,018
Digital	Digital	2,473			1,853			2,473			1,853			Digital	2,701			2,225			2,701			2,225
Total	Total	4,571			3,724			4,571			3,724			Total	5,174			4,243			5,174			4,243

Utilization rate by capability (4):	Utilization rate by capability (4):													Utilization rate by capability (4):
Consulting	Consulting	72.5		%	71.5		%	73.0		%	70.8		%	Consulting	76.0		%	73.2		%	76.1		%	72.4		%
Digital	Digital	70.1		%	74.2		%	71.6		%	72.9		%	Digital	74.7		%	74.3		%	72.8		%	73.6		%

(1)The majority of our revenue-generating professionals within our Commercial segment can provide services across all of our industries, including healthcare and education.

(2)Managed Services capability ~~revenue~~revenues within our Healthcare segment was ~~$17.6~~$17.3 million and ~~$13.6~~$16.1 million for the three months ended ~~September~~June 30, ~~2022~~2023 and ~~2021,~~2022, respectively; and ~~$47.5~~$37.1 million and ~~$35.4~~$29.9 million for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021,~~2022, respectively.

Managed Services capability ~~revenue~~revenues within our Education segment was ~~$4.1~~$4.9 million and ~~$2.3~~$3.9 million for the three months ended ~~September~~June 30, ~~2022~~2023 and ~~2021,~~2022, respectively; and ~~$11.3~~$9.6 million and ~~$6.8~~$7.3 million for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021,~~2022, respectively.

(3)The number of Managed Services revenue-generating professionals within our Healthcare segment as of ~~September~~June 30, 2023 and 2022 was 772 and ~~2021 was 547 and 518,~~504, respectively.

The number of Managed Services revenue-generating professionals within our Education segment as of ~~September~~June 30, 2023 and 2022 was 106 and ~~2021 was 97 and 68,~~96, respectively.

(4)Utilization rates are presented for our revenue-generating professionals who primarily bill on an hourly basis. We do not present utilization rates for our Managed Services professionals as most of the revenues generated by these employees are not billed on an hourly basis.

~~(5)~~During the first quarter of 2022, we reclassified certain Digital revenue-generating professionals within our Healthcare and Education segments to our Commercial segment as these professionals can provide services across all of our industries. This reclassification did not impact the total headcount within our Digital capability for any period. The prior period headcount has been revised for consistent presentation.

2926

Table of Contents

Non-GAAP Measures

Three Months Ended
September 30, Nine Months Ended
September 30,
2022 2021 2022 2021
Revenues $ 285,370 $ 224,007 $ 818,744 $ 657,346
Net income $ 17,741 $ 13,727 $ 58,468 $ 31,929
Add back:
Income tax expense 7,662 1,968 26,739 6,958
Interest expense, net of interest income 3,111 2,217 7,753 5,965
Depreciation and amortization 7,019 6,534 21,238 19,640
Earnings before interest, taxes, depreciation and amortization (EBITDA) 35,533 24,446 114,198 64,492
Add back:
Restructuring charges 1,332 1,677 4,956 3,166
Other losses (gains) (67) 56 (34) 98
Transaction-related expenses — 194 50 335
Unrealized gain on preferred stock investment — — (26,964) —
Foreign currency transaction losses (gains), net (328) 43 (409) 398
Adjusted EBITDA $ 36,470 $ 26,416 $ 91,797 $ 68,489
Adjusted EBITDA as a percentage of revenues 12.8 % 11.8 % 11.2 % 10.4 %
Reconciliation of Net Income to EBITDA and Adjusted EBITDA

Three Months Ended
September 30, Nine Months Ended
September 30,
2022 2021 2022 2021
Net income $ 17,741 $ 13,727 $ 58,468 $ 31,929
Weighted average shares - diluted 20,615 21,531 20,899 21,904
Diluted earnings per share $ 0.86 $ 0.64 $ 2.80 $ 1.46
Add back:
Amortization of intangible assets 2,818 2,235 8,496 6,923
Restructuring charges 1,332 1,677 4,956 3,166
Other losses (gains) (67) 56 (34) 98
Transaction-related expenses — 194 50 335
Unrealized gain on preferred stock investment — — (26,964) —
Tax effect of adjustments (1,082) (1,103) 3,576 (2,788)
Total adjustments, net of tax 3,001 3,059 (9,920) 7,734
Adjusted net income $ 20,742 $ 16,786 $ 48,548 $ 39,663
Adjusted weighted average shares - diluted 20,615 21,531 20,899 21,904
Adjusted diluted earnings per share $ 1.01 $ 0.78 $ 2.32 $ 1.81


	Three Months Ended June 30,						Six Months Ended June 30,
	2023			2022			2023			2022
Revenues	$	346,759		$	273,325		$	664,654		$	533,374
Net income	$	24,712		$	13,875		$	38,131		$	40,727
Add back:
Income tax expense	10,273			7,802			12,701			19,077
Interest expense, net of interest income	5,796			2,446			10,099			4,642
Depreciation and amortization	6,330			7,097			12,883			14,219
EBITDA	47,111			31,220			73,814			78,665
Add back:
Restructuring charges	1,699			2,069			3,983			3,624
Other losses (gains)	(623)			21			(188)			33


Transaction-related expenses	—			—			—			50
Unrealized gain on preferred stock investment	—			—			—			(26,964)
Foreign currency transaction losses (gains), net	288			(100)			368			(81)
Adjusted EBITDA	$	48,475		$	33,210		$	77,977		$	55,327
Adjusted EBITDA as a percentage of revenues	14.0		%	12.2		%	11.7		%	10.4		%

Reconciliation of Net Income to Adjusted Net Income and Adjusted Diluted Earnings per Share


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Net income	$	24,712	$	13,875	$	38,131	$	40,727
Weighted average shares - diluted	19,486		20,967		19,598		21,047
Diluted earnings per share	$	1.27	$	0.66	$	1.95	$	1.94
Add back:
Amortization of intangible assets	1,974		2,818		4,205		5,678
Restructuring charges	1,699		2,069		3,983		3,624
Other losses (gains)	(623)		21		(188)		33


Transaction-related expenses	—		—		—		50
Unrealized gain on preferred stock investment	—		—		—		(26,964)
Tax effect of adjustments	(808)		(1,301)		(2,120)		4,658


Total adjustments, net of tax	2,242		3,607		5,880		(12,921)
Adjusted net income	$	26,954	$	17,482	$	44,011	$	27,806
Adjusted weighted average shares - diluted	19,486		20,967		19,598		21,047
Adjusted diluted earnings per share	$	1.38	$	0.83	$	2.25	$	1.32

3027

Table of Contents

Three Months Ended ~~September~~June 30, ~~2022~~2023 Compared to Three Months Ended ~~September~~June 30, ~~2021~~2022

Revenues

Revenues by segment and capability for the three months ended ~~September~~June 30, ~~2022~~2023 and ~~2021~~2022 were as follows:


Revenues (in thousands)	Revenues (in thousands)	Three Months Ended September 30,				Increase / (Decrease)				Revenues (in thousands)	Three Months Ended June 30,				Increase / (Decrease)
		2022		2021		$		%			2023		2022		$		%
Segment:	Segment:									Segment:
Healthcare	Healthcare	$	131,319	$	104,620	$	26,699	25.5	%	Healthcare	$	173,768	$	128,474	$	45,294	35.3	%
Education	Education	94,347		63,244		31,103		49.2	%	Education	110,694		88,225		22,469		25.5	%
Commercial	Commercial	59,704		56,143		3,561		6.3	%	Commercial	62,297		56,626		5,671		10.0	%
Total revenues	Total revenues	$	285,370	$	224,007	$	61,363	27.4	%	Total revenues	$	346,759	$	273,325	$	73,434	26.9	%

Capability:	Capability:									Capability:
Consulting and Managed Services	Consulting and Managed Services	$	155,901	$	135,021	$	20,880	15.5	%	Consulting and Managed Services	$	197,255	$	147,871	$	49,384	33.4	%
Digital	Digital	129,469		88,986		40,483		45.5	%	Digital	149,504		125,454		24,050		19.2	%
Total revenues	Total revenues	$	285,370	$	224,007	$	61,363	27.4	%	Total revenues	$	346,759	$	273,325	$	73,434	26.9	%

Revenues increased ~~$61.4~~$73.4 million, or ~~27.4%~~26.9%, to ~~$285.4~~$346.8 million for the ~~third~~second quarter of ~~2022~~2023 from ~~$224.0~~$273.3 million for the ~~third~~second quarter of ~~2021.~~2022. The overall increase in revenues reflects continued strength in demand for ~~our Digital capability services across all industries as companies continue to invest in cloud-based technology and analytic solutions, as well as strengthened demand for~~both our Consulting and Managed Services ~~offerings within~~capability and Digital capability across all segments, which reflects our ~~Education~~focus on accelerating growth in our healthcare and ~~Healthcare segments.~~education industries and growing our presence in commercial industries. Additional information on our revenues by segment follows.

•Healthcare revenues increased ~~$26.7~~$45.3 million, or 35.3%, primarily driven by strong results in our performance improvement solution due to strengthened demand and exceeding performance expectations on certain performance-based arrangements. The increase in Healthcare revenue was also attributable to strengthened demand for our financial advisory solutions within our Consulting and Managed Services capability and our technology and analytics services within our Digital capability. Revenues in the second quarter of 2023 included $0.3 million of incremental revenues from our acquisition of Customer Evolution, LLC, which was completed in December 2022.

The number of revenue-generating professionals within our Healthcare segment grew 27.2% to 2,059 as of June 30, 2023, compared to 1,619 as of June 30, 2022.

•Education revenues increased $22.5 million, or 25.5%, driven by strengthened demand for our technology and analytics services ~~within our Digital capability, as well as strengthened demand for our corporate finance advisory, revenue cycle managed services,~~ and performance improvement solutions within our Consulting and Managed Services capability. Revenues in the third quarter of 2022 included $1.2 million of incremental revenues from our acquisition of Perception Health, Inc., which was completed in December 2021.

~~The number of revenue-generating professionals within our Healthcare segment grew 7.0% to 1,686 as of September 30, 2022, compared to 1,575 as of September 30, 2021.~~

•~~Education~~ ~~revenues increased $31.1 million, or 49.2%, driven by strengthened demand for our technology and analytics services~~software products within our Digital capability, as well as strengthened demand for our strategy and operations ~~research,~~ and ~~student~~research solutions within our Consulting and Managed Services capability. ~~Revenues in the third quarter of 2022 included $2.2 million of incremental revenues from our acquisition of Whiteboard Communications Ltd., which was completed in December 2021.~~

The number of revenue-generating professionals within our Education segment grew ~~61.1%~~20.9% to ~~1,543~~1,701 as of ~~September~~June 30, ~~2022,~~2023, compared to ~~958~~1,407 as of ~~September~~June 30, ~~2021.~~2022.

•Commercial revenues increased ~~$3.6~~$5.7 million, or ~~6.3%~~10.0%, driven by strengthened demand for our financial advisory solutions within our Consulting and Managed Services capability and our technology and analytics services within our Digital capability, partially offset by a decrease in ~~revenues due to the divestiture of~~demand for our Life Sciences business in the fourth quarter of 2021. The Life Sciences business generated $5.1 million of revenues in the third quarter of 2021. Revenues in the third quarter of 2022 included $0.4 million of incremental revenues fromstrategy and innovation solution within our ~~acquisition of AIMDATA, LLC, which was completed in January 2022.~~Consulting and Managed Services capability.

The number of revenue-generating professionals within our Commercial segment grew ~~12.7%~~16.2% to ~~1,342~~1,414 as of ~~September~~June 30, ~~2022,~~2023, compared to ~~1,191~~1,217 as of ~~September~~June 30, 2021. This increase includes the impact of the divestiture of our Life Sciences business completed in the fourth quarter of 2021. The Life Sciences business employed 66 revenue-generating professionals as of September 30, 2021.2022.

3128

Table of Contents

Operating Expenses

Operating expenses for the ~~third~~second quarter of ~~2022~~2023 increased ~~$53.5~~$63.4 million, or ~~25.5%~~25.2%, over the ~~third~~second quarter of ~~2021.~~2022.

Operating expenses and operating expenses as a percentage of revenues were as follows:


Operating Expenses (in thousands, except amounts as a percentage of revenues)	Operating Expenses (in thousands, except amounts as a percentage of revenues)	Three Months Ended September 30,						Increase / (Decrease)		Operating Expenses (in thousands, except amounts as a percentage of revenues)	Three Months Ended June 30,						Increase / (Decrease)
		2022			2021						2023			2022
Direct costs	Direct costs	$	193,368	67.8%	$	153,902	68.7%	$	39,466	Direct costs	$	235,198	67.8%	$	189,233	69.2%	$	45,965
Reimbursable expenses	Reimbursable expenses	6,917		2.4%	3,914		1.7%	3,003		Reimbursable expenses	8,121		2.3%	7,576		2.8%	545
Selling, general and administrative expenses	Selling, general and administrative expenses	54,458		19.1%	43,576		19.5%	10,882		Selling, general and administrative expenses	64,019		18.5%	46,033		16.8%	17,986
Restructuring charges	Restructuring charges	1,332		0.5%	1,677		0.7%	(345)		Restructuring charges	1,699		0.5%	2,069		0.8%	(370)
Depreciation and amortization	Depreciation and amortization	6,812		2.3%	6,322		2.9%	490		Depreciation and amortization	6,143		1.8%	6,902		2.5%	(759)
Total operating expenses	Total operating expenses	$	262,887	92.1%	$	209,391	93.5%	$	53,496	Total operating expenses	$	315,180	90.9%	$	251,813	92.1%	$	63,367

Direct Costs

Direct costs increased ~~$39.5~~$46.0 million, or ~~25.6%~~24.3%, to ~~$193.4~~$235.2 million for the ~~three months ended September 30, 2022~~second quarter of 2023 from ~~$153.9~~$189.2 million for the ~~three months ended September 30, 2021.~~second quarter of 2022. The ~~$39.5~~$46.0 million increase primarily related to a ~~$28.9~~$41.2 million increase in compensation costs for our revenue-generating professionals as we continue to invest in and grow our talented team to meet increased market demand. Specifically, the increase in compensation costs is primarily attributable to a $25.2 million increase in salaries and related expenses driven by increased headcount and annual salary increases that went into effect in the first quarter of ~~2022 and an~~2023, a $14.4 million increase in performance bonus expense, and a $2.1 million increase in share-based compensation expense. Additional increases in direct costs include ~~an $8.1~~a $1.7 million increase in ~~contractor expense~~project costs and a ~~$1.9~~$1.5 million increase in technology costs. As a percentage of revenues, direct costs decreased to 67.8% during the ~~third~~second quarter of ~~2022,~~2023, compared to ~~68.7%~~69.2% during the ~~third~~second quarter of ~~2021,~~2022, primarily due to revenue growth that outpaced the ~~increase~~increases in compensation costs for our revenue-generating ~~professionals;~~professionals and contractor expenses; partially offset by the increase in ~~contractor expense,~~project costs, as a percentage of revenues.

Reimbursable Expenses

Reimbursable expenses are billed to clients at cost and primarily relate to travel and out-of-pocket expenses incurred in connection with client engagements. These expenses are also included in total revenues and reimbursable expenses. We manage our business on the basis of revenues before reimbursable expenses, which we believe is the most accurate reflection of our services because it eliminates the effect of reimbursable expenses that are also included as a component of operating expenses.

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased by ~~$10.9~~$18.0 million, or ~~25.0%~~39.1%, to ~~$54.5~~$64.0 million in the ~~third~~second quarter of ~~2022~~2023 from ~~$43.6~~$46.0 million in the ~~third~~second quarter of ~~2021.~~2022. The ~~$10.9~~$18.0 million increase primarily related to a ~~$6.4~~$14.7 million increase in non-payroll costs which includes a $2.8 million increase in practice administration and meetings expenses, a $1.9 million increase in promotion and marketing expenses, and a $1.0 million increase in software and data hosting expenses. Additionally, selling, general and administration expenses increased $4.4 million due to an increase in compensation costs for our support personnel, driven by a ~~$2.7~~$6.3 million increase ~~in salaries and related expenses and a $1.9 million increase in performance bonus expense, partially offset by a $1.1 million decrease~~ in deferred compensation expense attributable to the change in ~~the~~ market value of our deferred compensation ~~liability.~~liability, a $4.2 million increase in salaries and related expenses, a $2.7 million increase in performance bonus expense, and a $1.6 million increase in share-based compensation expense. The ~~decrease~~increase in deferred compensation expense is ~~fully~~ offset by an increase in the ~~loss~~gain recognized for the change in the market value of investments that are used to fund our deferred compensation liability and recognized in other income, ~~(expense),~~ net. Additionally, selling, general and administrative expenses increased by $3.2 million for non-payroll costs, which includes a $0.9 million increase in software and data hosting expenses and a $0.8 million increase in promotion and marketing expenses. As a percentage of revenues, selling, general and administrative expenses ~~decreased~~increased to ~~19.1%~~18.5% during the ~~third~~second quarter of ~~2022,~~2023, compared to ~~19.5%~~16.8% during the ~~third~~second quarter of ~~2021.~~2022. This ~~decrease~~increase was primarily attributable to an increase in deferred compensation expense, as a percentage of revenues; partially offset by revenue growth that outpaced the increase in ~~compensation costs~~salaries and related expenses for our support ~~personnel; partially offset by the increase in non-payroll costs, as a percentage of revenues.~~personnel.

Restructuring Charges

Restructuring charges for the ~~third~~second quarter of ~~2022~~2023 were ~~$1.3~~$1.7 million, compared to ~~$1.7~~$2.1 million for the ~~third~~second quarter of 2021. The $1.3 million of restructuring charges incurred in the third quarter of 2022 included $0.7 million for rent and related expenses, net of sublease income, for previously vacated office spaces, $0.5 million for the early termination of a contract, and $0.1 million of employee-related expenses.2022. The $1.7 million of restructuring charges ~~incurred~~recognized in the ~~third~~second quarter of ~~2021 consisted of $0.7~~2023 included $0.9 million of ~~third-party transaction expenses~~employee-related expenses; $0.3 million related to the ~~evaluation~~abandonment of ~~the divestiture of our Life Sciences business, $0.5~~a capitalized software development project; $0.2 million of rent and related expenses, net of sublease income, for previously vacated office ~~spaces,~~spaces; and ~~$0.5~~$0.2 million related to non-cash lease impairment charges driven by updated sublease assumptions for previously vacated office spaces.

The $2.1 million of restructuring charges recognized in the second quarter of 2022 included $1.1 million of employee-related ~~expenses.~~expenses; $0.4 million of rent and related expenses, net of sublease income, for previously vacated office spaces; $0.5 million for third-party transaction expenses related to the modification of our operating model; and $0.1 million related to the divestiture of our Life Sciences business in the fourth quarter of 2021.

3229

Table of Contents

Depreciation and Amortization

Depreciation and amortization expense ~~which includes amortization of intangible assets and software development costs previously presented separately, increased $0.5~~decreased $0.8 million, or ~~7.8%~~11.0%, to ~~$6.8~~$6.1 million ~~for~~in the ~~three months ended September 30, 2022,~~second quarter of 2023, compared to ~~$6.3~~$6.9 million ~~for~~in the ~~three months ended September 30, 2021.~~second quarter of 2022. The ~~$0.5~~$0.8 million ~~increase~~decrease in depreciation and amortization expense was primarily attributable to ~~an increase~~intangible assets acquired in business acquisitions that were fully amortized in prior periods and a decrease in amortization of intangible assets acquired in business acquisitions ~~completed subsequent~~due to the ~~third quarter~~accelerated basis of ~~2021.~~amortization in prior periods.

Operating Income and Operating Margin

Operating income increased ~~$11.0~~$10.7 million, or 36.9%, to ~~$29.3~~$39.7 million in the ~~third~~second quarter of ~~2022~~2023 from ~~$18.3~~$29.0 million in the ~~third~~second quarter of ~~2021.~~2022. Operating margin, which is defined as operating income expressed as a percentage of revenues, increased to ~~10.3%~~11.5% for the three months ended ~~September~~June 30, ~~2022,~~2023, compared to ~~8.2%~~10.6% for the three months ended ~~September~~June 30, ~~2021.~~2022.

Operating income and operating margin for each of our segments is as follows. See the Segment and Consolidated Operating Results table above for a reconciliation of our total segment operating income to consolidated Huron operating income.


Segment Operating Income (in thousands, except operating margin percentages)	Segment Operating Income (in thousands, except operating margin percentages)	Three Months Ended September 30,						Increase / (Decrease)		Segment Operating Income (in thousands, except operating margin percentages)	Three Months Ended June 30,						Increase / (Decrease)
		2022			2021						2023			2022
Healthcare	Healthcare	$	33,045	25.2%	$	32,157	30.7%	$	888	Healthcare	$	49,151	28.3%	$	30,364	23.6%	$	18,787
Education	Education	22,851		24.2%	14,516		23.0%	8,335		Education	27,397		24.8%	21,691		24.6%	5,706
Commercial	Commercial	14,153		23.7%	8,262		14.7%	5,891		Commercial	10,472		16.8%	11,915		21.0%	(1,443)
Total segment operating income	Total segment operating income	$	70,049		$	54,935		$	15,114	Total segment operating income	$	87,020		$	63,970		$	23,050

•Healthcare operating income ~~slightly~~ increased primarily due to the increase in revenues, largely offset by increases in compensation costs for our revenue-generating professionals, contractor expenses, and practice administration and meetings expenses. The increase in compensation costs was driven by an increase in headcount and annual salary increases that went into effect in the first quarter of 2022. Healthcare operating margin decreased primarily due to the increases in non-payroll costs and compensation costs for our revenue-generating professionals, as percentages of revenues.

•~~Education~~ ~~operating income increased~~$18.8 million, or 61.9%, primarily due to the increase in revenues, partially offset by increases in compensation costs for our revenue-generating professionals, contractor ~~expense, technology~~ expenses, compensation costs for our support personnel, and ~~promotion and marketing expenses.~~project costs. The ~~increase~~increases in compensation costs ~~was~~for our revenue-generating professionals and support personnel were primarily driven by an increase in headcount, annual salary increases that went into effect in the first quarter of ~~2022,~~2023, and an increase in performance bonus expense. Healthcare operating margin increased to 28.3% from 23.6% primarily due to the revenue growth that outpaced the increase in compensation costs for our revenue-generating professionals; partially offset by increases in contractor expenses and project costs, as percentages of revenues.

•Education operating income increased $5.7 million, or 26.3%, primarily due to the increase in revenues as well as a decrease in contractor expenses, partially offset by increases in compensation costs for our revenue-generating professionals and technology expenses. The increase in compensation costs was primarily driven by an increase in headcount, annual salary increases that went into effect in the first quarter of 2023, and an increase in performance bonus expense. Education operating margin increased ~~due~~ to ~~revenue growth that outpaced~~24.8% from 24.6% primarily driven by the ~~increase~~decrease in contractor expenses; largely offset by increases in compensation ~~costs; partially offset by the increases in non-payroll~~ costs for our revenue-generating professionals and technology expenses, as percentages of ~~revenues.~~revenue.

•Commercial operating income ~~increased~~decreased $1.4 million, or 12.1%, primarily due to ~~the increase in revenues and a decrease~~increases in compensation costs for our revenue-generating professionals, ~~partially~~largely offset by an increase in ~~contractor expense.~~revenues. The ~~decrease~~increase in compensation costs for our revenue-generating professionals was primarily related to an increase in performance bonus expense, an increase in headcount, and annual salary increases that went into effect in the first quarter of 2023. The increase in performance bonus expense primarily reflects an increase in the performance bonus adjustment recorded in the second quarter of 2023 compared to the second quarter of 2022 to adjust our year-to-date performance bonus accrual to reflect the revised full-year forecasts. Commercial operating margin decreased to 16.8% from 21.0% primarily driven by the ~~divestiture of our Life Sciences business in the fourth quarter of 2021. Commercial operating margin increased primarily due to the decrease~~increase in compensation costs for our revenue-generating ~~professionals; partially offset by the increase in contractor expense,~~professionals, as a percentage of revenues.

Other Income (Expense), Net

Interest expense, net of interest income increased ~~$0.9~~$3.4 million to ~~$3.1~~$5.8 million in the ~~third~~second quarter of 2023 from $2.4 million in the second quarter of 2022, ~~from $2.2 million in the third quarter of 2021~~which was primarily attributable to higher interest rates and higher levels of borrowing under our credit facility ~~and higher interest rates~~ during the ~~third~~second quarter of ~~2022~~2023 compared to the ~~third~~second quarter of ~~2021.~~2022. See “Liquidity and Capital Resources” below and Note 76 “Financing Arrangements” within the notes to our consolidated financial statements for additional information about our senior secured credit facility.

Other ~~expense,~~income (expense), net increased ~~$0.4~~$5.9 million to ~~$0.8~~income of $1.1 million in the ~~third~~second quarter of ~~2022~~2023 from ~~$0.4~~expense of $4.9 million in the ~~third~~second quarter of ~~2021.~~2022. The increase in other ~~expense,~~income, net was primarily attributable to the ~~$1.1~~$6.4 million increase in the ~~unrecognized loss~~gain recognized for the market value of our investments that are used to fund our deferred compensation liability, partially offset by ana $0.4 million increase in foreign currency transaction ~~gains and a realized gain on a portion of~~losses. During the ~~investments used to fund our deferred compensation liability recognized in the third~~second quarter of ~~2022. During the third quarter of 2022,~~2023, we recognized a ~~$1.5~~$1.3 million ~~loss~~gain for the market value of our deferred compensation investments compared to a ~~$0.4~~$5.0 million loss recognized in the ~~third~~second quarter of ~~2021.~~2022.

Table of Contents

Income Tax Expense

~~Table of Contents~~

For the three months ended September 30, 2021, our effective tax rate was 12.5% as we recognized income tax expense of $2.0 million on income of $15.7 million. The effective tax rate of 12.5% was more favorable than the statutory rate, inclusive of state income taxes, of 26.6%, primarily due to a discrete tax benefit for U.S. federal return to provision adjustments related to the 2020 corporate income tax return.

Net Income ~~from Continuing Operations~~ and Earnings per Share

EBITDA and Adjusted EBITDA

EBITDA increased ~~$11.1~~$15.9 million to ~~$35.5~~$47.1 million for the ~~three months ended September 30, 2022~~second quarter of 2023 from ~~$24.4~~$31.2 million for the ~~three months ended September 30, 2021.~~second quarter of 2022. The increase in EBITDA was primarily attributable to the increase in segment operating ~~income; partially~~income, offset by anthe increase in corporate expenses, excluding the impact of the change in the market value of our deferred compensation ~~liability on corporate expenses.~~liability.

Adjusted EBITDA increased ~~$10.1~~$15.3 million to ~~$36.5~~$48.5 million in the ~~third~~second quarter of ~~2022~~2023 from ~~$26.4~~$33.2 million in the ~~third~~second quarter of ~~2021.~~2022. The increase in adjusted EBITDA was primarily attributable to the increase in segment operating ~~income;~~income, excluding the impact of segment restructuring charges; partially offset by anthe increase in corporate expenses, excluding the impacts of the change in the market value of our deferred compensation liability and corporate restructuring ~~charges on these items.~~charges.

Adjusted Net Income ~~from Continuing Operations~~ and Adjusted Earnings per Share

Adjusted net income increased ~~$4.0~~$9.5 million to ~~$20.7~~$27.0 million in the ~~third~~second quarter of ~~2022~~2023, compared to ~~$16.8~~$17.5 million in the ~~third~~second quarter of ~~2021.~~2022. As a result of the increase in adjusted net income, adjusted diluted earnings per share was ~~$1.01~~$1.38 for the ~~third~~second quarter of ~~2022,~~2023, compared to ~~$0.78~~$0.83 for the ~~third~~second quarter of ~~2021.~~2022.

~~Nine~~Six Months Ended ~~September~~June 30, ~~2022~~2023 Compared to ~~Nine~~Six Months Ended ~~September~~June 30, ~~2021~~2022

Revenues

Revenues by segment and capability for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021~~2022 were as follows:


Revenues (in thousands)	Revenues (in thousands)	Nine Months Ended September 30,				Increase / (Decrease)				Revenues (in thousands)	Six Months Ended June 30,				Increase / (Decrease)
		2022		2021		$		%			2023		2022		$		%
Segment:	Segment:									Segment:
Healthcare	Healthcare	$	381,669	$	315,345	$	66,324	21.0	%	Healthcare	$	322,817	$	250,350	$	72,467	28.9	%
Education	Education	263,234		175,061		88,173		50.4	%	Education	214,841		168,887		45,954		27.2	%
Commercial	Commercial	173,841		166,940		6,901		4.1	%	Commercial	126,996		114,137		12,859		11.3	%
Total revenues	Total revenues	$	818,744	$	657,346	$	161,398	24.6	%	Total revenues	$	664,654	$	533,374	$	131,280	24.6	%

Capability:	Capability:									Capability:
Consulting and Managed Services	Consulting and Managed Services	$	454,356	$	402,576	$	51,780	12.9	%	Consulting and Managed Services	$	374,449	$	298,455	$	75,994	25.5	%
Digital	Digital	364,388		254,770		109,618		43.0	%	Digital	290,205		234,919		55,286		23.5	%
Total revenues	Total revenues	$	818,744	$	657,346	$	161,398	24.6	%	Total revenues	$	664,654	$	533,374	$	131,280	24.6	%

Revenues increased ~~$161.4~~$131.3 million, or 24.6%, to ~~$818.7~~$664.7 million for the first ~~nine~~six months of ~~2022~~2023 from ~~$657.3~~$533.4 million for the first ~~nine~~six months of ~~2021.~~2022. The overall increase in revenues reflects continued strength in demand for ~~our Digital capability services across all industries as companies continue to invest in cloud-based technology and analytic solutions, as well as strengthened demand for~~both our Consulting and Managed Services ~~offerings within~~capability and Digital capability across all segments, which reflects our ~~Education~~focus on accelerating growth in our healthcare and ~~Healthcare segments partially the result of a favorable comparison against Education's results~~education industries and growing our presence in the first two quarters of 2021 which were more significantly impacted by the COVID-19 pandemic. During 2020 and 2021, some clients reprioritized and delayed certain projects as a result of the uncertainties surrounding the pandemic.commercial industries. Additional information on our revenues by segment follows.

3431

Table of Contents

•Healthcare revenues increased ~~$66.3~~$72.5 million, or ~~21.0%~~28.9%, primarily driven by strong results in our performance improvement solution due to strengthened demand and exceeding performance expectations on certain performance-based arrangements. The increase in Healthcare revenues was also attributable to strengthened demand for our financial advisory and revenue cycle managed services solutions within our Consulting and Managed Services capability and our technology and analytics services within our Digital capability. Revenues in the first six months of 2023 included $0.6 million of incremental revenues from our acquisition of Customer Evolution, LLC, which was completed in December 2022.

The number of revenue-generating professionals within our Healthcare segment grew 27.2% to 2,059 as of June 30, 2023, compared to 1,619 as of June 30, 2022.

•Education revenues increased $46.0 million, or 27.2%, driven by strengthened demand for our technology and analytics services and software products within our Digital capability, as well as strengthened demand for our ~~revenue cycle managed services, performance improvement~~strategy and ~~corporate finance advisory~~operations and research solutions within our Consulting and Managed Services capability. ~~Revenues in the first nine months of 2022 included $3.0 million of incremental revenues from our acquisition of Perception Health, Inc., which was completed in December 2021.~~

~~The number of revenue-generating professionals within our Healthcare segment grew 7.0% to 1,686 as of September 30, 2022, compared to 1,575 as of September 30, 2021.~~

•~~Education~~ revenues increased $88.2 million, or 50.4%, driven by strengthened demand across all of our services and products within our Consulting and Managed Services and Digital capabilities. Revenues in the first nine months of 2022 included $6.4 million of incremental revenues from our acquisition of Whiteboard Communications Ltd., which was completed in December 2021.

•Commercial revenues increased ~~$6.9~~$12.9 million, or ~~4.1%~~11.3%, driven by strengthened demand for our financial advisory solutions within our Consulting and Managed Services capability and our technology and analytics services within our Digital capability, partially offset by a decrease in demand for our strategy and ~~our corporate finance advisory~~innovation solution within our Consulting and Managed Services capability, largely offset by a decrease in revenues due to the divestiture of our Life Sciences business in the fourth quarter of 2021 and a decrease in demand for our financial advisory solutions within the Consulting and Managed Services capability. The Life Sciences business generated $14.8 million of revenues in the first nine months of 2021. Revenues in the first nine months of 2022 included $2.3 million of incremental revenues from our acquisitions of AIMDATA, LLC and Unico Solution, Inc., which were completed in January 2022 and February 2021, respectively.

Operating Expenses

Operating expenses for the first ~~nine~~six months of ~~2022~~2023 increased ~~$140.0~~$122.5 million, or ~~22.4%~~24.5%, over the first ~~nine~~six months of ~~2021.~~2022.

Operating expenses and operating expenses as a percentage of revenues were as follows:


Operating Expenses (in thousands, except amounts as a percentage of revenues)	Operating Expenses (in thousands, except amounts as a percentage of revenues)	Nine Months Ended September 30,						Increase / (Decrease)		Operating Expenses (in thousands, except amounts as a percentage of revenues)	Six Months Ended June 30,						Increase / (Decrease)
		2022			2021						2023			2022
Direct costs	Direct costs	$	569,848	69.6%	$	463,543	70.5%	$	106,305	Direct costs	$	463,581	69.7%	$	376,480	70.6%	$	87,101
Reimbursable expenses	Reimbursable expenses	19,249		2.4%	9,233		1.4%	10,016		Reimbursable expenses	16,745		2.5%	12,332		2.3%	4,413
Selling, general and administrative expenses	Selling, general and administrative expenses	148,886		18.2%	128,574		19.6%	20,312		Selling, general and administrative expenses	126,308		19.0%	94,428		17.7%	31,880
Restructuring charges	Restructuring charges	4,956		0.6%	3,166		0.5%	1,790		Restructuring charges	3,983		0.6%	3,624		0.7%	359
Depreciation and amortization	Depreciation and amortization	20,578		2.5%	19,031		2.9%	1,547		Depreciation and amortization	12,517		2.0%	13,766		2.6%	(1,249)
Total operating expenses	Total operating expenses	$	763,517	93.3%	$	623,547	94.9%	$	139,970	Total operating expenses	$	623,134	93.8%	$	500,630	93.9%	$	122,504

Direct Costs

Direct costs increased ~~$106.3~~$87.1 million, or ~~22.9%~~23.1%, to ~~$569.8~~$463.6 million for the first ~~nine~~six months of ~~2022~~2023 from ~~$463.5~~$376.5 million for the first ~~nine~~six months of ~~2021.~~2022. The ~~$106.3~~$87.1 million increase primarily related to ~~an $81.6~~a $76.5 million increase in compensation costs for our revenue-generating professionals as we continue to invest in and grow our talented team to meet increased market demand. Specifically, the increase in compensation costs is primarily attributable to a $50.3 million increase in salaries and related expenses driven by increased headcount and annual salary increases that went into effect in the first quarter of ~~2022, and increases~~2023, a $23.0 million increase in performance bonus expense, and a $3.6 million increase in share-based compensation expense. Additional increases in direct costs include ~~an $18.5~~a $3.3 million increase in contractor ~~expense,~~expenses, a ~~$4.9~~$2.7 million increase in technology costs, and a ~~$1.7~~$2.4 million increase in ~~product and event~~project costs. As a percentage of revenues, direct costs decreased to ~~69.6%~~69.7% during the first ~~nine~~six months of ~~2022,~~2023, compared to ~~70.5%~~70.6% during the first ~~nine~~six months of ~~2021,~~2022, primarily due to revenue growth that outpaced the increase in compensation costs for our revenue-generating ~~professionals,~~professionals; partially offset by the increase in ~~contractor expense,~~project costs, as a percentage of revenues.

Reimbursable Expenses

3532

Table of Contents

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased by ~~$20.3~~$31.9 million, or ~~15.8%~~33.8%, to ~~$148.9~~$126.3 million in the first ~~nine~~six months of ~~2022~~2023 from ~~$128.6~~$94.4 million in the first ~~nine~~six months of ~~2021.~~2022. The ~~$20.3~~$31.9 million increase primarily related to a ~~$15.1~~$23.3 million increase in non-payroll costs including a $5.0 million increase in promotion and marketing expenses, a $4.8 million increase in practice administration and meetings expense, a $2.7 million increase in software and data hosting expenses, a $2.1 million increase in third-party professional fees, and a $1.6 million increase in training expenses. Additionally, selling, general and administrative expenses increased by $5.0 million related to compensation costs for our support personnel ~~which includes~~driven by a ~~$9.3~~$10.6 million increase ~~in salaries and related expenses, a $4.0 million increase in performance bonus expense and a $2.5 million increase in share-based compensation expense; partially offset by an $11.6 million decrease~~ in deferred compensation expense attributable to the change in ~~the~~ market value of our deferred compensation ~~liability.~~liability, a $6.0 million increase in salaries and related expenses, a $3.3 million increase in performance bonus expense, and a $3.2 million increase in share-based compensation expense. The ~~decrease~~increase in deferred compensation expense is ~~fully~~ offset by ~~a decrease~~an increase in the gain recognized for the change in the market value of investments that are used to fund our deferred compensation liability and recognized in other income, ~~(expense),~~ net. Additionally, selling, general and administrative expenses increased $8.5 million for non-payroll costs driven by a $2.7 million increase in promotion and marketing expenses, a $2.4 million increase in practice administration and meetings expenses, a $1.7 million increase in software and data hosting expenses, and a $1.0 million gain recognized in the first quarter of 2022 related to the sale of our aircraft. As a percentage of revenues, selling, general and administrative expenses ~~decreased~~increased to ~~18.2%~~19.0% during the first ~~nine~~six months of ~~2022,~~2023, compared to ~~19.6%~~17.7% during the first ~~nine~~six months of ~~2021.~~2022. This ~~decrease~~increase was primarily attributable to an increase in deferred compensation expense, as a percentage of revenues; partially offset by revenue growth that outpaced the increase in other compensation costs for our support personnel.

Restructuring Charges

Restructuring charges for the first ~~nine~~six months of ~~2022~~2023 were ~~$5.0~~$4.0 million, compared to ~~$3.2~~$3.6 million for the first ~~nine~~six months of ~~2021.~~2022. The ~~$5.0~~$4.0 million of restructuring charges incurred in the first ~~nine~~six months of ~~2022~~2023 included ~~$1.7~~a $1.9 million non-cash impairment charge on the fixed assets and right-of-use operating lease asset related to our office space in Hillsboro Oregon, which we exited in the first quarter of 2023; $0.9 million of employee-related ~~expenses, $1.7~~expenses; $0.6 million for rent and related expenses, net of sublease income, for previously vacated office ~~spaces,~~spaces; $0.3 million related to the abandonment of a capitalized software development project; and $0.2 million related to non-cash lease impairment charges driven by updated sublease assumptions for previously vacated office spaces.

The $3.6 million of restructuring charges incurred in the first six months of 2022 included $1.6 million of employee-related expenses; $1.0 million of rent and related expenses, net of sublease income, for previously vacated office spaces; $0.6 million for third-party transaction expenses related to the modification of our operating ~~model, $0.5 million for the early termination of a contract,~~model; $0.3 million of accelerated amortization of capitalized software implementation costs for a cloud-computing arrangement that is no longer in ~~use,~~use; and $0.1 million related to the divestiture of our Life Sciences business in the fourth quarter of 2021. The $3.2 million of restructuring charges incurred in the first nine months of 2021 consisted of $1.8 million of rent and related expenses, net of sublease income, and accelerated depreciation on furniture and fixtures for vacated office spaces, $0.9 million of third-party transaction expenses related to the evaluation of the divestiture of our Life Sciences business, and $0.5 million of employee-related expenses.

Depreciation and Amortization

Depreciation and amortization expense, which includes amortization of intangible assets and software development costs previously presented separately, ~~increased $1.5~~decreased $1.2 million, or ~~8.1%~~9.1%, to ~~$20.6~~$12.5 million for the first ~~nine~~six months of ~~2022,~~2023, compared to ~~$19.0~~$13.8 million for first ~~nine~~six months of ~~2021.~~2022. The ~~$1.5~~$1.2 million ~~increase~~decrease in depreciation and amortization expense was primarily attributable to ~~an increase~~intangible assets acquired in business acquisitions that were fully amortized in prior periods and a decrease in the amortization of intangible assets acquired in business acquisitions ~~completed subsequent to the third quarter of 2021, partially offset by decreasing amortization expense for certain intangible assets acquired~~ due to the accelerated basis of amortization in prior periods.

Operating Income and Operating Margin

Operating income increased ~~$31.6~~$13.2 million to ~~$74.3~~$58.2 million in the first ~~nine~~six months of ~~2022~~2023 from ~~$42.7~~$45.0 million in the first ~~nine~~six months of ~~2021.~~2022. Operating margin, which is defined as operating income expressed as a percentage of revenues, increased to ~~9.1%~~8.7% for the first ~~nine~~six months of ~~2022,~~2023, compared to ~~6.5%~~8.4% for the first ~~nine~~six months of ~~2021.~~2022.


Segment Operating Income (in thousands, except operating margin percentages)	Segment Operating Income (in thousands, except operating margin percentages)	Nine Months Ended September 30,						Increase / (Decrease)		Segment Operating Income (in thousands, except operating margin percentages)	Six Months Ended June 30,						Increase / (Decrease)
		2022			2021						2023			2022
Healthcare	Healthcare	$	91,441	24.0%	$	86,511	27.4%	$	4,930	Healthcare	$	81,406	25.2%	$	58,396	23.3%	$	23,010
Education	Education	58,848		22.4%	37,195		21.2%	21,653		Education	50,562		23.5%	35,997		21.3%	14,565
Commercial	Commercial	38,282		22.0%	29,152		17.5%	9,130		Commercial	24,539		19.3%	24,129		21.1%	410
Total segment operating income	Total segment operating income	$	188,571		$	152,858		$	35,713	Total segment operating income	$	156,507		$	118,522		$	37,985

•Healthcare operating income increased $23.0 million, or 39.4%, primarily due to the increase in revenues, partially offset by increases in compensation costs for our revenue-generating professionals, contractor ~~expense, practice administration~~expenses, compensation costs for our support personnel, and ~~meetings expenses, technology expenses, and amortization of intangible assets.~~project costs. The ~~increase~~increases in compensation costs for our revenue-generating professionals ~~was~~and support personnel were primarily driven by an increase in headcount, ~~and~~ annual salary increases that went into effect in the first quarter of ~~2022~~2023, an increase in performance bonus expense, and an increase in share-based compensation ~~expense, partially offset by decreases in performance bonus expense and signing, retention and other bonus~~ expense. Healthcare operating margin ~~decreased~~increased to 25.2% from 23.3% primarily due to the ~~increases~~revenue growth that outpaced the increase in ~~contractor expense,~~ compensation costs for our revenue-generating ~~professionals~~professionals; partially offset by increases in contractor expenses and ~~practice administration and meetings expenses,~~project costs, as percentages of revenues.

3633

Table of Contents

•Education operating income increased $14.6 million, or 40.5%, primarily due to the increase in revenues as well as a decrease in contractor expenses, partially offset by increases in compensation costs for our revenue-generating professionals, ~~contractor expense,~~ technology expenses, and promotion and marketing expenses. The increase in compensation costs was primarily driven by an increase in headcount, ~~and~~ annual salary increases that went into effect in the first quarter of ~~2022, as well as increases~~2023, and an increase in performance bonus ~~expense, signing, retention and other bonus expense and share-based compensation~~ expense. Education operating margin increased ~~due~~ to ~~revenue growth that outpaced~~23.5% from 21.3% primarily driven by the ~~increase~~decrease in ~~compensation costs;~~contractor expenses; partially offset by ~~the increases~~an increase in ~~non-payroll costs,~~technology expenses, as ~~percentages~~a percentage of revenues.

•Commercial operating income increased $0.4 million, or 1.7%, primarily due to the increase in revenues, largely offset by an increase in compensation costs for our revenue-generating professionals. The increase in compensation costs was primarily driven by an increase in headcount, annual salary increases that went into effect in the first quarter of 2023, and an increase in performance bonus expense. The increase in performance bonus expense primarily reflects an increase in the performance bonus adjustment recorded in the first six months of 2023 compared to the first six months of 2022 to adjust our year-to-date performance bonus accrual to reflect the revised full year forecasts. Commercial operating margin decreased to 19.3% from 21.1% primarily driven by an increase in compensation costs for our revenue-generating professionals, as a percentage of revenues; partially offset by a decrease in compensation costs for our ~~revenue-generating professionals and the increase in revenues, partially offset by increases in contractor expenses, promotion and marketing expenses, and compensation costs for our~~ support personnel. The decrease in compensation costs for our revenue-generating professionals was primarily driven by the divestiture of our Life Sciences business in the fourth quarter of 2021, partially offset by increases in performance bonus expense and signing, retention and other bonus expense. Commercial operating margin increased due to the decrease in compensation costs for our revenue-generating professionals; partially offset by the increases in non-payroll costs and compensation costs for our support personnel, as percentages of revenues.

Other Income (Expense), Net

Interest expense, net of interest income increased ~~$1.8~~$5.5 million to ~~$7.8~~$10.1 million in the first ~~nine~~six months of ~~2022~~2023 from ~~$6.0~~$4.6 million in the first ~~nine~~six months of ~~2021~~2022, which was primarily attributable to higher interest rates and higher levels of borrowing under our credit facility during the first ~~nine~~six months of ~~2022~~2023 compared to the first ~~nine~~six months of ~~2021.~~2022. See “Liquidity and Capital Resources” below and Note 76 “Financing Arrangements” within the notes to our consolidated financial statements for additional information about our senior secured credit facility.

Other income, net ~~increased $16.5~~decreased $16.7 million to ~~$18.7~~$2.8 million in the first ~~nine~~six months of ~~2022~~2023 from ~~$2.2~~$19.5 million in the first ~~nine~~six months of ~~2021.~~2022. The ~~increase~~decrease in other income, net was primarily attributable to a $27.0 million unrealized gain recognized in the first quarter of 2022 related to the increase in the fair value of our preferred stock investment in Medically Home. See Note 109 “Fair Value of Financial Instruments” within the notes to our consolidated financial statements for additional information on our preferred stock investment in Medically Home. This ~~increase~~decrease in other income, net was partially offset by ~~the $11.6~~a $10.7 million ~~decrease~~increase in the gain recognized for the market value of our investments that are used to fund our deferred compensation liability. During the first ~~nine~~six months of ~~2022,~~2023, we recognized a ~~$9.1~~$3.1 million ~~loss~~gain for the market value of our deferred compensation investments compared to a ~~$2.6~~$7.6 million ~~gain~~loss recognized in the first ~~nine~~six months of ~~2021.~~2022.

Income Tax Expense

For the ~~nine~~six months ended ~~September~~June 30, 2023, our effective tax rate was 25.0% as we recognized income tax expense of $12.7 million on income of $50.8 million. The effective tax rate of 25.0% was more favorable than the statutory rate, inclusive of state income taxes, of 26.6% primarily due to a discrete tax benefit for share-based compensation awards that vested during the first quarter of 2023 and a tax benefit related to non-taxable gains on our investments used to fund our deferred compensation liability. These favorable items were partially offset by certain nondeductible expense items.

For the six months ended June 30, 2022, our effective tax rate was ~~31.4%~~31.9% as we recognized income tax expense of ~~$26.7~~$19.1 million on income of ~~$85.2~~$59.8 million. The effective tax rate of ~~31.4%~~31.9% was less favorable than the statutory rate, inclusive of state income taxes, of 26.4%, primarily due to tax expense related to nondeductible losses on our investments used to fund our deferred compensation liability and certain nondeductible expense items.

For the nine months ended September 30, 2021, our effective tax rate was 17.9% as we recognized income tax expense of $7.0 million on income of $38.9 million. The effective tax rate of 17.9% was more favorable than the statutory rate, inclusive of state income taxes, of 26.6%, primarily due to a discrete tax benefit recognized in the third quarter of 2021 related to U.S. federal return to provision adjustments related to the 2020 corporate income tax return. The effective tax rate also reflected the positive impact of certain federal tax credits and a discrete tax benefit recognized during the second quarter of 2021 related to electing the Global Intangible Low-Taxed Income ("GILTI") high-tax exclusion retroactively for the 2018 tax year. On July 20, 2020, the U.S. Treasury issued and enacted final regulations related to GILTI that allow certain U.S. taxpayers to elect to exclude foreign income that is subject to a high effective tax rate from their GILTI inclusions. The GILTI high-tax exclusion is an annual election and is retroactively available. These favorable items were partially offset by certain nondeductible expense items.

Net Income from Continuing Operations and Earnings per Share

Net income ~~increased $26.5~~decreased $2.6 million to ~~$58.5~~$38.1 million for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 from ~~$31.9~~$40.7 million for the same period last year. ~~As a result of the increase in net income, diluted~~Diluted earnings per share for the ~~nine~~six months ended ~~September~~June 30, 2023 slightly increased to $1.95 compared to $1.94 for the six months ended June 30, 2022 ~~was $2.80 compared~~primarily due to ~~$1.46 for~~a reduction in diluted shares outstanding resulting from the ~~nine months ended September 30, 2021.~~share repurchases completed subsequent to the second quarter of 2022, partially offset by the decrease in net income.

EBITDA and Adjusted EBITDA

EBITDA ~~increased $49.7~~decreased $4.9 million to ~~$114.2~~$73.8 million for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 from ~~$64.5~~$78.7 million for the ~~nine~~six months ended ~~September~~June 30, ~~2021.~~2022. The ~~increase~~decrease in EBITDA was primarily attributable to the ~~increase in segment operating income and the~~ $27.0 million unrealized gain recognized in the first quarter of 2022 related to the increase in the fair value of our preferred stock investment; ~~partially offset by an~~as well as the increase in corporate expenses, excluding the impact of the change in the market value of our deferred compensation ~~liability on corporate expenses.~~liability. These decreases to EBITDA were largely offset by the increase in segment operating income.

Adjusted EBITDA increased ~~$23.3~~$22.7 million to ~~$91.8~~$78.0 million in the first ~~nine~~six months of ~~2022~~2023 from ~~$68.5~~$55.3 million in the first ~~nine~~six months of ~~2021.~~2022. The increase in adjusted EBITDA was primarily attributable to the increase in segment operating income; excluding the impact of segment restructuring charges; partially offset by anthe increase in corporate expenses, excluding the ~~impact~~impacts of the change in the market value of our deferred compensation liability and corporate restructuring ~~charges on these items.~~charges.

3734

Table of Contents

Adjusted Net Income from Continuing Operations and Adjusted Earnings per Share

Adjusted net income increased ~~$8.9~~$16.2 million to ~~$48.5~~$44.0 million in the first ~~nine~~six months of ~~2022~~2023 compared to ~~$39.7~~$27.8 million in the first ~~nine~~six months of ~~2021.~~2022. As a result of the increase in adjusted net income, adjusted diluted earnings per share was ~~$2.32~~$2.25 for the ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, compared to ~~$1.81~~$1.32 for the ~~nine~~six months ended ~~September~~June 30, ~~2021.~~2022.

LIQUIDITY AND CAPITAL RESOURCES

Cash and cash equivalents were ~~$8.8~~$16.6 million and ~~$20.8~~$11.8 million at ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021.~~2022, respectively. As of ~~September~~June 30, ~~2022,~~2023, our primary sources of liquidity are cash on hand, cash flows from our U.S. operations, and borrowing capacity available under our credit facility.


		Nine Months Ended September 30,					Six Months Ended June 30,
Cash Flows (in thousands):	Cash Flows (in thousands):	2022		2021		Cash Flows (in thousands):	2023		2022
Net cash used in operating activities	Net cash used in operating activities	$	(5,779)	$	(28,206)	Net cash used in operating activities	$	(13,880)	$	(50,236)
Net cash used in investing activities	Net cash used in investing activities	(10,779)		(18,726)		Net cash used in investing activities	(15,763)		(7,608)
Net cash provided by (used in) financing activities		4,752		(9,245)
Net cash provided by financing activities						Net cash provided by financing activities	34,333		49,076
Effect of exchange rate changes on cash	Effect of exchange rate changes on cash	(144)		189		Effect of exchange rate changes on cash	59		(55)
Net decrease in cash and cash equivalents		$	(11,950)	$	(55,988)
Net increase (decrease) in cash and cash equivalents						Net increase (decrease) in cash and cash equivalents	$	4,749	$	(8,823)

Operating Activities

Our operating assets and liabilities consist primarily of receivables from billed and unbilled services, accounts payable and accrued expenses, accrued payroll and related benefits, operating lease obligations and deferred revenues. The volume of services rendered and the related billings and timing of collections on those billings, as well as payments of our accounts payable and salaries, bonuses, and related benefits to employees affect these account balances. Our purchase obligations primarily consist of payments for software and other information technology products to support our business and corporate infrastructure.

Net cash used in operating activities decreased ~~$22.4~~$36.4 million to ~~$5.8~~$13.9 million for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 from ~~$28.2~~$50.2 million for the ~~nine~~six months ended ~~September~~June 30, ~~2021.~~2022. The decrease in net cash used in operating activities was primarily related to an increase in cash collections in the first ~~nine~~six months of ~~2022~~2023 compared to the same prior year period; partially offset by an increase in salaries and related expenses for our revenue-generating ~~professionals;~~professionals, an increase in payments for selling, general and administrative expenses for the first six months of 2023 compared to the same prior year period, and an increase in the amount paid for annual performance bonuses in the first quarter of ~~2022~~2023 compared to the first quarter of ~~2021; and increases in payments for selling, general and administrative expenses and contractor fees~~2022.

Additionally, for the first ~~nine~~six months of ~~2022 compared~~2023, our unbilled receivables increased, partially driven by certain large Healthcare and Education engagements where our services performed and revenue recognized exceeded the amounts billed to clients in accordance with the ~~same prior year period.~~contractual billing terms. We expect to bill and collect for these services in the second half of 2023. In the future, we may enter into additional client engagements with similar deferred billing terms.

Investing Activities

Our investing activities primarily consist of purchases of complementary businesses; purchases of property and equipment, primarily related to computers and related equipment for our employees and leasehold improvements and furniture and fixtures for office spaces; payments related to internally developed cloud-based software sold to our clients; and investments. Our investments include a convertible note investment in Shorelight Holdings, LLC, a preferred stock investment in Medically Home Group, Inc., and investments in life insurance policies that are used to fund our deferred compensation liability.

~~The use of~~Net cash inused by investing activities was $15.8 million for the ~~first nine~~six months ~~of 2022~~ended June 30, 2023 which primarily consisted of ~~$9.8~~$13.0 million for payments related to internally developed software to advance our Healthcare and Education software products; $3.7 million for purchases of property and equipment, primarily related to purchases of computers and related equipment; and $2.2 million for contributions to our life insurance policies. These uses of cash for investing activities were partially offset by $3.0 million of cash received for distributions from our life insurance policies that are used to fund our deferred compensation liability.

Net cash used by investing activities was $7.6 million for the six months ended June 30, 2022 which primarily consisted of $6.8 million for purchases of property and equipment, primarily related to purchases of computers and related equipment and leasehold improvements and furniture for certain office spaces; ~~$6.9~~$4.0 million for payments related to internally developed software; and $1.9 million for the purchase of a business. These uses of cash for investing activities were partially offset by $4.8 million of cash received for the sale of our aircraft in the first quarter of ~~2022 and $3.0 million of cash received for a distribution from our life insurance policies used to fund our deferred compensation liability.~~

The use of cash in the first nine months of 2021 primarily consisted of $8.9 million for purchases of property and equipment, primarily related to purchases of leasehold improvements for certain office spaces and computers and related equipment; $5.9 million for the purchase of a business and $3.6 million for payments related to internally developed software.2022.

We estimate that cash utilized for purchases of property and equipment and software development in ~~2022~~2023 will total approximately ~~$20~~$35 million to ~~$25~~$40 million; primarily consisting of software development costs, information technology related equipment to support our corporate infrastructure, and leasehold improvements and furniture and fixtures for certain office locations.

3835

Table of Contents

Financing Activities

Our financing activities primarily consist of borrowings and repayments under our senior secured credit facility, share repurchases, shares redeemed for employee tax withholdings upon vesting of share-based compensation, and payments for contingent consideration liabilities related to business acquisitions. See “Financing Arrangements” below for additional information on our senior secured credit facility.

Net cash provided by financing activities was ~~$4.8~~$34.3 million for the ~~nine~~six months ended ~~September~~June 30, 2023. During the six months ended June 30, 2023, we borrowed $230.0 million primarily to fund our operations, including our annual performance bonus payment in the first quarter of 2023, and made repayments on our borrowings of $125.0 million. Additionally, during the first six months of 2023, we paid $60.4 million for share repurchases, including $1.1 million related to the settlement of share repurchases that were accrued as of December 31, 2022, and reacquired $9.7 million of common stock as a result of tax withholdings upon vesting of share-based compensation. We also made deferred acquisition payments of $1.5 million to the sellers of certain businesses we acquired. These payments were primarily the result of achieving specified financial performance targets in accordance with the related purchase agreements.

Net cash provided by financing activities was $49.1 million for the six months ended June 30, 2022. During the ~~nine~~six months ended ~~September~~June 30, 2022, we borrowed ~~$287.0~~$224.0 million under our credit facility primarily to fund our operations, including our annual performance bonus payment in the first quarter of 2022, and made repayments on our borrowings of ~~$178.8~~$114.8 million. The repayments on our borrowings included the repayment of the outstanding principal of our promissory note due 2024 of $2.7 million from the proceeds received for the sale of our aircraft. Additionally, during the first ~~nine~~six months of 2022, we repurchased and retired ~~$97.9~~$52.2 million of our common stock under our share repurchase program, ~~discussed below, of which $2.6 million settled in the fourth quarter of 2022,~~ and settled $0.2 million of share repurchases that were accrued as of December 31, 2021. In the first ~~nine months~~half of 2022, we reacquired ~~$7.5~~$7.0 million of common stock as a result of tax withholdings upon vesting of share-based compensation. We also made deferred acquisition payments of $1.9 million to the sellers of certain businesses we acquired. These payments were primarily the result of achieving specified financial performance targets in accordance with the related purchase agreements.

Net cash used in financing activities was $9.2 million for the nine months ended September 30, 2021. During the nine months ended September 30, 2021, we borrowed $189.0 million primarily to fund our annual performance bonus payment, and made repayments on our borrowings of $129.4 million. Additionally, during the first nine months of 2021, we repurchased and retired $60.2 million of our common stock under our share repurchase program. We also reacquired $9.3 million of common stock as a result of tax withholdings upon vesting of share-based compensation.

Share Repurchase Program

In November 2020, our board of directors authorized a share repurchase program permitting us to repurchase up to $50 million of our common stock through December 31, 2021. ~~Through~~Subsequent to the ~~third quarter of 2022,~~initial authorization, our board of directors authorized extensions of the share repurchase program through December 31, 2023 and increased the authorized amount ~~to $200 million. In the fourth quarter of 2022, our board of directors increased the authorized amount under the share repurchase program from $200 million~~ to $300 million. The amount and timing of repurchases under the share repurchase program were and will continue to be determined by management and depend on a variety of factors, including the trading price of our common stock, capacity under our credit facility, general market and business conditions, and applicable legal requirements. As of ~~September~~June 30, ~~2022, $32.3~~2023, $49.6 million remained available for share repurchases under our share repurchase program.

Financing Arrangements

At ~~September~~June 30, ~~2022,~~2023, we had ~~$341.0~~$395.0 million outstanding under our senior secured credit facility, as discussed below.

The Company has a $600 million five-year senior secured revolving credit facility, subject to the terms of a ~~Second~~Third Amended and Restated Credit Agreement dated as of ~~March 31, 2015, as amended to date~~November 15, 2022 (as amended, ~~and modified~~ the "Amended Credit Agreement"), that becomes due and payable in full upon maturity on ~~September 27, 2024.~~November 15, 2027. The Amended Credit Agreement provides the option to increase the revolving credit facility or establish term loan facilities in an aggregate amount of up to ~~$150~~$250 million, subject to customary conditions and the approval of any lender whose commitment would be increased, resulting in a maximum available principal amount under the Amended Credit Agreement of ~~$750~~$850 million. ~~Borrowings~~The initial borrowings under the Amended Credit Agreement were used to refinance borrowings outstanding under a prior credit agreement, and future borrowings under the Amended Credit Agreement may be used for working capital, capital expenditures, ~~acquisitions of businesses,~~ share repurchases, permitted acquisitions, and other general corporate purposes.

Table of Contents

Credit Agreement). In addition, we have the right to permanently reduce or terminate the unused portion of the commitments provided under the Amended Credit Agreement at any time.

The Amended Credit Agreement contains usual and customary representations and warranties; affirmative and negative covenants, which include limitations on liens, investments, additional indebtedness, and restricted payments; and two quarterly financial covenants as follows: (i) a maximum Consolidated Leverage Ratio (defined as the ratio of debt to consolidated EBITDA) of 3.75 to 1.00; however the maximum permitted Consolidated Leverage Ratio will increase to ~~4.00~~4.25 to 1.00 upon the occurrence of ~~certain transactions,~~a Qualified Acquisition (as defined in the Amended Credit Agreement), and (ii) a minimum Consolidated Interest Coverage Ratio (defined as the ratio of consolidated EBITDA to interest) of ~~3.50~~3.00 to 1.00. Consolidated EBITDA for purposes of the financial covenants is calculated on a continuing operations basis and includes adjustments to add back non-cash goodwill impairment charges, share-based compensation costs, certain non-cash restructuring charges, pro forma historical EBITDA for businesses acquired, and other specified items in accordance with the Amended Credit Agreement. For purposes of the Consolidated Leverage Ratio, total debt is on a gross basis and is not netted against our cash balances. At ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, we were in compliance with these financial covenants. Our Consolidated Leverage Ratio

~~Table of Contents~~

as of ~~September~~June 30, ~~2022~~2023 was ~~2.06~~2.17 to 1.00, compared to ~~1.73~~1.92 to 1.00 as of December 31, ~~2021.~~2022. Our Consolidated Interest Coverage Ratio as of ~~September~~June 30, ~~2022~~2023 was ~~18.36~~11.23 to 1.00, compared to ~~18.43~~14.04 to 1.00 as of December 31, ~~2021.~~2022.

The Amended Credit Agreement contains restricted payment provisions, including a potential limit on the amount of dividends we may pay. Pursuant to the terms of the Amended Credit Agreement, if our Consolidated Leverage Ratio is greater than ~~3.25,~~3.50, the amount of dividends and other Restricted Payments (as defined in the Amended Credit Agreement) we may pay is limited to an amount up to ~~$25~~$50 million.

Principal borrowings outstanding under the Amended Credit Agreement at ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021~~2022 totaled ~~$341.0~~$395.0 million and ~~$230.0~~$290.0 million, respectively. These borrowings carried a weighted average interest rate of ~~3.6%~~4.6% at ~~September~~June 30, ~~2022~~2023 and ~~2.7%~~3.8% at December 31, ~~2021,~~2022, including the impact of the interest rate swaps described in Note 98 “Derivative Instruments and Hedging Activity” within the notes to the consolidated financial statements. The borrowing capacity under the revolving credit facility is reduced by any outstanding borrowings under the revolving credit facility and outstanding letters of credit. At ~~September~~June 30, ~~2022,~~2023, we had outstanding letters of credit totaling $0.7 million, which are used as security deposits for our office facilities. As of ~~September~~June 30, ~~2022,~~2023, the unused borrowing capacity under the revolving credit facility was ~~$258.3~~$204.3 million.

~~For further information, see Note 7 “Financing Arrangements” within the notes to the consolidated financial statements.~~

Future Financing Needs

~~Throughout 2021, our~~Our primary financing need ~~was~~is to support our operations and maintain our liquidity during the COVID-19 pandemic. As such, we took proactive measures to increase available cash on hand, including, but not limited to, borrowing under our senior secured credit facility, reducing discretionary operating and capital expenses, and electing to defer the deposit of our employer portion of social security taxes as provided for under the CARES Act.

~~Given improved visibility to our project backlog and access to capital resources, our primary financing need has returned to funding~~fund our long-term growth. Our growth strategy is to expand our service offerings, which may require investments in new hires, acquisitions of complementary businesses, possible expansion into other geographic areas, and related capital expenditures.

We believe our internally generated liquidity, together with our available cash, and the borrowing capacity available under our revolving credit facility will be adequate to support our current financing needs and long-term growth strategy. Our ability to secure additional financing ~~if needed,~~ in the future, if needed, will depend on several factors, including our future profitability, the quality of our accounts receivable and unbilled services, our relative levels of debt and equity, and the overall condition of the credit markets.

OFF-BALANCE SHEET ARRANGEMENTS

We are not a party to any material off-balance sheet arrangements.

CRITICAL ACCOUNTING POLICIES

Management’s discussion and analysis of financial condition and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). We regularly review our financial reporting and disclosure practices and accounting policies to ensure that our financial reporting and disclosures provide accurate information relative to the current economic and business environment. The preparation of financial statements in conformity with GAAP requires management to make assessments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Critical accounting policies are those policies that we believe present the most complex or subjective measurements and have the most potential to impact our financial position and operating results. While all decisions regarding accounting policies are important, we believe there are five accounting policies that could be considered critical: revenue recognition, allowances for doubtful accounts and unbilled services, business combinations, carrying values of goodwill and other intangible assets, and accounting for income taxes. For a detailed discussion of these critical accounting policies, see Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies” in our Annual Report on Form 10-K for the year ended December 31, ~~2021. Below is an update to our critical accounting policy related to the carrying values of goodwill and other intangible assets.~~2022. There have been no ~~other~~ material changes to our critical accounting policies during the ~~first nine~~six months ofended June 30, 2023.

NEW ACCOUNTING PRONOUNCEMENTS

No new accounting pronouncements or changes in accounting pronouncements have been issued or adopted that are material to our consolidated financial statements since those included in our Annual Report on Form 10-K for the year ended December 31, 2022.

~~Carrying Values of Goodwill and Other Intangible Assets~~

~~First Quarter 2022 Goodwill Reallocation~~

4037

Table of Contents

reporting structure, each segment includes all revenue and costs associated with engagements delivered in the respective segments' industries. The new Healthcare and Education segments include some revenue and costs historically reported in the Business Advisory segment and the Healthcare segment includes some revenue and costs historically reported in the Education segment.

~~NEW ACCOUNTING PRONOUNCEMENTS~~

~~See Note 3 “New Accounting Pronouncements” within the notes to the consolidated financial statements for information on new accounting pronouncements.~~


ITEM 3.			QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

We are exposed to market risks primarily from changes in interest rates and foreign currency exchange rates and changes in the market value of our investments. We use certain derivative instruments to hedge a portion of the interest rate and foreign currency exchange rate risks.

Interest Rate Risk

We have exposure to changes in interest rates associated with borrowings under our bank credit facility, which ~~has~~have variable interest rates tied to ~~LIBOR~~Term SOFR or an alternate base rate, at our option. At ~~September~~June 30, ~~2022,~~2023, we had borrowings outstanding under the credit facility totaling ~~$341.0~~$395.0 million that carried a weighted average interest rate of ~~3.6%~~4.6%, including the impact of the interest rate swaps described below. A hypothetical 100 basis point change in the interest rate would have a ~~$1.4~~$1.5 million effect on our pretax income on an annualized basis, including the effect of the interest rate swaps. At December 31, ~~2021,~~2022, we had borrowings outstanding under the credit facility totaling ~~$230.0~~$290.0 million that carried a weighted average interest rate of ~~2.7%~~3.8% including the impact of the interest rate swaps described below. A hypothetical 100 basis point change in the interest rate would have had a ~~$0.3~~$0.9 million effect on our pretax income on an annualized basis, including the effect of the interest rate swaps.

We enter into forward interest rate swap agreements to hedge against the interest rate risks of our variable-rate borrowings. Under the terms of the interest rate swap agreement, we receive from the counterparty interest on the notional amount based on one month ~~LIBOR~~Term SOFR and we pay to the counterparty a stated, fixed rate. As of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, the aggregate notional amount of our forward interest rate swap agreements was $250.0 million and $200.0 ~~million.~~million, respectively. The outstanding interest rate swap agreements as of ~~September~~June 30, ~~2022~~2023 are scheduled to mature on a staggered basis through ~~August 31, 2027.~~

In 2017, the Financial Conduct Authority (FCA) in the U.K. announced that it would phase out LIBOR as a benchmark rate by the end of 2021. In March 2021, the ICE Benchmark Administration Limited, the administrator of LIBOR, extended the transition dates of certain LIBOR tenors (including all U.S. Dollar LIBOR tenors other than one-week and two-month U.S. Dollar LIBOR tenors) to June 30, 2023, after which LIBOR reference rates will cease to be provided. Our Amended Credit Agreement and interest rate swap agreements provide for any transitions away from LIBOR to a successor rate to be based on prevailing or equivalent standards.February 29, 2028.

Foreign Currency Risk

We have exposure to changes in foreign currency exchange rates between the U.S. Dollar (USD) and the Indian Rupee (INR) related to our operations in India. We hedge a portion of our cash flow exposure related to our INR-denominated intercompany expenses by entering into non-deliverable foreign exchange forward contracts. ~~These~~As of June 30, 2023 and December 31, 2022, the aggregate notional amounts of these contracts were INR 625.1 million, or $7.6 million, and INR 657.9 million, or $8.0 million, respectively, based on the exchange rates in effect as of each period end. The outstanding foreign exchange forward contracts ~~have an aggregate notional amount of INR 405.1 million, or $5.0 million based on the exchange rate in effect~~ as of ~~September~~June 30, ~~2022, and~~2023 are scheduled to mature monthly through ~~July 2023.~~April 30, 2024.

We use a sensitivity analysis to determine the effects that market foreign currency exchange rate fluctuations may have on the fair value of our foreign currency exchange rate hedge portfolio. The sensitivity of the hedge portfolio is computed based on the market value of future cash flows as affected by changes in exchange rates. This sensitivity analysis represents the hypothetical changes in value of the hedge position and does not

~~Table of Contents~~

reflect the offsetting gain or loss on the underlying exposure. A hypothetical 100 basis point change in the foreign currency exchange rate between the USD and INR would have an immaterial impact on the fair value of our hedge instruments as of ~~September~~June 30, 2023 and December 31, 2022.

Market Risk

We have a 1.69% convertible debt investment in Shorelight Holdings, LLC, a privately-held company, which we account for as an available-for-sale debt security. As such, the investment is carried at fair value with unrealized holding gains and losses excluded from earnings and reported in other comprehensive income. As of ~~September~~June 30, ~~2022,~~2023, the fair value of the investment was ~~$62.2~~$63.6 million, with a total cost basis of $40.9 million. At December 31, ~~2021,~~2022, the fair value of the investment was ~~$65.9~~$57.6 million, with a total cost basis of $40.9 million.

We have a preferred stock investment in Medically Home Group, Inc. ("Medically Home"), a privately-held company, which we account for as an equity security without a readily determinable fair value using the measurement alternative. As such, the investment is carried at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment. Any unrealized holding gains and losses resulting from observable price changes are recorded in our consolidated statement of operations. As of ~~September~~June 30, 2023 and December 31, 2022, the carrying value of the investment was $33.6 ~~million, with a total cost basis of $5.0 million. As of December 31, 2021, the carrying value of the investment was $6.7~~ million with a total cost basis of $5.0 million. During the first quarter of 2022, we recognized an unrealized gain of $27.0 million on our preferred stock investment resulting from an observable price change of preferred stock with similar rights and preferences to our preferred stock investment issued by Medically Home. Following our purchase, we have not identified any impairment of our investment.

We do not use derivative instruments for trading or other speculative purposes. From time to time, we invest excess cash in short-term marketable securities. These investments principally consist of overnight sweep accounts. Due to the short maturity of these investments, we have concluded that we do not have material market risk exposure. Refer to Note 98 “Derivative Instruments and Hedging Activity” within the notes to our consolidated financial statements for additional information on our derivative instruments.

Table of Contents


ITEM 4.			CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of ~~September~~June 30, ~~2022.~~2023. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of ~~September~~June 30, ~~2022,~~2023, our disclosure controls and procedures were effective in recording, processing, summarizing and reporting, on a timely basis, information required to be disclosed by us in the reports we file or submit under the Exchange Act, and such information is accumulated and communicated to management as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the three months ended ~~September~~June 30, ~~2022~~2023 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II—OTHER INFORMATION


ITEM 1.			LEGAL PROCEEDINGS.

~~The information required by this item is incorporated by reference from Note 13 “Commitments, Contingencies and Guarantees” included in Part I, Item 1 of this Form 10-Q.~~

From time to time, we are involved in legal proceedings and litigation arising in the ordinary course of business. As of the date of this Quarterly Report on Form 10-Q, we are not a party to any litigation or legal proceeding or subject to any claim that, in the current opinion of management, could reasonably be expected to have a material adverse effect on our financial position or results of operations. However, due to the risks and uncertainties inherent in legal proceedings, actual results could differ from current expected results.


ITEM 1A.			RISK FACTORS.

See Part 1, Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, ~~2021,~~2022, which was filed with the Securities and Exchange Commission on February ~~24, 2022,~~28, 2023, for a complete description of the material risks we face.

~~Table of Contents~~


ITEM 2.			UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

Our Stock Ownership Participation Program ~~2012 Omnibus Incentive Plan,~~ and ~~2004 Omnibus Stock Plan, which was replaced by the~~ 2012 Omnibus Incentive Plan permit the netting of common stock upon vesting of restricted stock awards to satisfy individual tax withholding requirements. During the quarter ended ~~September~~June 30, ~~2022,~~2023, we reacquired ~~8,020~~2,518 shares of common stock with a weighted average fair market value of ~~$65.96~~$80.24 as a result of such tax withholdings.

In November 2020, our board of directors authorized a share repurchase program permitting us to repurchase up to $50 million of our common stock through December 31, 2021. ~~Through~~Subsequent to the ~~third quarter of 2022,~~initial authorization, our board of directors authorized extensions of the share repurchase program through December 31, 2023 and increased the authorized amount ~~to $200 million. In the fourth quarter of 2022, our board of directors increased the authorized amount under the share repurchase program from $200 million~~ to $300 million. The amount and timing of repurchases under the share repurchase program were and will continue to be determined by management and depend on a variety of factors, including the trading price of our common stock, capacity under our credit facility, general market and business conditions, and applicable legal requirements. As of June 30, 2023, $49.6 million remained available for share repurchases under our share repurchase program.

The following table provides information with respect to purchases we made of our common stock during the quarter ended ~~September~~June 30, ~~2022.~~2023.

Period
Total Number of Shares Purchased (1)
Average Price
Paid per Share Total Number of
Shares Purchased
as Part of Publicly
Announced Plans
or Programs
Dollar Value of Shares
that may yet be
Purchased under the
Plans or Programs (2)
July 1, 2022 - July 31, 2022 45,531 $ 62.59 41,966 $ 75,298,682
August 1, 2022 - August 31, 2022 257,805 $ 67.78 253,350 $ 58,114,892
September 1, 2022 - September 30, 2022 390,325 $ 66.06 390,325 $ 32,316,573
Total 693,661 $ 66.48 685,641


Period	Total Number of Shares Purchased (1)	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Dollar Value of Shares that may yet be Purchased under the Plans or Programs (2)
April 1, 2023 - April 30, 2023	2,518	$	80.24	—	$	64,836,694
May 1, 2023 - May 31, 2023	193,648	$	78.64	193,648	$	49,602,177
June 1, 2023 - June 30, 2023	—	N/A		—	$	49,602,177
Total	196,166	$	78.66	193,648

(1)The number of shares repurchased included ~~3,565~~2,518 shares in ~~July 2022 and 4,455 shares in August 2022~~April 2023 to satisfy employee tax withholding requirements. These shares do not reduce the repurchase authority under the share repurchase program.

(2)As of the end of the period.

Table of Contents


ITEM 3.			DEFAULTS UPON SENIOR SECURITIES.

None.


ITEM 4.			MINE SAFETY DISCLOSURES.

Not applicable.


ITEM 5.			OTHER INFORMATION.

~~None.~~Securities Trading Plans of Directors and Executive Officers

The following table describes contracts, instructions or written plans for the sale or purchase of our securities adopted by our executive officers and/or directors during the second quarter of 2023, each of which is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), referred to as Rule 10b5-1 trading plans.

Name and Title

Action

Date of Rule 10b5-1 Trading Plan Action

Scheduled Expiration Date of Rule 10b5-1 Trading Plan

Aggregate Number of Shares to be Sold

Ekta Singh-Bushell - Director

Adoption

5/8/2023

4/30/2025

1,164

Debra L. Zumwalt - Director

Adoption

5/9/2023

4/30/2024

1,036

James H. Roth - Vice Chairman, Client Relations

Adoption

5/18/2023

4/2/2024

42,548

During the second quarter of 2023, none of our executive officers or directors terminated a Rule 10b5-1 trading plan or adopted or terminated a non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K).

4340

Table of Contents


ITEM 6.			EXHIBITS.

(a) The following exhibits are filed as part of this Quarterly Report on Form 10-Q.

Incorporated by Reference

Exhibit
Number

Exhibit Description

Filed
herewith

Furnished
herewith

Form

Period
Ending

Exhibit

Filing
Date

3.1

Amendment to Huron Consulting Group Inc.'s Third Amended and Restated Certificate of Incorporation, effective May 15, 2023.

DEF 14A

Appendix A

4/5/2023

3.2

Amended and Restated Bylaws of Huron Consulting Group Inc. (as amended on May 15, 2023).

8-K

3.2

5/19/2023

10.1*

Amendment to the Huron Consulting Group Inc. Amended and Restated 2012 Omnibus Incentive Plan, effective May 15, 2023

DEF 14A

Appendix B

4/5/2023

31.1

Certification of the Chief Executive Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2

Certification of the Chief Financial Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1

Certification of the Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2

Certification of the Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS

Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101.SCH

Inline XBRL Taxonomy Extension Schema Document

101.CAL

Inline XBRL Taxonomy Extension Calculation Link base Document

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document

104

Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

~~Incorporated by Reference~~

Exhibit
Number

~~Exhibit Description~~

Filed
herewith

Furnished
herewith

~~Form~~

Period
Ending

~~Exhibit~~

Filing
Date

~~31.1~~

~~Certification of~~Indicates the ~~Chief Executive Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.~~exhibit is a management contract or compensatory plan or arrangement.

~~31.2~~

~~Certification of the Chief Financial Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.~~

~~32.1~~

~~Certification of the Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.~~

~~32.2~~

~~Certification of the Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.~~

~~101.INS~~

~~Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.~~

~~101.SCH~~

~~Inline XBRL Taxonomy Extension Schema Document~~

~~101.CAL~~

~~Inline XBRL Taxonomy Extension Calculation Linkbase Document~~

~~101.LAB~~

~~Inline XBRL Taxonomy Extension Label Linkbase Document~~

~~101.PRE~~

~~Inline XBRL Taxonomy Extension Presentation Linkbase Document~~

~~101.DEF~~

~~Inline XBRL Taxonomy Extension Definition Linkbase Document~~

~~104~~

~~Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)~~

4441

Table of Contents

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Huron Consulting Group Inc.

(Registrant)

Date:

~~November 1, 2022~~July 27, 2023

/S~~/ JOHN~~ s/ JOHN D. KKELLY~~ELLY~~

John D. Kelly

Executive Vice President,
Chief Financial Officer and Treasurer

4542


		Page
Part I – Financial Information

Item 1.	Consolidated Financial Statements (Unaudited)
	Consolidated Balance Sheets	1
	Consolidated Statements of Operations and Other Comprehensive Income	2
	Consolidated Statements of Stockholders’ Equity	3
	Consolidated Statements of Cash Flows	4
	Notes to Consolidated Financial Statements	5

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	2220

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	4138

Item 4.	Controls and Procedures	4239

Part II – Other Information

Item 1.	Legal Proceedings	4239

Item 1A.	Risk Factors	4239

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	4339

Item 3.	Defaults Upon Senior Securities	4340

Item 4.	Mine Safety Disclosures	4340

Item 5.	Other Information	4340

Item 6.	Exhibits	4441

Signature		4542


	Healthcare		Education		Commercial(1)		Total
Balance as of December 31, 2021:
Goodwill	$	642,951	$	121,570	$	312,250	$	1,076,771
Accumulated impairment losses	(208,081)		—		(247,811)		(455,892)
Goodwill, net as of December 31, 2021	434,870		121,570		64,439		620,879
Goodwill reallocation(1)	18,057		(1,417)		(16,640)		—
Goodwill recorded in connection with business acquisitions(2)(3)	162		2,082		718		2,962

Goodwill, net as of September 30, 2022	$	453,089	$	122,235	$	48,517	$	623,841


	Employee Costs		Office Space Reduction		Other		Total
Balance as of December 31, 2021	$	573	$	—	$	567	$	1,140
Additions	1,711		—		1,085		2,796
Payments	(1,432)		—		(1,025)		(2,457)
Adjustments	—		87		40		127
Balance as of September 30, 2022	$	852	$	87	$	667	$	1,606


	Three Months Ended September 30, 2022						Three Months Ended September 30, 2021
	Before Taxes		Tax (Expense) Benefit		Net of Taxes		Before Taxes		Tax (Expense) Benefit		Net of Taxes
Foreign currency translation adjustments	$	(1,034)	$	—	$	(1,034)	$	(246)	$	—	$	(246)
Unrealized gain (loss) on investment	$	(1,128)	$	298	$	(830)	$	1,577	$	(419)	$	1,158
Interest rate swaps:
Change in fair value	$	5,302	$	(1,402)	$	3,900	$	(192)	$	47	$	(145)
Reclassification adjustments into earnings	(89)		24		(65)		613		(159)		454
Net unrealized gain (loss) on interest rate swaps	$	5,213	$	(1,378)	$	3,835	$	421	$	(112)	$	309
Foreign exchange forward contracts:
Change in fair value	$	(98)	$	26	$	(72)	$	—	$	—	$	—
Reclassification adjustments into earnings	(1)		—		(1)		—		—		—
Net unrealized gain (loss) on foreign exchange forward contracts	$	(99)	$	26	$	(73)	$	—	$	—	$	—
Other comprehensive income (loss)	$	2,952	$	(1,054)	$	1,898	$	1,752	$	(531)	$	1,221


	Nine Months Ended September 30, 2022						Nine Months Ended September 30, 2021
	Before Taxes		Tax (Expense) Benefit		Net of Taxes		Before Taxes		Tax (Expense) Benefit		Net of Taxes
Foreign currency translation adjustments	$	(1,733)	$	—	$	(1,733)	$	236	$	—	$	236
Unrealized gain (loss) on investment	$	(3,694)	$	976	$	(2,718)	$	(2,815)	$	747	$	(2,068)
Interest rate swaps:
Change in fair value	$	11,994	$	(3,172)	$	8,822	$	692	$	(212)	$	480
Reclassification adjustments into earnings	420		(111)		309		1,994		(518)		1,476
Net unrealized gain (loss) on interest rate swaps	$	12,414	$	(3,283)	$	9,131	$	2,686	$	(730)	$	1,956
Foreign exchange forward contracts:
Change in fair value	$	(98)	$	26	$	(72)	$	—	$	—	$	—
Reclassification adjustments into earnings	(1)		—		(1)		—		—		—
Net unrealized gain (loss) on foreign exchange forward contracts	$	(99)	$	26	$	(73)	$	—	$	—	$	—
Other comprehensive income (loss)	$	6,888	$	(2,281)	$	4,607	$	107	$	17	$	124